%PDF-1.6 % 72 0 obj <> endobj 93 0 obj <>/Filter/FlateDecode/ID[<9AFDE652F89FFA44BC72CE157973B37D>]/Index[72 31]/Info 71 0 R/Length 93/Prev 207554/Root 73 0 R/Size 103/Type/XRef/W[1 2 1]>>stream hbbd``b`:$CA  $D >$]D`^ 2*&XAH3012\ 063 endstream endobj startxref 0 %%EOF 102 0 obj <>stream hb``f``rg`a`Hb`@FV8G޾ X00x@H HQA-n e(!pGMG@0jss T endstream endobj 73 0 obj <> endobj 74 0 obj <>/ProcSet[/PDF/Text/ImageB/ImageC]/XObject<>>>/Rotate 0/Type/Page>> endobj 75 0 obj <>stream hެ 0Ee~٦`Aѕi$&JS7(A 0 `T,CJ`(Ej:".H=L&[߇+X]yfH}_L)IZ&aCy;gTA㒾6 endstream endobj 76 0 obj <>stream HWKoFW((dYX"H;^Jt#lڜۂ`jPq_H+1,"mVB˛-Avϋo N`Sd0uj\#f4SL5I:JB`倭@$,1L!Gƽ(ݰϓ~EԖWH㐈 P4<B;?4b\U5VLGP39`)Cl'gT*Y2){A_rL49R Z&h]5P1Lptl_@5w/ȃEqrC>tJH..>>ЫoɈv)@,.þ  VxS#ȘW8_}ћ7׻޾p&g_xt(:X `4.+Y)5050\Dn9N) )BשG4`Mgvnh "UQ G! HX3>$ Q$֫zLQbwtbU:U?ܵ#?2wI vtۮva3"Ju}ֽ\2hI1s7)c6pY]LLsuێ:{D`}n~b$ш֞j~J@uX n|(n.)*XtMo `fBgZ(:qn=-F.aj5ڶ4nDaeR pgX &qB*y(3,C5ΐ @ SykL.4d裡u>%mV!9vi_ Op v8^S~FUC=>p $wPן7bpU4&0OPROK-yR]agh*~3$4`L ':yAS@ 9;qYOy8U 3QC)%~I%ɽ{ ;7jD5j p*5ϧ`Mo֙uQp$Y>UW&>)&IX7?4N͗ͯgNr-W J8N,lى'L0QVIQAO؄Ѯ.yy.U0mX\'.EZIτZN$Y= 7Vm|>"#՟ͧ́lMYl]?cLMJE8s+ R!3` endstream endobj 77 0 obj <>stream HWKo8W P3|(PX(kaK,7~C(iz p#y:HQfqsnW,|wΧcz '>}0#Un|`p>.~7Z|^ LVol0 -5XcT,FN7Um8hsp0Hd;M)<̞ǔsq +)Ҝ'ZՒi:(qBrLJup+1$e|_o?+d͍|>m 0#J<&t I~誦>㛪>F`pW$BtRi_ [Ik-$G`5,lWmw 4Znވ$pP>Qb~aI.JJaǢj@.`$YllߘmZ!B )Ats1$Q #:Dnx] ISJZq-Qzѕ5zf "=WnWzrnTp5UcB q L_৹8J hEyW`,! rƑ5hy.o%,  .c&*F(\Q2vE1&}'N!S̠7fusn5–#-ծ:ߖ1Sw޼\K⡓ qrLa $G͹Y"dخ& DfKU:/񠜗]gjaiҝXSSfpb+E8(QY&`JK?$63zr\9ﱊC'XVC8b؏[x*nu;՞>UCoY0r#<7/_0H⩂ty 8e 8^1zXqv݄X9(86OLD"=DX pLH=D 0%_OD>O@[X1 rUM ˂L 5y/~Wԫ 9<:GU 虂* ̿aP}aKᅫ̨5:73ʉv@m_dC@7utB |mw>?q~Zc8˅ .e[>A)'7QmYLx1Y3XsghƘe 0UQ endstream endobj 78 0 obj <>stream HWnH+x@N !S\"`@K-(:~ɖ@w#F #M0P$Y%(j?h^P${sZaxCp{ׇSʙ FH*M8\nQх$\eaK3>Tw7BL!px6#}DO2yvhT%*Dnx CsKd%y7&~t7&==+識F!͐M t G۵"cY炨p~3X~,4GOF,beh*`t/x`9&Z_qc<#x+d$c9ݥd5M@4~E,0~~nĆ?Q tS,$h8S`0Z6>&R{5s}Ch'.:Pw;C>9+9ˤ s)MĞ>tŸ0< n7td7Cۮ?s[ ߓIOw>]R2-{6ݻ/`; Zeݭ9+<&s h@8R ]y݁BJj[2.F 5J+MGiۺH3 ֵfk#*Vk7ܓD_hNcCRhYdĩλMx7XDnly։s],\ʴ-X~#3 }cnJU+Ӄ\׹Sh ]pIG Tq>hαQl]( lPÏf8ԧz *㞧9ۅ(.gB/sTtYOXƩf3LAjSeCTLEQW| C 33Z1Pz{- z-(KA@A|R*K+2aǒCT>&J'YN0ۋ˙RL^U uN8Ĵ_EXkJbfjcT{xy?4qtF,L`g|p7t^ӸӌL;/D='btY`l"Ü^>,lt$v~a=8W 0’b endstream endobj 79 0 obj <>stream HWɎFWvm0 O0A(瀖ZH}WnCX]]իj(g#(/֛"MUh:[n:IB]UG#LwB$;4hԫUݜ%Z('rFQΎ!_nyw+FWXA\x뮿l혪H޶]ߖSHU{*n 8Y#*xid G۝vR.$!DV~ fPqbyfI&BwP1vhve{cPqVKlQтI,$2Tv,iLg6UmBd`ya$몿7vIAW#GU?*ei@}y6tE2 0ʜ8?P1aLz߹d˗܈pAn(ng87ƛp@F!u ] Cx".$5qh<ڪ:2`;۹c}&^GN(M&pB$\~.k"8DHU h7Q;3 A3$5&$nO{nYiG+ܦ9~n𦿊h{3 "B; }b(ptSWgKO#XEш>gl͛Ҵ͢y`'H68G\X=6/:$t~e̟)gJ2ă NqAuni25{3x)s,Lh]0ս!5M`2܉I|ð}$U]Uڳu[S= x.eeFδQ,t ۣȯ~ ؐ c endstream endobj 80 0 obj <>stream HWKkHWhB`H=ae٣f4HV?rTC| vME0L ъqZno_-o@-:)TP!T"Ml=Q2"vMkRΜ&j )e>>^i2f̊0Df2P b ar#%}ZH\z*[>U(Kħrm{ Yc-gʃvja[@刪 "?vjw#.~=.RvOyQzA!})ۜi$2EzuK@#{w47/x9b:6DiM k5%?=P_)q UX8#@ 6CwP.f)M? 2,}6xzNm3Wo|O U8ZtiJ=MCT0杭Mv )l 4wCD*c~"Hnj%Md`Lnrچgp U8g}4~xqiqژtodN5sh? ޱ@Ø3)5`mNu7:WI$jd O)9^#szJөC;#qzjMpHf hNe3Uk (x)Hy ~P3ta䖜u@3G"5km]Z6K;T+dY|,fJK`d°6[ܸ#~7eF0} nb(Ry*;x!NWzsa~wv-. h6M`qRn,Ӆ8zr;~Rn\L|+cV4AK9b4,A?fJfm%?CrU]wmܴ[jw^+(tǸӵK"]G$g”#rǶzJ.<98tñP^kSs<pK<PN!r!]o6<.sb+˩)6;CaMBnal(Fb;C߮_"0mRomd"cb[0 &]4* `vlz !Mrq秼1œ&E;`e_,:+őkC!"ꚦ۱LZJK4Lt{U:w\iL*V3D?ℹ`, [x}fh$vPJopSsqϸt3 |5GOs;c_{񅷙U}uM)uׯFÑY/=0Lz \!J>stream HWɎFW09u#qK䀤<ߧ8HWol{#ITGpC9G5RIܽӧϋ%F(> a8ΌZNNaBKwob-T΂!bLxl? exg;XL0އaNi^4ݷ`W!EtnEX!kR"v;F ^~h~l bDF4 2bTb?*1{폫{ 2a.by_G0ݹ-88őƑ+@"(RDK$w_)]o&.tYWXniZ.Ns<N];}M.aS50@ȱ{D"1+t>vkS hx奵8e!TT&oǜ<:~BngT"L)ԻJWla.@Ҕ@ f qiW԰JAKg\lvnh2@؍p@UeDRƕZR&fjw2; %G ҫyb_a$q}ݤ*Crf:I*/O g*Bt25m/W"倻B-D.J C\VʐmڰvY'n(UeAbIM8uŸ} !(R]A1!/ r[+;wf4P$I 3QYTw7 bc)5T;~KL}9UIIi hqv <. /ZNKA"Y Lw'~0F[VC&vUʧ<3H#5..5K{EǤ`Ǚc0'yc:ashjkAvzqL2nUWoktj?(2[i PS-X=4Al^rg"1Dk'Je[xA4r{t#fѺp7kI8r}|mÖ(93"V81/0JۍNU`xIJOB^PV16֚I4S%~Te)IHT$Wo42|& $6 0* endstream endobj 82 0 obj <>stream H|Wn8+tt*@`0s0l&R/?EqEsrêb{U5'0ňsYD0+vj4CVi) <~ic>b$$1.Tbw`OvXpDYjl{ٓ1P8VzRΜ{iqAEQx)ЩWk^V0F{6`NC^(*JD\eƺrqR0.2v uwy1&}FXRɓз6/'^*o=_Tl$[%Xhбހo:4aP3Lac@Bmwews4\ hO_N?yZ?pB;$Z#׮[0}|8c(K K2l9'mkLqUv9j^ԦheP6﻾z0|)1e^Ӵ7 V ?6MGCBùմOaP"N@ jzޔU륊!ehNM0iQ"@a:7 51,8!&&a|K "_*g,@X{uM;vWDNBxJjgլ9^ 8A%Y*<{'ۇsYs9cBi[euv`/F}Znu7rG, ĮY[X[ EMQ y.;y`O~HTx]T% &G*npo L%X+AXjoah#fJ< >Nxdv寊3cgn؟6t+}7hg Z.@>[dbrJ$N?P5 LwY*R:o " `L pvM;M2,q-Y *m endstream endobj 83 0 obj <>stream HWYoF~pNURM,6 );rOQO>4;3#T"T+KdqKXX cS+^@%x1aR9n4=HĜ3Y]w`!D\.C|?p.-QJICw׿GSś7olo߽).^߸z;e]SJ ,[bXqy  ,*?orn.u~fܙTxP6O("\Ñ(vC8bj-qћt1↨ۦkx/.0jMw_uU {栠qj[䐚{]Ph%lsu꼺/voMvBCWMi̎\ +IR5?qRS1[jC R r%HlT~z,nS(HВL9yL !GsW1P0r #/W鉘. hͣyt?5cF>(OI#Ǫn8*أkxc`Ezr0zh̟iw؀Oe4.ִmnYO#XQIaCԓ>LplD%l`"U'wrI@gLF҃`!'Jc8Eo1JV=z_K/2*س,XDbl.?a endstream endobj 84 0 obj <>/Filter/JBIG2Decode/Height 1752/ImageMask true/Length 23087/Name/X/Subtype/Image/Type/XObject/Width 1240>>stream 5r = = XxH>~H'mIT1?K_z86ƒ"6ÈZמ|.O? t+rxiQn+a(K+rO]^u`әO3m=ɡ9h)c"E1vVZ̃=Fl׃nMa?&&qA^qw}QZFc+ý>MZ{uR')kz/*yp3dFS6R:dO0@bȜ1i-by7h=.E?{2CQ)TO(-գ_*V&`r/1q5W u.I-"A)#h-"I9`UݱS?48n7a"o +kXl?2fh/zD%mvu5F{Zw8X f(QW,f,°5<'y}@Xfm]&yX6|+9UV j!@o,ˁf\CpEvdEԍ}IeX:Q}~du!j`1C008_1`. SB%^U.<SՙZ:޻B꿀{񅊢,aJa2tP>mJ1- {''&S&GY?8"8qc02^yHE{HAɣo=;xhI;@W"vϵ8P5XQE\ot1 %bl[3tٖ9)ҏ$t-&e;?]Km௺JiC *~E TM0zZ{+%cj,=PԡaTi$x|><,?'C,/6`#TBfcUum#L AT<¯sB#LvީTY'I ŦMf2@rdE[g=В 5coՑ{BC[ \Mn&qcuJ(xzE2jEU*yxտ ep]GE|B3DЌހ.4H2,ݿ(8gDWa y`QUx5MJ##*p(Ru&欃dvk_˷ _Ct@si@¬Ģ e<_g_bqid:ΝL!yW-x:uUa7ZۋZR|ڇWJ=Vn`h݂m,|bME _ muoh}lyu%DlâWmᕋD9z'@ZEGe}98!mQ(z83ir(rzgBwzg8#z7=A&˽⩵o0J'@dGEKtTW+`I"$iM{ ^a-/H54žF j9[>8_~1=O^)A4XuMNio]koO5 : 5 33NN}$N<}rJ&$DVWF_q?W!k{^m?ضP ဩ߮2.$P?Q4s"B5㢼c tj_X \JK8'm_nṪt?*iWVzwuX|RM1+fFxʃS0gS,%uiD̘ړo#j[jqN Ԟr։RC㑷,HVV'Z,EBwP\y~)6?þY 'q͊+/HD^<.' ڜ^龍XC7ge{.ُ9f[Q0m"/4 3pL{Htd&*ՁQZ8gihS*rfB4U.-vMR&t=kHPb4Y{,$$?ymlOdC ɔsLg饂,Ën(^61>0b fI;R [F{޷!2;Er>O7-u/WVǶҩv%Jº8>F~a@ MDY=U޲ '7ؔ{~mLNG̮z{$Ťw|3Wwn2.z/ZECCdב pѾo rb\-j:O~Hb%OPendKd(4?{M@˽b\$P+|A;PV F]$a/x&9 դ%4˦};om +0Ue:za*rv.߱`jA>8T!"D˧xc4+6d_ހ_Bۋ>]aP DUƸlDG|7mjsy5/idntoac!~b$C)OKF JL6ϑsQG?w=鑎yV͂,3D3>ηJD>+F7;թOz>Sff /M>]Ȍw] &\2Hk];Tv#qɸ*9"\͈Iq<22َVj4 jxd+!Mݎem%G )KISbyg0U2Z=OC'nvuf=6^, ^ꃽIn6 __ {7kNZ *QIe]o:GمCKnbOK9 `@ ^ʺ|򟳲ܕ*nSGe./K8 v{2S@8P=;Z1IZJ=r9q5HVA"l %җ#oŰDp3Ak+Z8ȑ Xu3/D+=88*" 'OꁰCBdLχybXN[u)$JZ[1."*Em"c'f{u}ywf3Q(q$) >5}M,qԦb Ô|;L;6}Y`}Z[8 ݳ~;:F\Rvp?M7۶UpAVZU;u%[rۇ_L@]H2W'~'f)8^8z#̡ŭ}/J1tjqߦ>2~T: )ub|g>B&ӶeXCy3>. n??2>wM']}ZWk/BVj\c\v|Ug& B̩JxE k,GTз ofv-WԑVH%3!(Ig9Ӑ]q%|UC?[jsԶ<h[DepQIԻj?MQr2;zg‰5l#f5*@ؘf>Hi7{!HY,06a6SMj5 dK$r9:7q&wvV{3B qg#W`5q'Mfۇ mvZ8zK ,7RMƼf:"99aI08`u4$IJhډ#]GYQĠ Z *tԂ #zN][$MF1Up`"^2] U|5r 0e@V]8U& L3o;(]P3YCAmWHmP5 #1DN0Fv9%AmTJ%bq~i?Nhj_rܦAc3,9'V3= UiCxdhv߈sc,n2,0 rL=̻ L~qOzo?SOA꼯HӅbR>|^ARZ dn8^.\ C#Tq^JK|GL~|WWk'JZwªÜ-.O؍ WpP)#;K\zyXyHXwrSغ IQj>mV a:+qQʛ_5pgQ B .iM+ F@H?s'ߊ}3y%eizB*z=ϭnfO/@B+Ptue0ruL2LO`Ӻh7<1UL(E$O#Lz 6cT/ WiAh{Rms>tV_ ȠN{i'NR4s#@ < cDn[hC(n+'DM"P|։D e%"'M-#fJZ#OȻq4fȦD7Yrg/rduZE xx._(i@~Se`EjnZ&W0Rses$2(>&pe&X@a,Y\M|9jl&\ oí?.XP pij6$ɜF! ]h !k>׆ܩ}eS|Mܶ'/`0m ypcg2|?KY{K*tRaa PUd`|G\7j_&sk^bD"'+הDpſӵu; ]_Vͺ/Cꃶ/,xVﰀ1mGL- g_(:g'n/y49-V4K0My#G8@S)7G?+D!Ƃ;/7ܷIsEvVkOw҆KeŊehl5lP6k}X};u@HIu1KLWjA`v}Ͼ\Gl~{c|o5qǾﵕI85vu?'ݴԺA,k9/f=@:40Vi.W+ԧ>H15`f]Xc䋀kPˆןӴٓ%]܂*,~@e-|r>a}^ a%$,Z',Ecz 1աTPx*Ԕ\]&Λ]#xo1aϷ?+#scsdSΟCГ&zuvW~Ƣc2HNPzd 7ШFY`fGw&c⟲34TzZ&w#(h眄D#)p1]Qz'@ڼUEu#uae Vg[RX<20<% w%5Z?2llS<0$J cʞ VSW;T;%Uo`Zo%m}Y$BdĝG<RCM:G/I't r?>t97 Onv,,mpeЖb9ljFCUsqKҺ"E=KtD㠽t쵘v"o)| b,V3Iam%e1 kjHQyc@As[+1GFk>cZ7? gK<ܕs`?_JĤ!mkx!_ʭN s^N[j< I=}k(rG9 )#$R@ Y!o?R«xKwM{jO6_3'7jL0K2ip:%r͊Jb6XݎR]މM@L=[w]Ҧ. 1OPt=W1X$oQ̝9_:WX W2=~%*B0ٵ S&y=#lltܥoH!ufd8"Ϥ~EOe*ZKdpBvT|-kΘѽf欜AUW( 'w:VzQY',a}64( 4WSG>jHLb.蚡5p i](hl"{fr|n8?^N"]>|U+xOSɂBxlQ[pj Kv1-x.,1qV{̉:h@euAw9vǧaiCA^̹H$$E懜b2\*^{eaTsYfx :3` )Q7gjxc#Rk/.ê͘# UB8PFpꢖay>ԛٶ)JNw;rz| 6c GTC9\%Z7{[cϴeC4uݳebh7| ,0PN}|~Dבtf{0(03MZ%.o'v\p\8Pyʥ6"3IΚEN^&ê1lcjbpPL9Lϗ[AC''n ?Fˆڇ))H?Ē(YDݫ2&(څ=GڡܜBI7D?ܺyz%.nQ+%)Y#S7Nfp÷On:3 [jQڻI]Pg#FQޙ»>/[1{XHic%sG77qH\-cijh5GJ$?]&wκ$!ko>yC),bA~P &uF p ^DɈv0+BЦ)=O$`Oc>t_Np/}Mv=a iOԍnͰaDq~$b8iXkŗR*uDg#got[Q]U9efG$j<;JT cͭ6c\MKUQ-/mioY}ކ) vGԏ]V$g9K:k*qDOVvd9aL1_ _,zJbW73Kƴ?TdP=:K XW`h8Yʢ_7Wdb/YmVt`oܪwؔ$y Ɏ3  2N:q>`ErsN{Į7e mM'`ۄ)cK7kTy(0Q9~ 6zns- O?9?}KeQ8>ijNyE*hNw7GRm|mA%+-.qdFwi=ղ鸋6G ^y;3ϴG\C^ԝܚ%aonI+X[jNō.mtBX9y>7VcN -pj[Oc`[^0׉Y)_57:UıNE)uLG a@.H^z-0, v5Lfi}=ޘ[$is-Q1槪}q`'9O8A/!EwI?k|E4wS*"au|g@&S{伥MD 7{F6I ḰTZ܈o[3=ғ 9 Hr`}$)OOr#]U<*WlԎK4}w=6m- $KştZ}Qgw6ȫ LsMQ0 d`zTuC cwᤘ0]0%p)09cs!#k0o~yGb$C{-VÕ%ң7`/̑ꑻkX' 3Jj=}r+b[Z nr8{!G m83 .4m AmzV<|0 CP@,F-B\\|lS͘"9%U4~I{3Ճ?uDΝh7U*dxC))u{ݩ.%FkzjoRCX+թ;xI<{&PO4([_i9 q+hQ;,ˑ P ܍qoO^!d@EK"錰>>Qw$rOE8మİnA)s6XE>=MrAv)oX1nɋ]yRcjHݙH0zQ E2zsiBC)537pq`jLWbZM[=pӘ#^쁩6+jw |Q4M{`=!'#h+S۠R5-QTVMiNUѱ'%"gip̿pĞCHVԹU:QbɰgGf) ױ,ˁ~O -/'QpH: \L='9pEXA-j hm-󢸀 Zކ!s\KNGín)SeҬ\cʮoR`Lj5LcLͪN$8=oc.MȈ윯ۗjxK/*w&GcM!/]xFXX3Ծ0V,S6vfuaPvyOJʘRG2(eC،Ƽ/ħ84WαLu?kɚ*a#pne5X=ΠW(.۲d8!D#:,ܡ5P(h詨ҀM !3ނB(XϠ#;)69ɼ֜ϷBgxzrpSFtPr cs(Q^6Vrp;6'\X[34a~bnOy638-rYV'6M\h3:oye0 S I-K+mn omvs$l' +]nfgMs]GhKMK%YJ?K\k_;\ [|5:n x&jnI$dYf DL܉VGLʂwk6yx0} ;ĭ&¤ZB$yLDo ma:0#fzu9̐7AKV{eGuw J ;0|#zIAO`&&9P)s̱:]5n*h5 n:}2H Ӟgg_#RY_#dnPF S@ZZ[o:D]-EE 9s OvpⰩ.PB?Y(r!h3ƥÄ~/JosV-6@})`?a\u^?_*nf]C wwh'\ k>yD ŬgIKX: />} B(R,Z)B!yw&Ͷz'>_(;:-hk;~0IBBWGA U=FFˎ_NT,ƿ'y։񹝥BUOҐ*+k J=5[ W)rATHvgqOמʕO*3x&> i:w@2Y=mn-2:D Jolr~qÏ'oMl&s|_茉jnVߛ*K t#b{( 9|ـ x03)^ G8\l|J[^}jLyjښuG.U o| _Aa3XXR#B f%͘Ǔ ߯Ct_硞\ ў] 4$KO#=o%=xG~3l`SńgxV/ RF#Y?ޑH x5Vlg6hk’pKxِC6'r8Z_TˡNlDch7,9[QTu"E1 M[FHF@ \G$r0`(CeNMv< 8P6Ô2›RKnag'bv̢>mK9r|}-f VUB/>1:o:W2`Ͳ]y}?|oz{Hw|˄YJyO\7-qj"UM]'ǩHS}fi,D\3eɻmr v֏9s872yCX쵑ED(]\3"]c4hti>Ѹ4.tօbW6Qhœr?H&0@ $-/Hcp+bnOv6_CJd׳< U0jS=X9)KzAfLH;`ki>d8܀Q'9u2Gu>fO(o Jrpt8VD2 x:2P5 Π/:X Ie ,䧫˝Ѭ՝mrEGCd{`AwʻՋ׹_6Jv=ڣ-ps&/@gr)sL(]A k˂p*lSgkQ ZRf$X&'cKћF k~ǰ]k{CXЉ*Y yoYi}"Peo\*.{aVQ>#CBJZtz %% RHF?QS{%ڰ/HH5q+ކ1yGTHPlx>H \[*:#<{21dxo5[dB)/̅-0CK6o wM(hؤ@QZ Ws#B!L.7]jb3~Y(@Ē']p^b;IHίt oT S`0=l >mb1[,x!c3'bgERڥ&`AīŌ}J1ElB؍-m",DzT<Ӓ߆ɖ Y`0n8&ypsH5*Y\+`HpBz` [4ۤr=O|+UYzO;1x>]y7 Ȑb,%( "TВ1Wr =g<]hxlwѱ{"sx@V^X%Tex9Y\OyK:y[7 rf܂27|!9 )I_3x/{{9ZC@YHUa^b g}d{$`/| ?tu)ݭI*j=t}Ӥs޾33(("g8/̰.#\<\Q.H9jK|eP:kVޙ-h܀Mq\¥~@9#ܓcz~'ҴnbM7O<* E^b>6I7^H0kg3)XжJ9)җSֲt,wف{{xCx1RU)GPA<{sDj+赬e:doN_/;d(SI[ˢa*2˦丼Ƹ}xS'!kn#8cqP._D`Ζ[O]+`|: @L'M,yw֩NVXWBDwpeʛ}Ɏe`_qRoNXz[ :ѥ,%w_s%؞HczKռ f6Wm3遇4ed&8HˋQxega-B'gImdvؐ,hh,g* QhB66­of'ybV'4`qC<Z^}_0]H5 R$&iTbLc)'r,F*[_S'puFcr9 oP@8<^ K`t!c ? 1J`Ɂ"y 9ܖ%1>)ﱐm-7gm+F g HCmѕ`<eQF^ ms(,'Md?I-; Z c 6 !V4qA7KPh-`Zӛ(*a*7V^FZ6I=Q<DK9_aFԻ lvhip~ 4pN5t v!T<3)"{<^+A pUJ|eqC2y%vX5STװ'WN+x0oXA@J0[:; $1p z%:odLݰZ:ֹYY0M.7/jW $\m%M1RJ|j 'h5=HSOc+iWK|d gѮӁ7N,aN{:߇ c 7I ҃2Λc**]A~M}/Yex/Qb }8;P?XۿrRrg +fb( '!fiȁ?cdC0siKfݪ"-ql?ņF>13~؎{iFO6%_aF [X6,H$X6toQA 'itF$>,qGr{|]@?0ޑsRA7"F=Q')_sTI߉1<ذ͗undTu EVُvr0bNj}tZaBe匠-Qs9}&Joç)%$L9Kpp-Sc]{~ 㽒EڛصɓËzW!+ >k{o7 i>`xhI9Bvn>zCٝ'c> mV]AhŃ(WURKǙ+^a?-GWO{|X?`<&X:o⬫[fg=.P8lOƭk+ dSdV&ԅ !='u*VHxTT/25wy`~@hO;Jx"!}-RR}6f$Gܞmq1Y2OblŸxDg~ҎܴEL* 6[rv3o&^g(ck[i:n_L>}& .#]Rl,l3X:#&_DkeBa0;2LΑ&ezmk*i:æBhN;u@OLB.A[W,,wr}/`aיQv#1RIHey<\ d5/&\3ˤ8\|?H޻DS^%J(MAF'J'jZ L]n}B:17kbڦ}uɪ tmu >wF-=Cv|L@u*84F4W_: ϹA["f&'΅1s90_W(Oc0o߽_;PAsJIui'v!A y[ (@ qjm]צ耛Rk30Li.~}dMoi:>)<`hm i+4yz-+NaX.t7ؙ9' Ю9&YʾA"_Dhj )-i=Ƃ&|_jf-$Ůa"?ƚ~O#%@&&1=Pz@eÝ,;ip^ɽ1Xrv*0ar@FR;tЌC wn 'LcW+m (*=n{|Ț T*ZT(-5dhM5ʈAQ\E5'Q1M%ki_y9iIEMBuB\H G|b HMynB1&:i\;]JҰV2¿3i.rpWkoL!~x`.Sx3焼Wܗ9Ӝ^(4 Fg\:К"ArDX߭,.GrB4 E`cطe"J,8ٓpuf%^9zfi#3bmK^OGo-rZB.<7?`qE TP&m,37=%,[(jw80׶΃^9$~MpQCuD+^ k3I bh ø}r#( )U_6!JCxYʠ͸)8.x3QV䝠SΘC |KT{kj&D}RW̍TMq?r; (p1?bV#yV zd' Ϝȯ-9iq9Q@֙Ï^xaV3,cZqvBm)LJE~Jg 2Hi" 0Fe#o8IxFۃ$=r1`d$&(mpGe؟0d/{|`F/\Zww#78JFhQ[N AlH1l_ri1}) >" D֕.:b\9ҝ&Q C!0=`Kd[:Wh5{KEGK̴ݣ-k(* r" yo^ F.{|[HkuiN- YY"J-V~9іx8ȩ`|=Ra \hCNsof?)Hl p{k5{W.|0d3~_gR}BaHK"㋃?Oi#wm)^B+m3bB= FaJ/aL ›v^84gSiB[F)pwϞr++㽟Fs<|<_nhGFQ3M9A 4- k&) &ڍ0CDe9@ތau#l9@v {fj7A V,<>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr<:colrjp2cOQ/:<:<R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴPC z" 1@ :  }@ Bk 0 $F \ @B~    endstream endobj 86 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr*,colrmjp2cOQ/,*,*R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴPC " (|!@|!@>@ @     endstream endobj 87 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr&.colrcjp2cOQ/.&.&R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴf7CPz :  + |"T    endstream endobj 88 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr&colr}jp2cOQ/&&R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ t  : @ ' e:$ r6  h   endstream endobj 89 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrcolrjp2cOQ/R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴt @@ ,:: ~CҠ    endstream endobj 90 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr"colrxjp2cOQ/""R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ t    2|" : l*|"   endstream endobj 91 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr>colrsjp2cOQ/>>R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ  t ! : h |"^ H1W%.ڀ   endstream endobj 92 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr0colrsjp2cOQ/00R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ  t ! : ڀ :I:= +[͠ \+   endstream endobj 1 0 obj <>/ProcSet[/PDF/Text/ImageB/ImageC]/XObject<>>>/Rotate 0/Type/Page>> endobj 2 0 obj <>stream q 0.192 0.192 0.192 rg 595.1999969 0 0 840.9600067 0 0 cm /Im0 Do Q q 18.2400055 0 0 14.3999939 509.2799988 787.6799927 cm /Im1 Do Q q 12.4799957 0 0 20.1600037 568.8000031 781.9199982 cm /Im2 Do Q q 16.3200073 0 0 14.3999939 79.1999969 783.8399963 cm /Im3 Do Q q 11.0399933 0 0 25.9199982 0 743.5200043 cm /Im4 Do Q q 12.4799957 0 0 18.2400055 0.4799957 344.1600037 cm /Im5 Do Q q 11.0399933 0 0 18.2400055 0 113.7599945 cm /Im6 Do Q q 11.0399933 0 0 18.2400055 0 90.7200012 cm /Im7 Do Q q 11.0399933 0 0 33.6000061 0 44.6399994 cm /Im8 Do Q q 18.2400055 0 0 11.0399933 2.3999939 0 cm /Im9 Do Q BT /Suspect <>BDC 0.227 g /T1_0 1 Tf 0.05 Tc 3 Tr 9.6927 0 0 9.5 56.12 759.61 Tm (404 )Tj EMC ET BT /T1_0 1 Tf 9.87 0 0 7.9001 269.22 759.61 Tm (J. )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.024 Tc 9.8 0 0 9.8 280.76 759.61 Tm (BRITTON )Tj EMC ET BT /T1_0 1 Tf -0.0262 Tc 9.8 0 0 9.8 56.5556 735.6098 Tm (in )Tj 0.294 g 0.05 Tc 1.027 0 Td (each )Tj 0.027 Tc 2.255 0 Td (individual. )Tj ET BT /Suspect <>BDC 0.227 g /T1_0 1 Tf -0.0293 Tc 10.3 0 0 10.3 136.78 735.61 Tm (All )Tj EMC ET BT /T1_0 1 Tf 0.0476 Tc 9.8 0 0 9.8 152.18 735.61 Tm (pulmonary )Tj 0.294 g 0.0375 Tc 4.992 0 Td (measurements )Tj 0.227 g 0.0239 Tc 6.417 0 Td (were )Tj 0.294 g 0.0243 Tc -21.217 -1.078 Td (expressed )Tj 0.227 g 0.0117 Tc 4.555 0 Td (as )Tj 0 Tc 1.273 0 Td (a )Tj 0.032 Tc 0.894 0 Td (percentage )Tj 0.294 g 0.05 Tc 11.1292 0 0 9.8 171.25 725.05 Tm (of )Tj 0.227 g 0.0325 Tc 9.8 0 0 9.8 183.86 725.05 Tm (predicted )Tj 0.0239 Tc 4.404 0 Td (value )Tj 0.0196 Tc 2.685 0 Td (for )Tj 0.294 g 0.0472 Tc 1.617 0 Td (age )Tj 0.05 Tc 10.3398 0 0 9.8 56.05 714 Tm (and )Tj 0.227 g 0.0304 Tc 9.8 0 0 9.8 76.79 714 Tm (height )Tj -0.035 Tc 9.4074 0 0 9.6 106.81 714 Tm ([8]. )Tj 0.045 Tc 9.8 0 0 9.8 124.14 714 Tm (Students )Tj 0.0323 Tc 4.18 0 Td (t-test )Tj 0.0334 Tc 2.597 0 Td (was )Tj 0.0263 Tc 2.058 0 Td (used )Tj 0.05 Tc 9.8951 0 0 9.8 234.22 714 Tm (to )Tj 9.9384 0 0 9.8 246.62 714 Tm (compare )Tj 9.8624 0 0 9.8 56.18 703.44 Tm (pulmonary )Tj 0.0393 Tc 9.8 0 0 9.8 107.41 703.44 Tm (function )Tj 0.0375 Tc 4.123 0 Td (measurements )Tj 0.0184 Tc 6.664 0 Td (between )Tj 0.0459 Tc 3.909 0 Td (groups, )Tj 0.05 Tc 10.0265 0 0 9.8 56.06 692.41 Tm (and )Tj 0.0285 Tc 9.8 0 0 9.8 75.76 692.41 Tm (least-squares )Tj 0.0226 Tc 5.934 0 Td (regression )Tj 0.05 Tc 9.8951 0 0 9.8 179.98 692.41 Tm (to )Tj 0.0354 Tc 9.8 0 0 9.8 191.9 692.41 Tm (examine )Tj 0.0279 Tc 3.976 0 Td (the )Tj 0.0302 Tc 1.715 0 Td (relation\255)Tj 0.294 g 0 Tc -19.556 -1.128 Td (s)Tj 0.157 g 0.0492 Tc 0.405 0 Td (hip )Tj 0.227 g 0.0265 Tc 2.157 0 Td (between )Tj 0.0476 Tc 4.311 0 Td (pulmonary )Tj 0.0323 Tc 5.521 0 Td (function )Tj 0.0381 Tc 4.368 0 Td (measurements, )Tj 0.05 Tc 9.9374 0 0 9.8 56.07 670.8 Tm (duration )Tj 11.1292 0 0 9.8 95.89 670.8 Tm (of )Tj 0.157 g 9.8471 0 0 9.8 107.43 670.8 Tm (diabet)Tj 0.294 g 0.0077 Tc 9.8 0 0 9.8 133.82 670.8 Tm (es, )Tj 0.227 g 0.05 Tc 10.0265 0 0 9.8 147.74 670.8 Tm (and )Tj 0.0426 Tc 9.8 0 0 9.8 166.42 670.8 Tm (smoking )Tj 0.0231 Tc 4.03 0 Td (history. )Tj 0.05 Tc 10.2656 0 0 9.8 240.39 670.8 Tm (The )Tj 9.843 0 0 9.8 260.02 670.8 Tm (study )Tj 0.0334 Tc 9.8 0 0 9.8 56.15 659.76 Tm (was )Tj 0.05 Tc 9.8178 0 0 9.8 79.58 659.76 Tm (approved )Tj -0.0108 Tc 9.8 0 0 9.8 128.17 659.76 Tm (by )Tj 0.157 g 0.0391 Tc 1.807 0 Td (Ba)Tj 0.294 g 0 Tc 1.165 0 Td (s)Tj 0.157 g 0.0308 Tc 0.398 0 Td (ing)Tj 0.294 g 0.05 Tc 9.8785 0 0 9.8 174.1 659.76 Tm (stoke )Tj 0.157 g 0 Tc 9.8 0 0 9.8 204.43 659.76 Tm (H)Tj 0.294 g 0.0412 Tc 0.829 0 Td (ospital )Tj 0.227 g 0.036 Tc 3.728 0 Td (Medical )Tj 0.0323 Tc -19.692 -1.126 Td (Ethics )Tj 0.0367 Tc 3.033 0 Td (Committee. )Tj ET BT /Suspect <>BDC 0.157 g /T1_0 1 Tf 0.0407 Tc 9.5 0 0 9.5 154.52 621.85 Tm (Results )Tj EMC ET BT 0.227 g /T1_0 1 Tf 0.0464 Tc 9.8 0 0 9.8 65.68 605.53 Tm (There )Tj 0.0075 Tc 2.995 0 Td (were )Tj 0.0248 Tc 2.497 0 Td (twenty )Tj 0.157 g 0.0428 Tc 3.335 0 Td (pati)Tj 0.294 g 0.0417 Tc 1.653 0 Td (ents )Tj 0.157 g 0.0228 Tc 2.206 0 Td (in )Tj 0.227 g 0.0337 Tc 1.271 0 Td (each )Tj 0.0447 Tc 2.402 0 Td (group. )Tj 0.05 Tc 9.9342 0 0 9.8 258.15 605.53 Tm (There )Tj 0.0334 Tc 9.8 0 0 9.8 55.67 594.48 Tm (was )Tj 0.05 Tc 10.0889 0 0 9.8 74.87 594.48 Tm (no )Tj 0.294 g 0.0217 Tc 9.8 0 0 9.8 89.14 594.48 Tm (significant )Tj 0.227 g 0.0192 Tc 4.707 0 Td (difference )Tj 0.0265 Tc 4.516 0 Td (between )Tj 0.05 Tc 9.8357 0 0 9.8 217.42 594.48 Tm (the )Tj 0.0446 Tc 9.8 0 0 9.8 233.75 594.48 Tm (retinopathy )Tj 0.294 g 0 Tc -18.181 -1.127 Td (a)Tj 0.157 g 0.05 Tc 10.0889 0 0 9.8 60.95 583.44 Tm (nd )Tj 0.227 g 0.0481 Tc 9.8 0 0 9.8 74.87 583.44 Tm (non-retinopathy )Tj 0.05 Tc 9.901 0 0 9.8 146.8 583.44 Tm (groups )Tj 0.0441 Tc 9.8 0 0 9.8 178.93 583.44 Tm (for )Tj -0.0166 Tc 1.613 0 Td (sex )Tj 0.05 Tc 9.9326 0 0 9.8 210.71 583.44 Tm (ratio )Tj 0.035 Tc 9.8 0 0 9.8 233.64 583.44 Tm (\(twe)Tj 0.098 g 0 Tc 1.914 0 Td (l)Tj 0.227 g -0.0069 Tc 0.251 0 Td (ve )Tj 0.05 Tc 10.3398 0 0 9.8 267.25 583.44 Tm (and )Tj 0.0114 Tc 9.8 0 0 9.8 55.57 572.89 Tm (fifteen )Tj 0.05 Tc 10.2407 0 0 9.8 90.22 572.89 Tm (ma)Tj 0.098 g 0 Tc 9.8 0 0 9.8 103.6 572.89 Tm (l)Tj 0.227 g 0.0204 Tc 0.243 0 Td (es )Tj 0.0173 Tc 1.674 0 Td (respectively\), )Tj 0.0473 Tc 6.514 0 Td (numbers )Tj 0.05 Tc 11.1292 0 0 9.8 230.77 572.89 Tm (of )Tj 0.0368 Tc 9.8 0 0 9.8 248.02 572.89 Tm (smokers )Tj 0.0456 Tc -19.639 -1.127 Td (\(t)Tj 0.098 g 0 Tc 0.697 0 Td (h)Tj 0.227 g 0.0384 Tc 0.532 0 Td (irteen )Tj 0.05 Tc 10.0265 0 0 9.8 94.46 561.85 Tm (and )Tj 0.0091 Tc 9.8 0 0 9.8 112.7 561.85 Tm (eleven\), )Tj 0.0227 Tc 3.576 0 Td (age )Tj 0.05 Tc 10.5727 0 0 9.8 164.54 561.85 Tm (or )Tj 0.0478 Tc 9.8 0 0 9.8 176.62 561.85 Tm (mean )Tj 0.0318 Tc 2.6 0 Td (pack-years )Tj 0.0494 Tc 4.882 0 Td (smoked )Tj 0.039 Tc -19.835 -1.128 Td (\(table )Tj -0.016 Tc 3.063 0 Td (1\). )Tj 0.157 g 0.05 Tc 9.8831 0 0 9.8 101.71 550.8 Tm (Duration )Tj 0.227 g 11.1292 0 0 9.8 146.29 550.8 Tm (of )Tj 0.0376 Tc 9.8 0 0 9.8 160.23 550.8 Tm (diabetes )Tj 0.0334 Tc 4.073 0 Td (was )Tj 0.0466 Tc 2.148 0 Td (greater )Tj 0.05 Tc 10.0636 0 0 9.8 256.24 550.8 Tm (in )Tj 10.2 0 0 9.8 269.74 550.8 Tm (the )Tj 0.294 g 0.0139 Tc 9.8 0 0 9.8 55.67 540.24 Tm (reti)Tj 0.157 g 0.05 Tc 9.8274 0 0 9.8 70.07 540.24 Tm (nopathy )Tj 0.227 g 10.1021 0 0 9.8 107.91 540.24 Tm (group )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0474 Tc 9.8 0 0 9.8 136.2 540.24 Tm (\(p>BDC /T1_0 1 Tf 0.05 Tc 10.0269 0 0 9.8 100.78 474.49 Tm (mmol\267 )Tj EMC ET BT /T1_2 1 Tf 0 Tc 15.8 0 0 15.8 130.47 474.49 Tm (r )Tj 0.294 g /T1_0 1 Tf 6.4001 0 0 6.4001 140.42 478.33 Tm (1)Tj 0.619 -0.6 Td (, )Tj 0.227 g 0.0405 Tc 9.8 0 0 9.8 150.14 474.49 Tm (creatin)Tj 0.098 g 0 Tc 2.99 0 Td (i)Tj 0.227 g 0.0399 Tc 0.301 0 Td (ne )Tj /T1_1 1 Tf -0.035 Tc 8.6688 0 0 9.8 195.75 474.49 Tm (69 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.017 Tc 9.8 0 0 9.8 209.22 474.49 Tm (Jlmol\267 )Tj EMC ET BT /T1_2 1 Tf 0 Tc 15.8 0 0 15.8 236.07 474.49 Tm (r )Tj /T1_0 1 Tf 6.4001 0 0 6.4001 246.02 478.33 Tm (1 )Tj 0.05 Tc 8.598 0 0 6.4001 249.55 474.49 Tm (\). )Tj 10.1596 0 0 9.8 259.25 474.49 Tm (None )Tj 11.1292 0 0 9.8 55.09 463.93 Tm (of )Tj 9.8357 0 0 9.8 67.66 463.93 Tm (the )Tj 0.0404 Tc 9.8 0 0 9.8 84.02 463.93 Tm (patients )Tj 0.157 g 0.0423 Tc 3.768 0 Td (reported )Tj 0.021 Tc 4.058 0 Td (limited )Tj 0.227 g 0.05 Tc 10.1713 0 0 9.8 192.24 463.93 Tm (joint )Tj 0.0237 Tc 9.8 0 0 9.8 216.46 463.93 Tm (mobility. )Tj 0.05 Tc 9.9402 0 0 9.8 65.24 452.89 Tm (Mean )Tj 11.1638 0 0 9.8 93.07 452.89 Tm (Kco )Tj 0.157 g 0.0272 Tc 9.8 0 0 9.8 116.55 452.89 Tm (did )Tj 0.227 g 0.05 Tc 10.1333 0 0 9.8 134.39 452.89 Tm (not )Tj 0.0184 Tc 9.8 0 0 9.8 152.07 452.89 Tm (differ )Tj 0.294 g 0.0316 Tc 2.741 0 Td (from )Tj 0.227 g 0.0264 Tc 2.511 0 Td (predicted )Tj 0.157 g 0.0228 Tc 4.398 0 Td (in )Tj 0.227 g 0.0489 Tc 1.173 0 Td (either )Tj 0.05 Tc 9.9115 0 0 9.8 55.12 441.84 Tm (group )Tj 11.1292 0 0 9.8 83.89 441.84 Tm (of )Tj 0.0267 Tc 9.8 0 0 9.8 95.86 441.84 Tm (subjects)Tj 0.38 g 0 Tc 3.428 0 Td (, )Tj 0.294 g 0.05 Tc 10.3398 0 0 9.8 135.25 441.84 Tm (and )Tj 0.157 g 0.0272 Tc 9.8 0 0 9.8 154.95 441.84 Tm (did )Tj 0.227 g 0.05 Tc 10.1333 0 0 9.8 172.31 441.84 Tm (not )Tj 0.0184 Tc 9.8 0 0 9.8 189.51 441.84 Tm (differ )Tj 0.0265 Tc 2.655 0 Td (between )Tj 0.05 Tc 9.901 0 0 9.8 253.36 441.84 Tm (groups )Tj 0.039 Tc 9.8 0 0 9.8 55.08 430.81 Tm (\(table )Tj 0.157 g 0.0054 Tc 10 0 0 10 84.41 430.81 Tm (I\). )Tj 0.05 Tc 9.9402 0 0 9.8 98.36 430.81 Tm (Mean )Tj ET BT /Suspect <>BDC 0.227 g /T1_0 1 Tf -0.035 Tc 9.2363 0 0 9.8 126.68 430.81 Tm (DLCO )Tj EMC ET BT /T1_0 1 Tf 0.0334 Tc 9.8 0 0 9.8 154.55 430.81 Tm (was )Tj 0.0187 Tc 2.044 0 Td (significantly )Tj 0.0384 Tc 5.639 0 Td (greater )Tj 0.05 Tc 10.0233 0 0 9.8 263.5 430.81 Tm (than )Tj 0.157 g 0.0325 Tc 9.8 0 0 9.8 55.22 420.25 Tm (predicted )Tj 0.227 g 0.0228 Tc 4.3 0 Td (in )Tj 0.05 Tc 9.8357 0 0 9.8 107.98 420.25 Tm (the )Tj 0.157 g 0.0483 Tc 9.8 0 0 9.8 123.83 420.25 Tm (non-retinop)Tj 0.294 g 0.05 Tc 9.8121 0 0 9.8 174.62 420.25 Tm (athy )Tj 0.227 g 10.1021 0 0 9.8 195.75 420.25 Tm (group )Tj 0.0499 Tc 10 0 0 10 223.56 420.25 Tm (\(p )Tj 0 Tc 9.8 0 0 9.8 234.19 420.25 Tm (< )Tj ET BT /Suspect <>BDC 0.157 g /T1_0 1 Tf 9.5 0 0 9.5 242.3 420.25 Tm (0)Tj 0.294 g 0.0198 Tc 0.596 0 Td (.05\), )Tj EMC ET BT 0.227 g /T1_0 1 Tf 0.05 Tc 9.8246 0 0 9.8 268.71 420.25 Tm (did )Tj 0.157 g 10.1333 0 0 9.8 55.19 409.21 Tm (not )Tj 0.227 g 0.0086 Tc 9.8 0 0 9.8 73.83 409.21 Tm (differ )Tj 0.0316 Tc 2.79 0 Td (from )Tj 0.0325 Tc 2.609 0 Td (predicted )Tj 0.0295 Tc 4.502 0 Td (values )Tj 0.157 g -0.0262 Tc 3.227 0 Td (in )Tj 0.227 g 0.05 Tc 9.8357 0 0 9.8 215.02 409.21 Tm (the )Tj 0.0446 Tc 9.8 0 0 9.8 233.27 409.21 Tm (retinopathy )Tj 0.05 Tc 10.1021 0 0 9.8 54.63 398.16 Tm (group )Tj 10.0265 0 0 9.8 85.82 398.16 Tm (and )Tj 0.0334 Tc 9.8 0 0 9.8 107.51 398.16 Tm (was )Tj 0.157 g 0.05 Tc 10.4827 0 0 9.8 129.11 398.16 Tm (not )Tj 0.227 g 0.0146 Tc 9.8 0 0 9.8 149.62 398.16 Tm (significantly )Tj 0.0243 Tc 5.785 0 Td (different )Tj 0.0265 Tc 4.271 0 Td (between )Tj 0.0377 Tc -19.748 -1.077 Td (groups. )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 9.9856 0 0 9.8 89.72 387.61 Tm (FEV )Tj EMC ET BT 0.157 g /T1_1 1 Tf 0 Tc 5.5001 0 0 5.5001 110.71 385.21 Tm (1 )Tj 0.227 g /T1_0 1 Tf 0.05 Tc 10.0265 0 0 9.8 117.02 387.61 Tm (and )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 10.1833 0 0 9.8 136.28 387.61 Tm (FVC )Tj EMC ET BT /T1_0 1 Tf 0.0239 Tc 9.8 0 0 9.8 159.83 387.61 Tm (were )Tj 0.0187 Tc 2.289 0 Td (significantly )Tj 0.0351 Tc 5.541 0 Td (lower )Tj 0.05 Tc 10.0233 0 0 9.8 263.5 387.61 Tm (than )Tj 0.0325 Tc 9.8 0 0 9.8 54.74 376.56 Tm (predicted )Tj 0.0295 Tc 4.404 0 Td (values )Tj 0.0228 Tc 3.08 0 Td (in )Tj 0.0279 Tc 1.28 0 Td (the )Tj 0.0446 Tc 1.715 0 Td (retinopathy )Tj 0 Tc 5.43 0 Td (g)Tj 0.098 g 0.546 0 Td (r)Tj 0.227 g 0.05 Tc 10.0279 0 0 9.8 219.74 376.56 Tm (oup )Tj 9.9989 0 0 9.8 239.88 376.56 Tm (\(p )Tj 0.294 g 0 Tc 9.8 0 0 9.8 250.51 376.56 Tm (< )Tj ET BT /Suspect <>BDC 0.227 g /T1_0 1 Tf 0.0329 Tc 9.5 0 0 9.5 258.62 376.56 Tm (0.05\), )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 10.18 0 0 9.8 54.73 365.53 Tm (but )Tj 0.0281 Tc 9.8 0 0 9.8 73.9 365.53 Tm (there )Tj 0.0089 Tc 2.646 0 Td (was )Tj 0.05 Tc 10.0889 0 0 9.8 120.47 365.53 Tm (no )Tj 0.294 g 0.0419 Tc 9.8 0 0 9.8 135.7 365.53 Tm (sig)Tj 0.157 g 0.0196 Tc 1.238 0 Td (nificant )Tj 0.227 g 0.0138 Tc 3.714 0 Td (difference )Tj 0.0184 Tc 4.712 0 Td (between )Tj 0.05 Tc 9.8357 0 0 9.8 269.26 365.53 Tm (the )Tj 0.0463 Tc 9.8 0 0 9.8 54.64 354.49 Tm (groups )Tj 0.0441 Tc 3.377 0 Td (for )Tj 0.0264 Tc 1.674 0 Td (these )Tj 0.034 Tc 2.596 0 Td (measurements. )Tj 0.157 g 0.05 Tc 10.4358 0 0 9.8 196.75 354.49 Tm (For )Tj 0.227 g 9.8357 0 0 9.8 216.46 354.49 Tm (the )Tj 0.0353 Tc 9.8 0 0 9.8 233.74 354.49 Tm (two )Tj 0.05 Tc 9.901 0 0 9.8 252.88 354.49 Tm (groups )Tj 0.042 Tc 9.8 0 0 9.8 54.14 343.44 Tm (combined, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 9.9856 0 0 9.8 102.2 343.44 Tm (FEV )Tj EMC ET BT /T1_1 1 Tf 0 Tc 6.2 0 0 6.2 123.16 341.05 Tm (1 )Tj /T1_0 1 Tf 0.05 Tc 10.3398 0 0 9.8 129.49 343.44 Tm (and )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 10.4109 0 0 9.8 148.75 343.44 Tm (PVC )Tj EMC ET BT /T1_0 1 Tf 0.0239 Tc 9.8 0 0 9.8 172.79 343.44 Tm (were )Tj 0.157 g 0.0171 Tc 2.351 0 Td (negatively )Tj 0.0372 Tc 4.653 0 Td (related )Tj 0.227 g 0.05 Tc 10.4772 0 0 9.8 273.57 343.44 Tm (to )Tj 10.6052 0 0 9.8 54.14 332.89 Tm (du)Tj 0.098 g 0 Tc 9.8 0 0 9.8 65.75 332.89 Tm (r)Tj 0.227 g 0.05 Tc 9.8814 0 0 9.8 69.02 332.89 Tm (ation )Tj 11.1292 0 0 9.8 94.93 332.89 Tm (of )Tj 0.157 g 10.4524 0 0 9.8 107.93 332.89 Tm (IDDM )Tj 0.227 g 9.9989 0 0 9.8 141.96 332.89 Tm (\(p )Tj 0 Tc 9.8 0 0 9.8 152.59 332.89 Tm (< )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0404 Tc 9.5 0 0 9.5 160.7 332.89 Tm (0.05\) )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 10.18 0 0 9.8 185.77 332.89 Tm (but )Tj 10.4827 0 0 9.8 203.99 332.89 Tm (not )Tj 0.0476 Tc 9.8 0 0 9.8 222.14 332.89 Tm (after )Tj 0.294 g 0 Tc 2.4 0 Td (a)Tj 0.157 g 0.0243 Tc 0.541 0 Td (llowing )Tj 0.098 g 0 Tc -20.036 -1.128 Td (f)Tj 0.227 g 0.05 Tc 10.5727 0 0 9.8 57.98 321.84 Tm (or )Tj 0.0318 Tc 9.8 0 0 9.8 72.5 321.84 Tm (pack-years )Tj 0.05 Tc 11.1292 0 0 9.8 123.25 321.84 Tm (of )Tj 0.294 g 9.8484 0 0 9.8 137.62 321.84 Tm (smok)Tj 0.098 g 0 Tc 9.8 0 0 9.8 160.72 321.84 Tm (i)Tj 0.227 g 0.0319 Tc 0.301 0 Td (ng )Tj 0.0499 Tc 10 0 0 10 179.4 321.84 Tm (\(p )Tj 0.294 g 0 Tc 9.8 0 0 9.8 189.55 321.84 Tm (< )Tj ET BT /Suspect <>BDC 0.157 g /T1_0 1 Tf -0.0256 Tc 9.8 0 0 9.8 198.1446 321.84 Tm (O.l)Tj 0.294 g 0 Tc 1.317 0 Td (, )Tj EMC ET BT 0.227 g /T1_0 1 Tf 0.05 Tc 10.2 0 0 9.8 218.86 321.84 Tm (tab)Tj 0.098 g 0 Tc 9.8 0 0 9.8 232.72 321.84 Tm (l)Tj 0.227 g 0.243 0 Td (e )Tj -0.0178 Tc 1.033 0 Td (2\). )Tj 0.05 Tc 10.1702 0 0 9.8 261.07 321.84 Tm (Pack )Tj 0.0371 Tc 9.8 0 0 9.8 54.23 310.81 Tm (years )Tj 0.0426 Tc 2.485 0 Td (smoking )Tj 0.0334 Tc 3.932 0 Td (was )Tj 0.043 Tc 1.852 0 Td (correlated )Tj 0.157 g 0.0299 Tc 4.662 0 Td (with )Tj 0.227 g 0.05 Tc 9.9374 0 0 9.8 201.51 310.81 Tm (duration )Tj 11.1292 0 0 9.8 240.85 310.81 Tm (of )Tj 0.098 g 10.4524 0 0 9.8 252.41 310.81 Tm (IDDM )Tj 0.227 g 9.9989 0 0 9.8 54.12 299.76 Tm (\(p )Tj 0 Tc 9.8 0 0 9.8 64.75 299.76 Tm (< )Tj ET BT /Suspect <>BDC 0.157 g /T1_0 1 Tf 0.0278 Tc 9.5 0 0 9.5 72.86 299.76 Tm (0.05\))Tj 0.294 g 0 Tc 2.218 0 Td (, )Tj EMC ET BT 0.227 g /T1_0 1 Tf 0.0369 Tc 9.8 0 0 9.8 101.2 299.76 Tm (indicating )Tj 0.05 Tc 10.215 0 0 9.8 148.78 299.76 Tm (that )Tj 0.0264 Tc 9.8 0 0 9.8 170.38 299.76 Tm (these )Tj 0.0337 Tc 2.645 0 Td (variables )Tj 0.0239 Tc 4.36 0 Td (were )Tj 0.05 Tc 9.8219 0 0 9.8 262.94 299.76 Tm (con\255)Tj 0.0393 Tc 9.8 0 0 9.8 54.13 289.21 Tm (founded, )Tj 0.05 Tc 10.0265 0 0 9.8 98.78 289.21 Tm (and )Tj 0.0404 Tc 9.8 0 0 9.8 121.9 289.21 Tm (there )Tj 0.0334 Tc 2.842 0 Td (was )Tj 0.05 Tc 10.0889 0 0 9.8 172.79 289.21 Tm (no )Tj 0.157 g 0.0388 Tc 9.8 0 0 9.8 190.07 289.21 Tm (relationship )Tj 0.0265 Tc 5.88 0 Td (between )Tj ET BT /Suspect <>BDC 0.294 g /T1_0 1 Tf 0.05 Tc 10.2291 0 0 9.8 54.2 278.16 Tm (FEV )Tj EMC ET BT /T1_0 1 Tf 0 Tc 6.2 0 0 6.2 75.63 275.76 Tm (1 )Tj 0.227 g 9.8 0 0 9.8 85.35 278.16 Tm (o)Tj 0.098 g 0.596 0 Td (r )Tj ET BT /Suspect <>BDC 0.227 g /T1_0 1 Tf 0.05 Tc 10.4201 0 0 9.8 101.23 278.16 Tm (FVC )Tj EMC ET BT /T1_0 1 Tf 10.0265 0 0 9.8 129.02 278.16 Tm (and )Tj 9.9374 0 0 9.8 151.59 278.16 Tm (duration )Tj 11.1292 0 0 9.8 195.25 278.16 Tm (of )Tj 0.157 g 10.6237 0 0 9.8 210.65 278.16 Tm (IDDM )Tj 0.227 g 10.0636 0 0 9.8 247.12 278.16 Tm (in )Tj 0.0432 Tc 9.8 0 0 9.8 262.55 278.16 Tm (non-)Tj 0.098 g /T1_1 1 Tf 0 Tc 8.5 0 0 8.5 53.71 244.57 Tm (T)Tj 0.227 g 0.0366 Tc 0.616 0 Td (able )Tj 0.05 Tc 9.369 0 0 8.5 77.94 244.57 Tm (1.-)Tj 0.157 g 0.0472 Tc 8.5 0 0 8.5 91.02 244.57 Tm (Mean )Tj 0.227 g 0.0381 Tc 2.827 0 Td (\(so\) )Tj 0.022 Tc 2.047 0 Td (values )Tj 0.0344 Tc 3.22 0 Td (for )Tj 0.0183 Tc 1.404 0 Td (age, )Tj 0.157 g 0.0291 Tc 2.204 0 Td (duration )Tj 0.227 g 0.05 Tc 8.91 0 0 8.5 224.56 244.57 Tm (of )Tj ET BT /Suspect <>BDC 0.157 g /T1_1 1 Tf 0.0086 Tc 8.5 0 0 8.5 234.08 244.57 Tm (lOOM, )Tj EMC ET BT 0.227 g /T1_1 1 Tf 0.0461 Tc 8.5 0 0 8.5 260.481 244.57 Tm (pack\255)Tj 0.157 g 0.04 Tc -24.381 -1.3 Td (years )Tj 0.227 g 0.0285 Tc 2.82 0 Td (smoking, )Tj 0.0248 Tc 4.459 0 Td (and )Tj 0.0417 Tc 1.968 0 Td (pulmonary )Tj 0.0314 Tc 5.155 0 Td (function )Tj 0.025 Tc 3.951 0 Td (tests )Tj 0.098 g 0 Tc 2.471 0 Td (i)Tj 0.227 g 0.282 0 Td (n )Tj 0.0345 Tc 0.734 0 Td (non-retino\255)Tj 0.157 g 0.0461 Tc -21.854 -1.241 Td (pathy )Tj 0.227 g 0.0248 Tc 2.945 0 Td (and )Tj 0.0322 Tc 2.081 0 Td (retinopathy )Tj 0.157 g 0.0328 Tc 5.544 0 Td (groups. )Tj 0.227 g /T1_0 1 Tf 0.05 Tc 8.6935 0 0 8.6 153.16 200.41 Tm (Non)Tj 0.38 g 0 Tc 8.6 0 0 8.6 169.34 200.41 Tm (-)Tj 0.227 g 0.0306 Tc 0.234 0 Td (retinopathy )Tj 0.0254 Tc 6.638 0 Td (Retinopathy )Tj 0.157 g 0.05 Tc 8.7328 0 0 8.6 152.62 189.37 Tm (mean )Tj ET BT /Suspect <>BDC 0.227 g /T1_0 1 Tf 9.9809 0 0 9.8 189.46 189.37 Tm (so )Tj EMC ET BT /T1_0 1 Tf 8.7328 0 0 8.6 225.58 189.37 Tm (mean )Tj 9.9809 0 0 9.8 261.94 189.37 Tm (so )Tj 0.0355 Tc 8.6 0 0 8.6 53.26 168.25 Tm (Age )Tj -0.0343 Tc 9.6 0 0 9.6 72.47 168.25 Tm (yrs )Tj /T1_1 1 Tf 0.05 Tc 9.0517 0 0 8.6 157.41 167.76 Tm (413 )Tj /T1_0 1 Tf 0.0041 Tc 8.8 0 0 8.8 189.78 167.76 Tm (11.6 )Tj 0.0399 Tc 4.557 0 Td (46.9 )Tj 0.0223 Tc 3.625 0 Td (13.4 )Tj 0.0212 Tc 8.6 0 0 8.6 53.24 157.21 Tm (Duration )Tj 0.05 Tc 10.0163 0 0 8.6 86.78 157.21 Tm (of )Tj 0.0282 Tc 8.6 0 0 8.6 96.88 157.21 Tm (diabetes )Tj -0.0343 Tc 9.6 0 0 9.6 133.91 157.21 Tm (yrs )Tj 0.0041 Tc 8.8 0 0 8.8 157.62 156.73 Tm (13.1 )Tj 0.0198 Tc 4.108 0 Td (8.9 )Tj 0.0048 Tc 4.157 0 Td (22.9 )Tj 0.0041 Tc 3.572 0 Td (11.6 )Tj 0.0366 Tc 8.6 0 0 8.6 52.64 146.16 Tm (Smoking )Tj 0.031 Tc 4.036 0 Td (history )Tj 0.0441 Tc 3.24 0 Td (pack )Tj 0.0179 Tc 8.8 0 0 8.8 139.19 146.16 Tm (yrs )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0223 Tc 8.8 0 0 8.8 157.6172 146.16 Tm (12.0 )Tj EMC ET BT /T1_0 1 Tf 0.0041 Tc 8.8 0 0 8.8 189.7812 146.16 Tm (14.7 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0048 Tc 8.8 0 0 8.8 229.874 146.16 Tm (20.1 )Tj EMC ET BT /T1_0 1 Tf 0.023 Tc 8.8 0 0 8.8 261.07 145.6936 Tm (27.7 )Tj -0.035 Tc 9.3766 0 0 11.4 52.76 134.16 Tm (FEVI )Tj 0.025 Tc 8.8 0 0 8.8 157.34 135.13 Tm (96.8 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0223 Tc 8.8 0 0 8.8 189.7768 135.13 Tm (13.0 )Tj EMC ET BT /T1_0 1 Tf 0.025 Tc 8.8 0 0 8.8 229.8168 134.646 Tm (91.9 )Tj -0.0141 Tc 3.632 0.055 Td (16.1 )Tj -0.035 Tc 9.3061 0 0 11.4 52.76 123.6 Tm (FVC )Tj ET BT /Suspect <>BDC 0.157 g /T1_0 1 Tf 0.025 Tc 8.8 0 0 8.8 157.34 123.12 Tm (99.0 )Tj EMC /Suspect <>BDC 0.227 g -0.0013 Tc 3.632 0 Td (13)Tj 0.098 g 0.05 Tc 8.8726 0 0 8.8 198.54 123.12 Tm (.0 )Tj EMC ET BT 0.227 g /T1_0 1 Tf 0.025 Tc 8.8 0 0 8.8 229.82 123.12 Tm (91.2 )Tj 0.157 g 0.0041 Tc 3.632 0 Td (17.9 )Tj ET BT /Suspect <>BDC 0.227 g /T1_1 1 Tf 0.0253 Tc 7 0 0 7 52.7 112.08 Tm (OLCO )Tj EMC /Suspect <>BDC 0.157 g /T1_0 1 Tf 0.0008 Tc 8.8 0 0 8.8 153.3 112.08 Tm (108.8 )Tj EMC ET BT 0.227 g /T1_0 1 Tf -0.0141 Tc 8.8 0 0 8.8 189.776 112.08 Tm (16.1 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0144 Tc 8.8 0 0 8.8 225.7768 112.08 Tm (100.4 )Tj EMC ET BT /T1_0 1 Tf -0.0141 Tc 8.8 0 0 8.8 262.2528 112.08 Tm (15.7 )Tj /T1_1 1 Tf -0.0161 Tc 9.5 0 0 9.5 52.6 101.04 Tm (Kco )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0008 Tc 8.8 0 0 8.8 153.3 101.04 Tm (104.5 )Tj EMC ET BT /T1_0 1 Tf 0.0223 Tc 8.8 0 0 8.8 189.3008 101.524 Tm (14.8 )Tj ET BT /Suspect <>BDC 0.157 g /T1_0 1 Tf 0.0221 Tc 8.8 0 0 8.8 225.7768 101.524 Tm (100)Tj 0.294 g 0.0017 Tc 1.541 0 Td (.7 )Tj EMC ET BT 0.227 g /T1_0 1 Tf -0.0141 Tc 8.8 0 0 8.8 261.7776 101.04 Tm (19.7 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.035 Tc 7.8724 0 0 11.4 52.78 90.48 Tm (VA )Tj EMC /Suspect <>BDC 0.0221 Tc 8.8 0 0 8.8 153.3 90.48 Tm (104)Tj 0.098 g 0 Tc 1.541 0 Td (.)Tj 0.227 g 0.173 0 Td (9 )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 8.829 0 0 8.8 189.29 90.48 Tm (14)Tj 0.098 g -0.035 Tc 8.5664 0 0 8.8 198.54 90.48 Tm (.3 )Tj ET BT /Suspect <>BDC 0.227 g /T1_0 1 Tf 0.0008 Tc 8.8 0 0 8.8 225.78 90.48 Tm (100.3 )Tj EMC ET BT /T1_0 1 Tf 0.0223 Tc 8.8 0 0 8.8 261.2968 90.48 Tm (14.3 )Tj 0.294 g 0.045 Tc 9.8 0 0 9.8 307.54 736.09 Tm (smokers )Tj 0.227 g 0.0292 Tc 3.92 0 Td (\(table )Tj -0.0178 Tc 2.749 0 Td (2\). )Tj 0.05 Tc 9.9342 0 0 9.8 386.31 736.09 Tm (There )Tj 0.0334 Tc 9.8 0 0 9.8 414.23 736.09 Tm (was )Tj 0.05 Tc 10.5475 0 0 9.8 432.95 736.09 Tm (no )Tj 0.0477 Tc 9.8 0 0 9.8 447.35 736.09 Tm (relationship )Tj 0.0265 Tc 5.586 0 Td (between )Tj 0.05 Tc 9.8357 0 0 9.8 307.66 725.05 Tm (the )Tj ET BT /Suspect <>BDC 0.157 g /T1_0 1 Tf 10.2291 0 0 9.8 324.44 725.05 Tm (FEV )Tj EMC /Suspect <>BDC 0.294 g -0.0281 Tc 9.8 0 0 9.8 345.54 725.05 Tm (J!)Tj 0.157 g 0.05 Tc 10.1833 0 0 9.8 352.76 725.05 Tm (FVC )Tj EMC ET BT 0.227 g /T1_0 1 Tf 0.0445 Tc 9.8 0 0 9.8 376.79 725.05 Tm (ratio, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 11.5638 0 0 9.8 403.15 725.05 Tm (Dtco )Tj EMC ET BT 0.294 g /T1_0 1 Tf 10.5727 0 0 9.8 430.94 725.05 Tm (or )Tj 0.157 g 10.8915 0 0 9.8 443.95 725.05 Tm (Kco )Tj 0.294 g 10.3398 0 0 9.8 466.93 725.05 Tm (and )Tj 0.227 g 10.0681 0 0 9.8 487.1 725.05 Tm (duration )Tj 11.1292 0 0 9.8 527.89 725.05 Tm (of )Tj 0.157 g 10.3699 0 0 9.8 307.61 714 Tm (IDDM. )Tj -0.0143 Tc 10.3 0 0 10.3 399.31 687.12 Tm (Discussion )Tj 0.0313 Tc 9.8 0 0 9.8 317.72 670.8 Tm (Previou)Tj 0.294 g 0 Tc 3.32 0 Td (s )Tj 0.227 g 0.05 Tc 10.0339 0 0 9.8 356.63 670.8 Tm (work )Tj 0.0462 Tc 9.8 0 0 9.8 381.59 670.8 Tm (has )Tj 0.05 Tc 9.8869 0 0 9.8 397.83 670.8 Tm (demonstrated )Tj 0.0377 Tc 9.8 0 0 9.8 459.34 670.8 Tm (mildly )Tj 0.0356 Tc 3.079 0 Td (diminished )Tj 0.0271 Tc -18.562 -1.127 Td (gas )Tj 0.0403 Tc 2.161 0 Td (transfer )Tj 0.157 g 0.0228 Tc 4.059 0 Td (in )Tj 0.227 g 0.0404 Tc 1.578 0 Td (patients )Tj 0.0299 Tc 4.111 0 Td (with )Tj 0.098 g 0.05 Tc 10.8254 0 0 9.8 450.64 659.76 Tm (IDD)Tj 0.227 g 0 Tc 9.8 0 0 9.8 471.32 659.76 Tm (M )Tj -0.035 Tc 9.7837 0 0 10.4 488.4 659.76 Tm ([1]. )Tj 0.098 g 0 Tc 9.8 0 0 9.8 509.21 659.76 Tm (I)Tj 0.227 g 0.388 0 Td (f )Tj 0.294 g 0.05 Tc 9.8357 0 0 9.8 523.66 659.76 Tm (the )Tj 0.227 g 0.0471 Tc 9.8 0 0 9.8 307.11 649.21 Tm (diminution )Tj -0.0131 Tc 5.389 0 Td (is )Tj 0.05 Tc 10.0131 0 0 9.8 371.91 649.21 Tm (due )Tj 0.294 g 9.8951 0 0 9.8 393.1 649.21 Tm (to )Tj 0.227 g 9.8624 0 0 9.8 407.54 649.21 Tm (pulmonary )Tj 9.8372 0 0 9.8 460.3 649.21 Tm (microangiopathy)Tj 0.38 g 0 Tc 9.8 0 0 9.8 534.09 649.21 Tm (, )Tj 0.227 g 0.0479 Tc -23.105 -1.127 Td (then )Tj 0.0453 Tc 2.247 0 Td (impairment )Tj 0.294 g 0.05 Tc 10.5727 0 0 9.8 382.46 638.17 Tm (of )Tj 0.227 g 0.0271 Tc 9.8 0 0 9.8 394.48 638.17 Tm (gas )Tj 0.0473 Tc 1.769 0 Td (transfer )Tj 0.0228 Tc 3.716 0 Td (in )Tj 0.157 g 0.05 Tc 10.6237 0 0 9.8 460.73 638.17 Tm (IDDM )Tj 0.227 g 0 Tc 9.8 0 0 9.8 494.26 638.17 Tm (s)Tj 0.098 g 0.405 0 Td (h)Tj 0.227 g 0.05 Tc 10.2564 0 0 9.8 503.9 638.17 Tm (ou)Tj 0.098 g 0 Tc 9.8 0 0 9.8 514.96 638.17 Tm (l)Tj 0.227 g 0.244 0 Td (d )Tj 0.0462 Tc 0.99 0 Td (be )Tj 0.035 Tc -22.444 -1.128 Td (associated )Tj 0.0299 Tc 4.711 0 Td (with )Tj 0.05 Tc 9.8899 0 0 9.8 374.31 627.12 Tm (other )Tj 0.0171 Tc 9.8 0 0 9.8 398.78 627.12 Tm (clinical )Tj 0.0458 Tc 3.339 0 Td (manifestations )Tj 0.05 Tc 11.6856 0 0 9.8 496.69 627.12 Tm (of )Tj 0.0365 Tc 9.8 0 0 9.8 508.3 627.12 Tm (micro\255)Tj 0.05 Tc 10.3398 0 0 9.8 307.09 616.56 Tm (ang)Tj 0.098 g 0 Tc 9.8 0 0 9.8 322.96 616.56 Tm (i)Tj 0.227 g 0.0472 Tc 0.293 0 Td (opathy, )Tj 0.0198 Tc 3.521 0 Td (since )Tj 0.0476 Tc 2.367 0 Td (pulmonary )Tj 0.294 g 0 Tc 4.984 0 Td (a)Tj 0.157 g 0.05 Tc 10.0889 0 0 9.8 437.75 616.56 Tm (nd )Tj 0.294 g 0.0361 Tc 9.8 0 0 9.8 450.58 616.56 Tm (systemic )Tj 0.227 g 0.0414 Tc 3.98 0 Td (microangi\255)Tj 0.05 Tc 10.0895 0 0 9.8 307.1 605.53 Tm (opathy )Tj 9.9087 0 0 9.8 340.7 605.53 Tm (are )Tj 0.0422 Tc 9.8 0 0 9.8 357.58 605.53 Tm (known )Tj 0.05 Tc 9.8951 0 0 9.8 390.22 605.53 Tm (to )Tj 0.0462 Tc 9.8 0 0 9.8 402.25 605.53 Tm (be )Tj 0.0405 Tc 1.36 0 Td (associated )Tj -0.0223 Tc 9.5 0 0 9.5 462.97 605.53 Tm ([4]. )Tj 0.157 g 0.05 Tc 9.8385 0 0 9.8 479.95 605.53 Tm (However)Tj 0.294 g 0 Tc 9.8 0 0 9.8 519.21 605.53 Tm (, )Tj 0.157 g 0.05 Tc 10.0889 0 0 9.8 525.59 605.53 Tm (no )Tj 0.0344 Tc 9.8 0 0 9.8 307.67 594.48 Tm (relationship )Tj 0.227 g 0.0347 Tc 5.586 0 Td (between )Tj 0.05 Tc 9.8138 0 0 9.8 401.68 594.48 Tm (impairment )Tj 11.6856 0 0 9.8 455.89 594.48 Tm (of )Tj 9.8216 0 0 9.8 469.84 594.48 Tm (gas )Tj 0.0473 Tc 9.8 0 0 9.8 489.1 594.48 Tm (transfer )Tj 0.05 Tc 10.5727 0 0 9.8 526.94 594.48 Tm (or )Tj 10.0265 0 0 9.8 307.1 583.44 Tm (any )Tj 10.1049 0 0 9.8 325.34 583.44 Tm (other )Tj 0.0273 Tc 9.8 0 0 9.8 350.3 583.44 Tm (aspects )Tj 0.05 Tc 10.5727 0 0 9.8 382.94 583.44 Tm (of )Tj 0.157 g 0.0495 Tc 9.8 0 0 9.8 394 583.44 Tm (lung )Tj 0.227 g 0.0393 Tc 2.152 0 Td (function )Tj 0.05 Tc 10.3398 0 0 9.8 453.49 583.44 Tm (and )Tj 9.8357 0 0 9.8 472.78 583.44 Tm (the )Tj 0.157 g 9.834 0 0 9.8 488.18 583.44 Tm (pres)Tj 0.294 g 9.8 0 0 9.8 505.82 583.44 Tm (ence )Tj 0.227 g 11.1292 0 0 9.8 527.41 583.44 Tm (of )Tj 10.0088 0 0 9.8 307.1 572.89 Tm (comp)Tj 0.098 g 0 Tc 9.8 0 0 9.8 331.12 572.89 Tm (l)Tj 0.227 g 0.0344 Tc 0.245 0 Td (ications )Tj 0.05 Tc 11.1292 0 0 9.8 369.49 572.89 Tm (of )Tj 0.0376 Tc 9.8 0 0 9.8 381.03 572.89 Tm (diabetes )Tj 0.0462 Tc 3.878 0 Td (has )Tj 0.0276 Tc 1.814 0 Td (been )Tj 0.0369 Tc 2.292 0 Td (described )Tj 0.05 Tc 9.8951 0 0 9.8 503.5 572.89 Tm (to )Tj 9.8099 0 0 9.8 514.95 572.89 Tm (date. )Tj 0.0339 Tc 9.8 0 0 9.8 307.12 561.85 Tm (This )Tj 0.294 g 0.05 Tc 9.843 0 0 9.8 328.18 561.85 Tm (study )Tj 0.227 g 0.0221 Tc 9.8 0 0 9.8 354.22 561.85 Tm (tests )Tj 0.294 g 0.05 Tc 9.8357 0 0 9.8 375.34 561.85 Tm (the )Tj 0.227 g 0.0261 Tc 9.8 0 0 9.8 391.19 561.85 Tm (hypothesis )Tj 0.05 Tc 10.5068 0 0 9.8 438.21 561.85 Tm (that )Tj 0.098 g 0 Tc 9.8 0 0 9.8 458.32 561.85 Tm (i)Tj 0.227 g 0.05 Tc 9.9608 0 0 9.8 461.26 561.85 Tm (mpairment )Tj 11.1292 0 0 9.8 511.09 561.85 Tm (of )Tj 9.8216 0 0 9.8 522.16 561.85 Tm (gas )Tj 0.0473 Tc 9.8 0 0 9.8 307.18 550.8 Tm (transfer )Tj 0.0228 Tc 3.716 0 Td (in )Tj 0.157 g 0.05 Tc 10.6237 0 0 9.8 355.13 550.8 Tm (IDDM )Tj 0.227 g 9.9629 0 0 9.8 388.66 550.8 Tm (should )Tj 0.0462 Tc 9.8 0 0 9.8 420.97 550.8 Tm (be )Tj 0.0466 Tc 1.362 0 Td (greater )Tj -0.0262 Tc 3.478 0 Td (in )Tj 0.0474 Tc 1.186 0 Td (patients )Tj 0.0462 Tc 3.817 0 Td (with )Tj 0.05 Tc 9.8899 0 0 9.8 307.11 540.24 Tm (overt )Tj 0.0253 Tc 9.8 0 0 9.8 331.58 540.24 Tm (clinica)Tj 0.098 g 0 Tc (l )Tj 0.227 g 0.0276 Tc 3.331 0 Td (evidence )Tj 0.05 Tc 11.1292 0 0 9.8 403.57 540.24 Tm (of )Tj 0 Tc 9.8 0 0 9.8 414.7 540.24 Tm (m)Tj 0.098 g 0.876 0 Td (i)Tj 0.227 g 0.05 Tc 9.8651 0 0 9.8 425.66 540.24 Tm (croa)Tj 0.098 g 0 Tc 9.8 0 0 9.8 444.95 540.24 Tm (n)Tj 0.227 g 0.05 Tc 10.0136 0 0 9.8 450.16 540.24 Tm (giopat)Tj 0.098 g 0 Tc 9.8 0 0 9.8 477.59 540.24 Tm (h)Tj 0.294 g 0.588 0 Td (y )Tj 0.227 g 0.05 Tc 10.0233 0 0 9.8 491.5 540.24 Tm (than )Tj 0.0488 Tc 9.8 0 0 9.8 513.58 540.24 Tm (those )Tj 0.0396 Tc -21.06 -1.126 Td (without, )Tj 0.0382 Tc 4.067 0 Td (by )Tj 0.05 Tc 10.118 0 0 9.8 361.34 529.21 Tm (compar)Tj 0.098 g 0 Tc 9.8 0 0 9.8 394 529.21 Tm (i)Tj 0.227 g 0.05 Tc 10.0889 0 0 9.8 396.47 529.21 Tm (ng )Tj 9.8216 0 0 9.8 410.8 529.21 Tm (gas )Tj 0.0473 Tc 9.8 0 0 9.8 429.58 529.21 Tm (transfer )Tj 0.0228 Tc 3.814 0 Td (in )Tj 0.05 Tc 9.8869 0 0 9.8 479.06 529.21 Tm (patients )Tj 0.0462 Tc 9.8 0 0 9.8 517.43 529.21 Tm (with )Tj 0.05 Tc 10.0265 0 0 9.8 307.1 518.17 Tm (and )Tj 0.047 Tc 9.8 0 0 9.8 327.83 518.17 Tm (without )Tj 0.0397 Tc 3.812 0 Td (diabetic )Tj 0.0446 Tc 3.927 0 Td (retinopathy. )Tj 0.157 g 0 Tc 5.873 0 Td (R)Tj 0.294 g 0.73 0 Td (e)Tj 0.157 g 0.05 Tc 10.0105 0 0 9.8 473.26 518.17 Tm (tinopathy )Tj 0.227 g 0.0334 Tc 9.8 0 0 9.8 520.31 518.17 Tm (was )Tj 0.0263 Tc -21.746 -1.078 Td (used )Tj 0.05 Tc 9.9203 0 0 9.8 330.62 507.61 Tm (as )Tj 0 Tc 9.8 0 0 9.8 344.06 507.61 Tm (a )Tj 0.05 Tc 9.9869 0 0 9.8 353.74 507.61 Tm (marke)Tj 0.098 g 0 Tc 9.8 0 0 9.8 381.11 507.61 Tm (r )Tj 0.227 g 0.05 Tc 11.1292 0 0 9.8 389.17 507.61 Tm (of )Tj 0.157 g 0.0485 Tc 9.8 0 0 9.8 402.7 507.61 Tm (microangiopathy )Tj 0.227 g 0.038 Tc 7.987 0 Td (because )Tj 0.0499 Tc 3.86 0 Td (it )Tj -0.0131 Tc 1.078 0 Td (is )Tj 0.0165 Tc -22.67 -1.128 Td (relatively )Tj 0.0353 Tc 4.595 0 Td (easy )Tj 0.05 Tc 10.4772 0 0 9.8 377.25 496.56 Tm (to )Tj 0.157 g 0.039 Tc 9.8 0 0 9.8 392.55 496.56 Tm (detec)Tj 0.294 g 0.0141 Tc 2.26 0 Td (t, )Tj 0.227 g 0.05 Tc 10.3398 0 0 9.8 426.61 496.56 Tm (and )Tj 0.294 g 0.0148 Tc 9.8 0 0 9.8 449.62 496.56 Tm (specific )Tj 0.098 g 0 Tc 3.882 0 Td (t)Tj 0.227 g 0.287 0 Td (o )Tj 0.05 Tc 10.3699 0 0 9.8 502.97 496.56 Tm (IDDM. )Tj 9.9448 0 0 9.8 307.1 485.53 Tm (Current )Tj 10.0265 0 0 9.8 347.42 485.53 Tm (and )Tj 0.0291 Tc 9.8 0 0 9.8 369.98 485.53 Tm (ex-smokers )Tj 0.0402 Tc 5.544 0 Td (were )Tj 0.0427 Tc 2.736 0 Td (included )Tj 0.0321 Tc 4.451 0 Td (since )Tj 0.157 g 0.0279 Tc 2.902 0 Td (the )Tj 0.227 g 0.05 Tc 9.8612 0 0 9.8 307.22 474.97 Tm (purpose )Tj 0.0089 Tc 9.8 0 0 9.8 345.11 474.97 Tm (was )Tj 0.05 Tc 9.8951 0 0 9.8 364.78 474.97 Tm (to )Tj 9.8093 0 0 9.8 376.7 474.97 Tm (compare )Tj 9.964 0 0 9.8 417.14 474.97 Tm (pulmonary )Tj 0.0393 Tc 9.8 0 0 9.8 467.89 474.97 Tm (function )Tj 0.049 Tc 4.116 0 Td (on )Tj 0.05 Tc 9.8357 0 0 9.8 523.18 474.97 Tm (the )Tj 0.0294 Tc 9.8 0 0 9.8 307.21 463.93 Tm (basis )Tj 0.05 Tc 11.1292 0 0 9.8 331.09 463.93 Tm (of )Tj 0.0269 Tc 9.8 0 0 9.8 343.22 463.93 Tm (presence )Tj 0.294 g 0.05 Tc 10.5727 0 0 9.8 382.46 463.93 Tm (or )Tj 0.227 g 0.0301 Tc 9.8 0 0 9.8 394.94 463.93 Tm (absence )Tj 0.294 g 0.05 Tc 10.5727 0 0 9.8 431.42 463.93 Tm (of )Tj 0.227 g 9.8698 0 0 9.8 443.03 463.93 Tm (retinopathy, )Tj 0.0245 Tc 9.8 0 0 9.8 499.6 463.93 Tm (irrespec\255)Tj 0.0079 Tc -19.635 -1.127 Td (tive )Tj 0.05 Tc 10.5727 0 0 9.8 325.82 452.89 Tm (of )Tj 10.1049 0 0 9.8 337.82 452.89 Tm (other )Tj 0.0419 Tc 9.8 0 0 9.8 363.38 452.89 Tm (potential )Tj 0.157 g 0.0229 Tc 4.258 0 Td (risk )Tj 0.227 g 0.0336 Tc 1.949 0 Td (factors )Tj 0.05 Tc 10.0841 0 0 9.8 456.85 452.89 Tm (for )Tj 0.0496 Tc 9.8 0 0 9.8 472.78 452.89 Tm (microangiopa\255)Tj 0.0142 Tc -16.898 -1.078 Td (thy. )Tj 0.05 Tc 10.5034 0 0 9.8 316.73 431.28 Tm (In )Tj 10.0673 0 0 9.8 329.66 431.28 Tm (order )Tj 10.4772 0 0 9.8 356.13 431.28 Tm (to )Tj 0.0407 Tc 9.8 0 0 9.8 368.06 431.28 Tm (ensure )Tj 0.05 Tc 10.215 0 0 9.8 399.34 431.28 Tm (that )Tj 9.8357 0 0 9.8 419.98 431.28 Tm (the )Tj 9.831 0 0 9.8 436.79 431.28 Tm (non-retinopathy )Tj 10.1021 0 0 9.8 510.15 431.28 Tm (group )Tj 9.8246 0 0 9.8 306.63 420.25 Tm (did )Tj 10.4827 0 0 9.8 324.95 420.25 Tm (not )Tj 0.027 Tc 9.8 0 0 9.8 344.56 420.25 Tm (include )Tj 0.0148 Tc 3.632 0 Td (newly )Tj 0.0334 Tc 2.98 0 Td (diagnosed )Tj 0.0337 Tc 4.893 0 Td (subjects )Tj 0.294 g 0.05 Tc 10.6555 0 0 9.8 495.27 420.25 Tm (in )Tj 0.227 g 9.9828 0 0 9.8 509.27 420.25 Tm (whom )Tj 10.0265 0 0 9.8 306.62 409.21 Tm (any )Tj 0.157 g 0.0331 Tc 9.8 0 0 9.8 325.35 409.21 Tm (diabetes-related )Tj 0.227 g 0.0384 Tc 7.15 0 Td (changes )Tj 0.0372 Tc 3.781 0 Td (woul)Tj 0.098 g 0 Tc 2.098 0 Td (d )Tj 0.227 g 0.0456 Tc 0.938 0 Td (therefore )Tj 0.0462 Tc 4.313 0 Td (be )Tj 0.0139 Tc 1.319 0 Td (very )Tj 0.0152 Tc -21.451 -1.128 Td (unlikely)Tj 0.38 g 0 Tc 3.462 0 Td (, )Tj 0.227 g 0.0474 Tc 0.605 0 Td (patients )Tj 0.05 Tc 9.8909 0 0 9.8 384.47 398.16 Tm (without )Tj 0.0495 Tc 9.8 0 0 9.8 422.39 398.16 Tm (retinopathy )Tj 0.0239 Tc 5.437 0 Td (were )Tj 0.0423 Tc 2.449 0 Td (required )Tj 0.05 Tc 10.4772 0 0 9.8 306.69 387.61 Tm (to )Tj 0.042 Tc 9.8 0 0 9.8 320.15 387.61 Tm (have )Tj 0.05 Tc 10.2918 0 0 9.8 345.11 387.61 Tm (had )Tj 0.157 g 10.6237 0 0 9.8 365.69 387.61 Tm (IDDM )Tj 0.227 g 0.0441 Tc 9.8 0 0 9.8 401.17 387.61 Tm (for )Tj 0.05 Tc 10.1194 0 0 9.8 418.46 387.61 Tm (at )Tj 0.0241 Tc 9.8 0 0 9.8 431.92 387.61 Tm (least )Tj -0.0179 Tc 2.446 0 Td (five )Tj 0.0287 Tc 2.018 0 Td (years. )Tj 0.0455 Tc 3.028 0 Td (Conse\255)Tj 0.157 g 0.041 Tc -20.277 -1.128 Td (quently )Tj 0.227 g 0.05 Tc 9.8357 0 0 9.8 341.74 376.56 Tm (the )Tj 0.0478 Tc 9.8 0 0 9.8 357.58 376.56 Tm (mean )Tj 0.05 Tc 9.9374 0 0 9.8 382.95 376.56 Tm (duration )Tj 11.1292 0 0 9.8 422.77 376.56 Tm (of )Tj 0.0446 Tc 9.8 0 0 9.8 434.31 376.56 Tm (diabetes )Tj 0 Tc 3.87 0 Td (i)Tj 0.098 g 0.301 0 Td (n )Tj 0.227 g 0.05 Tc 10.0136 0 0 9.8 483.85 376.56 Tm (both )Tj 9.901 0 0 9.8 505.84 376.56 Tm (groups )Tj 0.294 g 11.1292 0 0 9.8 306.61 365.53 Tm (of )Tj 0.227 g 10.1657 0 0 9.8 318.58 365.53 Tm (sub)Tj 0.098 g 0 Tc 9.8 0 0 9.8 332.87 365.53 Tm (j)Tj 0.227 g 0.0117 Tc 0.358 0 Td (ects )Tj 0.098 g 0 Tc 1.961 0 Td (i)Tj 0.227 g 0.288 0 Td (s )Tj 0.157 g 0.0165 Tc 0.748 0 Td (relatively )Tj 0.098 g 0.0106 Tc 4.31 0 Td (hi)Tj 0.227 g 0.0191 Tc 0.826 0 Td (gh, )Tj 0.05 Tc 10.3398 0 0 9.8 432.37 365.53 Tm (and )Tj 0.0466 Tc 9.8 0 0 9.8 452.08 365.53 Tm (greater )Tj 0.05 Tc 10.0233 0 0 9.8 485.74 365.53 Tm (than )Tj -0.0262 Tc 9.8 0 0 9.8 508.72 365.53 Tm (in )Tj 0.05 Tc 10.0265 0 0 9.8 519.74 365.53 Tm (any )Tj 0.0344 Tc 9.8 0 0 9.8 306.74 354.49 Tm (previous )Tj 0.157 g 0.0423 Tc 4.307 0 Td (report. )Tj 0.227 g 0.05 Tc 9.8385 0 0 9.8 383.47 354.49 Tm (However )Tj 0.0478 Tc 9.8 0 0 9.8 428.14 354.49 Tm (mean )Tj 0.05 Tc 10.481 0 0 9.8 456.38 354.49 Tm (ca)Tj 0.098 g 0 Tc 9.8 0 0 9.8 466.55 354.49 Tm (r)Tj 0.227 g 0.05 Tc 10.2616 0 0 9.8 470.41 354.49 Tm (bon )Tj 0.0454 Tc 9.8 0 0 9.8 492.94 354.49 Tm (monoxide )Tj 0.0403 Tc -19.004 -1.078 Td (transfer )Tj 0.0495 Tc 3.615 0 Td (factor )Tj 0.05 Tc 10.6532 0 0 9.8 369.97 343.93 Tm (and )Tj 0.0159 Tc 9.8 0 0 9.8 388.22 343.93 Tm (coefficient )Tj 0.0239 Tc 4.662 0 Td (were )Tj 0.05 Tc 9.8799 0 0 9.8 456.38 343.93 Tm (above )Tj 0.0387 Tc 9.8 0 0 9.8 484.82 343.93 Tm (predicted )Tj 0.0228 Tc 4.3 0 Td (in )Tj 0.05 Tc 10.0136 0 0 9.8 306.73 332.89 Tm (both )Tj 0.0463 Tc 9.8 0 0 9.8 329.2 332.89 Tm (groups )Tj 0.05 Tc 11.1292 0 0 9.8 361.33 332.89 Tm (of )Tj 0.0227 Tc 9.8 0 0 9.8 372.82 332.89 Tm (subjects, )Tj 0.0299 Tc 3.981 0 Td (with )Tj 0.05 Tc 10.0889 0 0 9.8 433.43 332.89 Tm (no )Tj 0 Tc 9.8 0 0 9.8 446.74 332.89 Tm (s)Tj 0.098 g 0.447 0 Td (i)Tj 0.227 g 0.05 Tc 10.2 0 0 9.8 453.51 332.89 Tm (gn)Tj 0.098 g 0 Tc 9.8 0 0 9.8 464.56 332.89 Tm (i)Tj 0.227 g 0.0314 Tc 0.242 0 Td (ficant )Tj 0.0192 Tc 2.745 0 Td (difference )Tj 0.0265 Tc -19.092 -1.128 Td (between )Tj 0.05 Tc 9.8357 0 0 9.8 344.62 321.84 Tm (the )Tj 0.0377 Tc 9.8 0 0 9.8 360.88 321.84 Tm (groups. )Tj 0.0446 Tc -4.555 -1.126 Td (These )Tj 0.0191 Tc 2.838 0 Td (findings )Tj 0.0184 Tc 3.724 0 Td (differ )Tj 0.157 g 0.0316 Tc 2.643 0 Td (from )Tj 0.227 g 0.0279 Tc 2.458 0 Td (the )Tj 0.05 Tc 10.0481 0 0 9.8 446.26 310.81 Tm (study )Tj 10.15 0 0 9.8 472.81 310.81 Tm (by )Tj -0.035 Tc 8.6904 0 0 9.8 486.08 310.81 Tm (SANDLER )Tj 0.294 g /T1_2 1 Tf 0.05 Tc 10.1514 0 0 9.9 527.43 310.81 Tm (et )Tj 0.227 g -0.035 Tc 10.1247 0 0 10.2 306.17 300.25 Tm (a/. )Tj /T1_0 1 Tf 0 Tc 10.2 0 0 10.2 321.35 300.25 Tm ([ )Tj 0.157 g 9.8 0 0 9.8 325.36 300.25 Tm (l )Tj 0.227 g -0.0088 Tc 0.341 0 Td (], )Tj 0.0228 Tc 1.08 0 Td (in )Tj 0.0273 Tc 1.33 0 Td (which )Tj 0.157 g 0.05 Tc 11.1638 0 0 9.8 382.03 300.25 Tm (Kco )Tj 0.227 g 0.0334 Tc 9.8 0 0 9.8 406.55 300.25 Tm (was )Tj 0.0294 Tc 2.098 0 Td (decreased )Tj 0.0228 Tc 4.703 0 Td (in )Tj 0 Tc 1.32 0 Td (a )Tj 0.05 Tc 10.2927 0 0 9.8 495.75 300.25 Tm (group )Tj 11.1292 0 0 9.8 526.45 300.25 Tm (of )Tj 0.0474 Tc 9.8 0 0 9.8 306.26 289.21 Tm (patients )Tj 0 Tc 3.768 0 Td (w)Tj 0.098 g 0.679 0 Td (i)Tj 0.227 g 0.05 Tc 9.8951 0 0 9.8 353.26 289.21 Tm (th )Tj 10.6237 0 0 9.8 364.73 289.21 Tm (IDDM )Tj 0.098 g 0 Tc 9.8 0 0 9.8 398.39 289.21 Tm (r)Tj 0.227 g 0.334 0 Td (e)Tj 0.098 g 0.492 0 Td (l)Tj 0.227 g 0.032 Tc 0.243 0 Td (ative )Tj 0.05 Tc 10.4772 0 0 9.8 432.45 289.21 Tm (to )Tj 9.8288 0 0 9.8 444.47 289.21 Tm (normal )Tj 0.0464 Tc 9.8 0 0 9.8 477.98 289.21 Tm (controls, )Tj 0.157 g 0.05 Tc 10.3398 0 0 9.8 519.25 289.21 Tm (and )Tj 0.227 g 0.0334 Tc 9.8 0 0 9.8 306.23 278.16 Tm (was )Tj 0.0388 Tc 1.95 0 Td (also )Tj 0 Tc 2.009 0 Td (d)Tj 0.098 g 0.589 0 Td (i)Tj 0.227 g 0.0371 Tc 0.251 0 Td (minished )Tj 0.0203 Tc 4.311 0 Td (relative )Tj 0.05 Tc 9.8951 0 0 9.8 429.58 278.16 Tm (to )Tj 0 Tc 9.8 0 0 9.8 441.14 278.16 Tm (p)Tj 0.098 g 0.585 0 Td (r)Tj 0.227 g 0.0371 Tc 0.334 0 Td (edicted )Tj 0.0237 Tc 3.437 0 Td (values. )Tj 0 Tc 3.276 0 Td (T)Tj 0.098 g 0.0106 Tc 0.742 0 Td (hi)Tj 0.227 g 0 Tc 0.819 0 Td (s )Tj 0.157 g 0.0332 Tc -22.966 -1.127 Td (discrepancy )Tj -0.0131 Tc 5.879 0 Td (is )Tj 0.0292 Tc 1.429 0 Td (unlikely )Tj 0.227 g 0.05 Tc 9.8951 0 0 9.8 419.5 267.12 Tm (to )Tj 0.042 Tc 9.8 0 0 9.8 435.35 267.12 Tm (have )Tj 0.05 Tc 9.9334 0 0 9.8 462.62 267.12 Tm (orig)Tj 0.098 g 0 Tc 9.8 0 0 9.8 479.92 267.12 Tm (i)Tj 0.227 g 0.0478 Tc 0.301 0 Td (nated )Tj 0.0316 Tc 3.222 0 Td (from )Tj 0.0127 Tc -21.255 -1.078 Td (differences )Tj 0.157 g 0.0228 Tc 5.438 0 Td (in )Tj 0.227 g 0.05 Tc 9.8357 0 0 9.8 376.3 256.56 Tm (the )Tj 0.0461 Tc 9.8 0 0 9.8 397.42 256.56 Tm (methodology )Tj 0.05 Tc 11.6856 0 0 9.8 462.13 256.56 Tm (of )Tj 9.8216 0 0 9.8 479.44 256.56 Tm (gas )Tj 0.0473 Tc 9.8 0 0 9.8 502.06 256.56 Tm (transfer )Tj 0.0413 Tc -19.984 -1.127 Td (measurement, )Tj 0.294 g 0.0198 Tc 6.306 0 Td (since )Tj 0.0264 Tc 2.412 0 Td (these )Tj 0.227 g 0.0239 Tc 2.45 0 Td (were )Tj 0.04 Tc 2.24 0 Td (similar )Tj 0.0228 Tc 3.288 0 Td (in )Tj 0.05 Tc 10.264 0 0 9.8 480.49 245.52 Tm (both )Tj 0.0263 Tc 9.8 0 0 9.8 502.9 245.52 Tm (studies. )Tj 0.05 Tc 10.2656 0 0 9.8 305.67 234.49 Tm (The )Tj 0.157 g 0.0388 Tc 9.8 0 0 9.8 325.43 234.49 Tm (higher )Tj 0.227 g 0.05 Tc 11.1638 0 0 9.8 354.67 234.49 Tm (Kco )Tj 0.0421 Tc 9.8 0 0 9.8 377.26 234.49 Tm (va)Tj 0.098 g 0 Tc 1.022 0 Td (l)Tj 0.227 g -0.0045 Tc 0.302 0 Td (ues )Tj 0.0228 Tc 1.657 0 Td (in )Tj 0.05 Tc 9.8357 0 0 9.8 417.58 234.49 Tm (the )Tj 0.0431 Tc 9.8 0 0 9.8 432.98 234.49 Tm (present )Tj 0.294 g 0.05 Tc 10.0481 0 0 9.8 466.42 234.49 Tm (study )Tj 0.227 g 10.1212 0 0 9.8 492.86 234.49 Tm (cannot )Tj -0.0028 Tc 9.8 0 0 9.8 525.61 234.49 Tm (be )Tj 0.0495 Tc -22.395 -1.128 Td (attributed )Tj 0.157 g 0.05 Tc 10.4772 0 0 9.8 352.29 223.44 Tm (to )Tj 0.227 g 0.0176 Tc 9.8 0 0 9.8 364.23 223.44 Tm (differences )Tj 0.0228 Tc 4.997 0 Td (in )Tj 0.05 Tc 10.0681 0 0 9.8 424.7 223.44 Tm (duration )Tj 11.1292 0 0 9.8 465.49 223.44 Tm (of )Tj 0.0294 Tc 9.8 0 0 9.8 477.51 223.44 Tm (disease, )Tj 0.0198 Tc 3.717 0 Td (since )Tj 0.0315 Tc -21.196 -1.077 Td (mean )Tj 0.05 Tc 10.6052 0 0 9.8 332.54 212.89 Tm (du)Tj 0.098 g 0 Tc 9.8 0 0 9.8 344.15 212.89 Tm (r)Tj 0.294 g 0.05 Tc 10.1009 0 0 9.8 347.42 212.89 Tm (ation )Tj 0.227 g 11.1292 0 0 9.8 373.33 212.89 Tm (of )Tj 0.157 g 10.6237 0 0 9.8 385.85 212.89 Tm (IDDM )Tj 9.9129 0 0 9.8 419.51 212.89 Tm (wa)Tj 0.294 g 0 Tc 9.8 0 0 9.8 431.86 212.89 Tm (s )Tj 0.227 g 0.041 Tc 0.79 0 Td (longer )Tj 0.05 Tc 10.0636 0 0 9.8 470.32 212.89 Tm (in )Tj 10.264 0 0 9.8 481.93 212.89 Tm (both )Tj 9.901 0 0 9.8 505.36 212.89 Tm (groups )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 10.0233 0 0 9.8 306.22 201.85 Tm (than )Tj EMC ET BT /T1_0 1 Tf 10.6555 0 0 9.8 327.27 201.85 Tm (in )Tj 0.157 g 9.8357 0 0 9.8 338.86 201.85 Tm (the )Tj 0.227 g 9.8471 0 0 9.8 354.15 201.85 Tm (diabet)Tj 0.098 g 0 Tc 9.8 0 0 9.8 381.04 201.85 Tm (i)Tj 0.227 g 0.243 0 Td (c )Tj 0.05 Tc 9.8869 0 0 9.8 390.26 201.85 Tm (patients )Tj 0.0457 Tc 9.8 0 0 9.8 426.58 201.85 Tm (studied )Tj 0.0382 Tc 3.444 0 Td (by )Tj -0.035 Tc 8.6904 0 0 9.8 473.12 201.85 Tm (SANDLER )Tj /T1_2 1 Tf 0.05 Tc 10.1514 0 0 9.9 513.99 201.85 Tm (et )Tj -0.0242 Tc 9.9 0 0 9.9 524.58 201.85 Tm (al. )Tj 0.157 g /T1_0 1 Tf 0.05 Tc 9.9723 0 0 9.8 305.67 190.8 Tm (The )Tj 0.227 g 0.0368 Tc 9.8 0 0 9.8 326.39 190.8 Tm (reason )Tj 0.0441 Tc 3.173 0 Td (for )Tj 0.05 Tc 9.8357 0 0 9.8 373.9 190.8 Tm (the )Tj 0.0418 Tc 9.8 0 0 9.8 390.16 190.8 Tm (low )Tj 0.157 g 0.05 Tc 10.6192 0 0 9.8 409.39 190.8 Tm (Kco )Tj 0.227 g 10.0471 0 0 9.8 431.03 190.8 Tm (reported )Tj 0.0382 Tc 9.8 0 0 9.8 471.85 190.8 Tm (by )Tj -0.035 Tc 8.8004 0 0 9.8 485.12 190.8 Tm (SANDLER )Tj /T1_2 1 Tf 0.05 Tc 10.1514 0 0 9.9 526.95 190.8 Tm (et )Tj 0 Tc 9.9 0 0 9.9 305.7 179.76 Tm (a/. )Tj /T1_0 1 Tf 0.0325 Tc 9.8 0 0 9.8 319.44 179.76 Tm ([I] )Tj 0.294 g -0.0131 Tc 1.437 0 Td (is )Tj 0.227 g 0.0395 Tc 1.035 0 Td (therefore )Tj 0.05 Tc 10.4827 0 0 9.8 385.43 179.76 Tm (not )Tj 0.0168 Tc 9.8 0 0 9.8 403.1 179.76 Tm (clear. )Tj 0.05 Tc 9.9723 0 0 9.8 315.75 169.21 Tm (The )Tj 0.157 g 9.8186 0 0 9.8 335.43 169.21 Tm (only )Tj 0.227 g 0.0266 Tc 9.8 0 0 9.8 356.98 169.21 Tm (significant )Tj 0.0418 Tc 4.755 0 Td (abnormalities )Tj 0.05 Tc 11.1292 0 0 9.8 465.49 169.21 Tm (of )Tj 0.157 g 0.0495 Tc 9.8 0 0 9.8 477.04 169.21 Tm (lung )Tj 0.227 g 0.0463 Tc 2.201 0 Td (function )Tj 0.0299 Tc -19.688 -1.128 Td (detected )Tj 0.0228 Tc 4.017 0 Td (in )Tj 0.0259 Tc 1.231 0 Td (this )Tj 0.294 g 0.05 Tc 9.843 0 0 9.8 376.18 158.16 Tm (study )Tj 0.227 g 0.0239 Tc 9.8 0 0 9.8 403.19 158.16 Tm (were )Tj 0.05 Tc 10.215 0 0 9.8 427.18 158.16 Tm (that )Tj 9.8357 0 0 9.8 447.82 158.16 Tm (the )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 10.2291 0 0 9.8 465.08 158.16 Tm (FEV )Tj EMC ET BT 0.294 g /T1_0 1 Tf 0 Tc 6.5001 0 0 6.5001 486.02 155.76 Tm (1 )Tj 0.227 g 0.05 Tc 10.0265 0 0 9.8 493.82 158.16 Tm (and )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 10.1833 0 0 9.8 514.04 158.16 Tm (FVC )Tj EMC ET BT /T1_0 1 Tf 0.0239 Tc 9.8 0 0 9.8 305.75 147.13 Tm (were )Tj 0.0356 Tc 2.49 0 Td (diminished )Tj 0.0273 Tc 5.347 0 Td (relative )Tj 0.05 Tc 9.8951 0 0 9.8 418.54 147.13 Tm (to )Tj 0.0325 Tc 9.8 0 0 9.8 432.5 147.13 Tm (predicted )Tj 0.0295 Tc 4.502 0 Td (values )Tj 0.0228 Tc 3.227 0 Td (in )Tj 0.05 Tc 9.8357 0 0 9.8 521.74 147.13 Tm (the )Tj 0.0495 Tc 9.8 0 0 9.8 305.75 136.57 Tm (retinopathy )Tj 0.05 Tc 9.8784 0 0 9.8 362.8 136.57 Tm (group, )Tj 10.0265 0 0 9.8 398.3 136.57 Tm (and )Tj 0.0308 Tc 9.8 0 0 9.8 421.43 136.57 Tm (when )Tj 0.05 Tc 10.264 0 0 9.8 451.21 136.57 Tm (both )Tj 0.0463 Tc 9.8 0 0 9.8 478.48 136.57 Tm (groups )Tj 0.0075 Tc 3.73 0 Td (were )Tj 0.0481 Tc -21.413 -1.128 Td (combined, )Tj 0.05 Tc 9.8138 0 0 9.8 352.72 125.52 Tm (impairment )Tj 11.6856 0 0 9.8 405.01 125.52 Tm (of )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 10.2291 0 0 9.8 416.6 125.52 Tm (FEV )Tj EMC ET BT /T1_0 1 Tf 0 Tc 6.2 0 0 6.2 438.03 123.12 Tm (1 )Tj 0.05 Tc 10.3398 0 0 9.8 443.89 125.52 Tm (and )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 10.1833 0 0 9.8 463.16 125.52 Tm (FVC )Tj EMC ET BT /T1_0 1 Tf 0.0334 Tc 9.8 0 0 9.8 486.71 125.52 Tm (was )Tj 0.0372 Tc 1.91 0 Td (related )Tj 0.294 g 0.009 Tc -20.328 -1.127 Td (to )Tj 0.227 g 0.05 Tc 9.8357 0 0 9.8 319.66 114.48 Tm (the )Tj 10.0681 0 0 9.8 336.86 114.48 Tm (duration )Tj 11.1292 0 0 9.8 379.09 114.48 Tm (of )Tj 10.3699 0 0 9.8 392.57 114.48 Tm (IDDM. )Tj 0.157 g 0.0444 Tc 9.8 0 0 9.8 430.51 114.48 Tm (However)Tj 0.294 g 0 Tc 3.957 0 Td (, )Tj 0.227 g 0.0404 Tc 0.748 0 Td (there )Tj 0.0089 Tc 2.695 0 Td (was )Tj 0.157 g 0.05 Tc 10.0889 0 0 9.8 523.67 114.48 Tm (no )Tj 0.227 g 0.0217 Tc 9.8 0 0 9.8 305.62 103.44 Tm (significant )Tj 0.157 g 0.0247 Tc 5.197 0 Td (difference )Tj 0.05 Tc 10.0636 0 0 9.8 405.52 103.44 Tm (in )Tj ET BT /Suspect <>BDC 0.227 g /T1_0 1 Tf 9.9856 0 0 9.8 421.88 103.44 Tm (FEV )Tj EMC ET BT /T1_0 1 Tf 0 Tc 6.5001 0 0 6.5001 442.82 101.04 Tm (1 )Tj 0.05 Tc 10.5727 0 0 9.8 453.98 103.44 Tm (or )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 10.1833 0 0 9.8 471.32 103.44 Tm (FVC )Tj EMC ET BT /T1_0 1 Tf 0.0265 Tc 9.8 0 0 9.8 500.17 103.44 Tm (between )Tj 0.05 Tc 9.994 0 0 9.8 305.75 92.4 Tm (ret)Tj 0.098 g 0.0228 Tc 9.8 0 0 9.8 317.2 92.4 Tm (in)Tj 0.227 g 0.05 Tc 10.0895 0 0 9.8 325.34 92.4 Tm (opathy )Tj 10.3398 0 0 9.8 358.93 92.4 Tm (and )Tj 9.831 0 0 9.8 379.19 92.4 Tm (non-retinopathy )Tj 0.0459 Tc 9.8 0 0 9.8 452.56 92.4 Tm (groups, )Tj 0.05 Tc 9.9809 0 0 9.8 488.5 92.4 Tm (so )Tj 9.8357 0 0 9.8 502.06 92.4 Tm (the )Tj 0.0418 Tc 9.8 0 0 9.8 518.8 92.4 Tm (low )Tj 0.0197 Tc -21.741 -1.078 Td (values )Tj 0.0239 Tc 3.087 0 Td (were )Tj 0.05 Tc 10.1333 0 0 9.8 359.51 81.84 Tm (not )Tj 0.0301 Tc 9.8 0 0 9.8 377.67 81.84 Tm (obviously )Tj 0.157 g 0.029 Tc 4.661 0 Td (related )Tj 0.227 g 0.05 Tc 9.8951 0 0 9.8 455.98 81.84 Tm (to )Tj 9.8357 0 0 9.8 468.46 81.84 Tm (the )Tj 0.157 g 0.0386 Tc 9.8 0 0 9.8 485.3 81.84 Tm (presen)Tj 0.294 g 0.0157 Tc 2.829 0 Td (ce )Tj 0.227 g 0.05 Tc 11.1292 0 0 9.8 525.49 81.84 Tm (of )Tj ET endstream endobj 3 0 obj <>/Filter/JBIG2Decode/Height 1752/ImageMask true/Length 20902/Name/X/Subtype/Image/Type/XObject/Width 1240>>stream '6 z1uqcc/i zKoe)eP6C{",29~Jd ㈃,Sligci$ȣ$5e*Ѣ+ecǂ>H84J0DVi]F8 kc%E1L#?čuYp[ &=s# MFڵɿү%ɱ쭕%7?+l6('8K/ v*M-('kX&|! _p4a9i 7bA [~6i"3#CtG@cN?t۽KP78d'n ,I s`we!Rz=~|`ϯ4TLƺIι d"bLe>m1:i5帯hwsEm)gqp(ݷmO ׁҝ,j71K@zwȰUY=Bi]bH9qxOhG:?u-{崆QΗ'x5jTT& T#rw.iȭPo+s< ٞ|d} *&et1aUٞςeρ˽&oq_;2LN4:j TunRHpRW0U-TCw.x&y3;ܙ}?O5"r Mj$3< $=̿.@BEU}د܅WhB2l؟/șhlF 3O̖ \ S>9ʇQ6S|AsJ>Ԫu4!>YѶu.N+ >@uJ@/obϡ;Rf ht&*(s&w$SII;_ƣ pVP9QGY7  rr0o 1%.\ uTndLnP~rzb XAu3`O;.ca䬱WK?&,=.p0ST¢Pg>W0`P?SOoUq%J gQGeظv~nlʿ1n76,[+^kʡ:hȉͦ$(*ro\&SJ% a $˫%`T?a2KLvê-__qΉg~C5g.F˽oyvWѵs3gvJ4KI3dxC! rÒ}$ 6/lJhHÓcnBP/s;L7,sme.8J{rr?yz !羚| %= <8=LE*[ę#qzS_@\.⮮H;Fq0'JUr]S 4@~nϷu{3jԱ% :LPˮ|7#V`%T@eT6H$29yGIphmE{g\99́*6;M:g`b0!Aء'OV9G) Pi? Hwsz/G KJ߇҈&#fn.[u ݟk0|i%2,zoH{A!ǧ{#&4`t́OŞ'и@\a*;c( dV/+Buf1 4t篣|)qCٮB8YQz^(Xj]h)$Od/]mC_[4Y# 'VV8?@R7s%;xqh(X D Oben` չ"TOG\ ΌJ3&8Bϻ]"-G|Qܺ^{۟khG$*FDvb;c@h{r$A,_DSd`u |ұ$C40OFIsk{sy"IsX3Z{vdj;6[TI^G{a^q3^nI8n o ivHGu'ߠÚ֜K[r*7)}n>l^Z|Xꎁ9dKcwyȖB*b q&mLZ7tͥlACWJB-Z]I:4ͥD5-fZH!1;Gx|aw k}6Nj$JY1P#V#|z܊rғp琍=,XН/䡂 R8\4wgV2m8"gi49ч|#j5~U֛h\q3ĪvtS I:WՇ<"_zHe ViJ$;I "YDxfϡ;Yhpc*u;r_#B̊/ZXf{磠g޻Gz!ov>E݆5F羧NMh>}&Q6Xȸ /ḒXd~4rV]!_=PJ<;x45 mV겦<= K7zs2?(H܄ҫ #o<]vĻɸkv0"5oغޒ $7n<c![`KqhآB"b5N(Sn#Y~&4/*#ߗh:-o =t?8n>b38{yVY8&Fu* T̐f"Pz:rjNX9x33/?`FPDO(?mJ|D}Bѯ?]΀)a<&"D %\/}cQ䤊ZQ @x47H 6o*Y͜Rý=&CYcu$ oͺzuGǸ]`ړEV15Sc$RWJ9p{tL+0 21'+7H2-mE/*SV÷ _Bԯ'4D(+T \J,^S UOzmby>5s7 \ x `ɓZNl5ܙ}1[s{#uUV-jc?.}rv@}ͤCf UN &<_GVI?ϑƣ:}V|G6܋hU⵩Sܣcwo" $x m wvcC=\Tը׍u\AJ:/m+(LR\4B g AnX^e9A '4<;FZlTTdus6zϴԳ2`Q) N|v=˄2 f,pWpqۚzxfR%R^_B&_๰ጅ_pz> |D_Isٮf@A]~y9N= Q-О'( q ;>}<7S1LLgR{r5"i3T5BtB3;Qǜ[|Ų^fXdynj_#q,E}? 6.AOlQ,n zaV("\zz?&Zg傼HtuIk!]plֶP]a5$ >wO%P-Tw-JPZZ+5x2U~j݄S$:rTe='C1^=ӗv-KǾ`Y}y1Ȥ 2IF)H@&o;ㇽH 6AA8.&@ڂ~IM)CSssЫDLC#\M{#()I {јeBEa噡 9 ZޕOslZ`d:"ha2X(kP!2D#f VXO%WXz!v[$VԏCqd Țo-~͞4%/BcFL[Q+drLJ>4I|R:ޭbTn"͡n?ECm7bL(S/iyx)ըOtW9"-[GMFUf\}TǺٮ$dv^|tSGw|;G@)TW CumZ+RY15Hy $n4s`8dۣ|)Ɗx+R!Fӧƞ-Ġ;g\ʖ$_țfRrL)ࣵk`+ ^A֣HE1 MѝU̽4nTۅwBcL +E|_W%bTxw\I^ħ*EYlvy׺#nPvI+UUhBL!dP* U!&N:;]$^$F>k9cˀ4!}3~^ eG/~Hf\c1ק4ڢvUƌ-hѰq mh o\H"A+V| ۏg y=: yCǒvHd$ L;2AY˄A7{A %K`hִsg%w%@>=6W@&-'B%9E w"'lGv˴^ͤMYoё\W&O/9y Yz'$ u02;rj*K|]gTt3r pӲ_gp>hP2W{5|#gbO3P΀xK!H]Xz AhɈ:|RGZ],:8 _+ڐ oĘ_<1 UОTHZl?IT_kv]aWhc:ׅN1Nej:4,Wg#g#9&*8`TU>"o'f1ps9[Qb!xP8* Ȇ#cɐeg7 #4}ںpw6K.@lFPѶ@|>}IALW '2ڏ qȏX}^^Xq!fࠜn;j`"E B6߲M"xnd*ktN` UlX؅dA<|wǒ9i)w\n;c |y41!4Cto5!a8 =ѭOhT~4q#m0jw˙.z$+~ ,.~ĻH@G*2/zACvo`kCR[ 䦪}!-. ?p5onFe &~2憷Ilfa:}pjK"Ta30\khӃ)eݡŵ#WC2ԉб~$삘Yi(UC;l>S.3s)Vx!4Dž{!ݫj،# w@\*Œ@Vq8}1,/s̳)LÏE 3Sgo3Yw\Raw8W7Q9$:}uVc|pO5vpJ-AX7ϑ@ĺVI>7s6;H7=3Rz)_!xWvlx{exP*m]at%34d/>g?-(OZG^\Ό+ٝa'xI1?״n-VЈZj ;7Sh}P0Q}]wXt< UJL)yLEc]m:HZQK%`hW&{'"ROiT[AUb ?֘e\2~F1gŧ;U\W&pL٨ 5>~;l"HpD(p#Oqu=QJ]pjɗw3H-dfd" BHQ# 8zuDh/pP(?]LV=Gȃ"`{~縓[{AsA b &X1b>Ȧ$u E CQ03O;R;̭Q9)-03N!ha\W\3Ԩ萻WT 2h w^vAHKj1 YGuNzjZխpW 8sZG?)o\U+J8z=oip8GfDOth {D4AP| ׸2vad &z>Xj>%^їpdr/S> V 7b2L@Җ~ U< )[;%N5lB2oaAvu6{CO]ƧQ%+3aU~k Ւ~"PiZnq$`&LLSS]⭡m~4#^:bBMD1Pvv蝣10Bs*V_:]֫gUKHJ>+n4p _c8$xT/C1tMa:h}x~v-X!b3|H̙͈<XC~"TgZg,Ť1 ÆSyZO WY\iIBbTpp -pP`_T=нbխj$@= facknS Iq`e}cp*3| 8VQK,gqgewK=z({DoVѳ7 I)>{NJ#òmNq1:d`m3c pHR>* k eakp($σ<@kS+=b  ?o|aČ稅6H>}1 5["8H~NGь˓@AG'scV5=Ƶjfb k'f^*xt7Q+l#H`ByӅ:*ԚRzK^&#P֧iO,/nbE7p8?7$60n}VoTVͿPcnkq/I!I!ScaҊH#kl_|%7Ϫ!o2Lh:m)ghG3qSfӍLU`^HWq͟Iz/6Zx4]Uu>O:4"=1 +:`S Sk՞IGNwjlt@Y߸jI]ښ9GxnKUI)+^]*ƕ {xQ*p/)7]pgwNX:g`Je)VIvu Gj*[T$0̢vVb$ KT!stj^ O9N=)# IWjsJ+l-C[Pq1!# uD$59m(DM,KNV~Pvh\Cmfm:- 'KEPA{C0] WKL7$ +CxMfkcmep1OSPRlDFس/p樓)?GovC#r6<^&v`+ɺ ;+SrVb\}(D&sp^:UZrnRE[3J<赁],Fё/5e,VGr51:$CB.z@ F7g tW:̳X n ËnqCqFjMO\|]p%v\ف|t\Rr"6u&O &n %0~2bLyyT/85v${bF!5 g{ =4w%i9> H RSK;7c6zAs\ay鸂4\gHUUGh=|3]ɽ{Vc£U~Ac @fyV\Tn)uo2H ޵'g^lJ|k5DrV'?',CpSuWM!$ͅS$'_Ggk0@ )6xy=]@yɤ t򝼰WAl$/6?#s0= 9b(VpW1Wz6{qMᬔ]ӡ?E:Q%rCĄ6vLSJ:l_S8Bq1yӅaRր4B0WrsA^9T"$RsAH6f'-gp={x%ģf*r3蠁[ kʔJFɰP|tEҫsFx {"="/i\jX?>Mrѩj)A>qF]Ee9Z2PAl|b&q0;ѕE6[`kf Zy[2og6 f]PbG/J\Q"IGTHQZ(WUHGf NZ.845 / *rߜI;׬R ѺEh] @ҐisMŪOV~)bY|]۪ G]fTjЌ_ҏ͈=}AD%d˥"!BHqTeze{XhiF~`Q̢Y'ƀ ]%gbh@w'9-ɀYnj<=2ӛXU9IJ..ڒ.?*fGŔ jtpKKh}[4(n{Ճ!`q&#g'$Z#SMg?%?bU%5{f>"ڳoa03Q-{ KAblK VtB NV=41>sUP#3q\&HȻe$I R){Xc_0r6~ra2W˿}k~Wr8CkZ[ 0:v}cԤڠ.WܶM~,]/W _nv Տti,mJ2>]f f~KSDۼtuyY%$vu5yi]o8ܷq;Pd*A.rZ#du'1Y P F⫆ e}K }O+^\4~V2LƊHw;!Ⱦ߰ER\k*1>Z88r"S8\!9]d?|0p8Τ I>7rEvKv;#nTwD ]?2mZIyxNu3'j_Rn+Y_/^1s4D%$7ޯ}O 2& -OQ'i=2.6,O$6DwZ'œ 6kiWuǀ9,HlAG_h]4:SH7z-نې [ӻOU#+4|0U! i;3uQm_#?!`4X#Nn%~KQVm*]zj0EhF^uZ qC#Ī '%8b~N0IӘHͫV'I=K(ƅ.!r@'?mWp4]=ʤu\]8΁xwIR_@Av1rU J٩ƛ j(}­Pr=Kx^+kK\HG<5N@KlK1 <؀T3nC!&tw~[|DcJ_QnOz$h|˯2>\vicC3Xd Dv9E(X t Vϻ>  k+uHBХ[ABe?ݲjGc^ b/,F?rk@`Yx<^)U\|:^Ʃ|8tXhX{Nj6z݀AG,#&kerdhKh~{x+ %vϾ(7C 'j^w_e Wh sݯ'eHnQj~Mb8Ln~$_㼊}4^s<Ip`Y Tピ9|^ &!*J'R.qO!LHk.A>p3xv /J́PW06}@̜um]VdlA'vC˿PB{+Sfzx nx%[`b1Y_w(ÜP{=6U<(O8'`mm G>*scIM$%/ 0Fѳ'MP ,\ &1愅T%PH 1>;kF7e6WJ4I?ga\ֈPn86fr{$ VP&b;n#R qȦA LɸAŻ6F^jII+.ߧ(u3C{/ b-]sWJp M{ܫS$TYǤ9'gm{m- d0i$Oy"5c[%QXl~ w4c,x" }{~g J҈ien )SQI,G֐q,xS f VJ*ﴐؒG]{4.D EZŰ#7:-\ 4scSvO@4%tt %o5A@3y@qfFe'^˛ b_wV´; ,XʂIsxdCg1TV>;x$ 4`'QYj1vR0[|찇=-4ڨMN"Õ=ɭ6g֟w~u~D<;f_>Aŝ`z@O *_y)h %iwϝa!ɷkC)Z_*x E'O)8N;{/X@L9PAX?8Ӑ"3VuBk?!g.> SDW% ka~`9>!g$I h O?ȗ6*1M5êdZvjOoiɾY*kD,?X?!ANCESUmiTnp~БaE; ӄ ϓ`OT$Q?D1aF6ixAܦO@`[ILmODѱ&%z${H~xx4{BRgrZ nIWIP]JHqjPO ?z?- ˈFo e=nvFr6p , ׼ Q O? {YT5]4ָdߠK1tTIQJىUQd@7!oGv3K- ˗@Sj᪰=u Il>+EGhWyڭB{?u}Z09bK[`s`iw.p ,@e n2+a1uP z%YX(h!]_xi1AB()AUb:D\>yȰn0H1Ҫ,jQ5o y&[k H34.) >C-r= fw1)b+y pdIM1u"9gjcM pL+ ]"kpsFg$ڢxO4{\-~d=*~s k{4|ШmyB3@>OCѴqt0=.A]ԎWo6:u*DRGɰS !LD6uYԵ 8k$4¾S03J?A+ڄz5e>֗H8]7)S_A lˤ%<0p…@sryOj  麶 zf3pIQqmklvSlh)ǹurS94ȽM5|.}8mTI Afy:x8"_d`m$>綫HLj 7cHhWR) Zao C|p0󝣼4a( ַl]BQ>ǽX"cԐ̉z,*<;F-* .4X7U#}\#+QQ)Y >o6gb yXDcj3ttbOYrpkxXfS_Y&i-g$*OnGw"8'pS|C*(9e`^P$vwi& %q8z}AHDd'B1c 4$Ta8Q4~JNUrihr%R0qmDd?_QYYhMff%/TYF៍ƀȳ;ɇ /WyuWpR)فXux|~SVmI60 mIcI"NXwr[Qzo>n5iԅLi ܳ t6PU'4jq yP#ndnR4p>ח2L{( زǜH΁]ﶲwig\Ƚ=+9=s*f5V8\#'|Es.Uw4T-) ~CI\Y,_$)5'Wp[RaަiI+ fg k8-K#0i#G:2vFN(%̭CP0[ .jW42_ֿ\ZSY=wmHNWq2΂ѤO>Z gjd+s$-@_kT!޽LNrA+ C*S_13c3vmKJ bBU}SЭp׾ʧ%1"e4qC ^uϗ-*f;E"Gײ!s L7R3]" թm1; {Q灊$ 0K=nzM"T&=t({>[Z֛zrEw NF>ѕo/%һv'OjT&廄 W{XV}߼q4D-A"ĿcZu#!hbyxMfN8>P-- TdXjRd7DQqK(k &署e<r eSz19PƢwZ0GJªG1ׁzv&h\NTN-wnUA= ؅=pw#4eڑAkc{q2fKB. oҪmMh(&}a2X0dU,B8HG3#Y$`j^3$\5YNS!_ܣ<ɕ̭w7\fqh)su\JLRLvB/s~Ԑk_dC$iWV0 hCteQG :hP楅|N/=Ԡe2aYae9H:9P'&!W>vO] i(R7O17qA?G-8n|Q67$oE]8D]Uvz)Q#uyh5:G rq#O3M+)8G4p]EkL71_F*TA6Kɒ%Jݺ^`!ChGFgBԝ' yJ9g>G"j*GIP笡G / h- 8 v#+E%BԌϾD)bK X ;ً)Me-]n+*=[*6MH=|spY-@wP3` Hd܉ۊF$+va˙p-,ނV׉I\b hdeGOe)#O Ck35\$ Ip0 ӊ^xv<#z%{9ǎ].t!*턟suks#'nl=#č㮧+ux 85V-|7I^<%!D䊀*]žgqu7'y%w _QfSKYizigT*M F46\qA.ONBBe蒎})mg|-k`| 0 ^KIf0"4as+\IX (K'Zpb2LzK{IQl#57"jZ+VBȇvΔbPPcoˍ'/ytӫ\IF懒$U_䟸$t*0E?wh=-A3.Ն2\oU5;I;9khd?%]'Z81ߩ)?UYbixouIvqTsl(0Էc Tw5o{Byko0o'O0Iu*y"#MO%SC$hxOɎwE,?y@@ʖ56:)3Jqw}$oҾy+I;Oɤ5;C5qЃ{xaH#E["߀Mê"k>J_vM}'R=Vn=V'T bS$#%<髆ʫ|;ٖBgH70-JM2E`/Jj}m̹x::i] R\W7suL?(*%Bnʀ>0MeuX%䙨i3rKalIRv/wm!fK zB{zl\\˫h,h© 3`^KvPHm)^e^˛.+>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr&colrqjp2cOQ/&&R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ  t  %: @@  _>:c    endstream endobj 5 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr*colr~jp2cOQ/**R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ t ڀ @@ @ + |"@:=  : E   endstream endobj 6 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr"colrmjp2cOQ/""R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ t  " : @ Ѡ>)D    endstream endobj 7 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr6colrejp2cOQ/66R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ t ! : m@ |! s    endstream endobj 8 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr&colrvjp2cOQ/&&R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ  t ! @:@  !:|" :o+   endstream endobj 9 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr&colryjp2cOQ/&&R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ t  &@@ :@   |!@   :    endstream endobj 10 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr&colr|jp2cOQ/&&R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ t  &@@ :@   |! #)  :0C   endstream endobj 11 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrFcolrijp2cOQ/FFR \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ #t "  :  |!    endstream endobj 12 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr&colrsjp2cOQ/&&R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ t ! "@: @  @: O   endstream endobj 13 0 obj <>stream h21S0P01W0U0P0W0475R0Q04210>m endstream endobj 14 0 obj <>/ProcSet[/PDF/Text/ImageB/ImageC]/XObject<>>>/Rotate 0/Type/Page>> endobj 15 0 obj <>stream q 0.208 0.208 0.208 rg 595.1999969 0 0 840.9600067 0 0 cm /Im0 Do Q q 16.3200073 0 0 15.3600006 71.5200043 782.8800049 cm /Im1 Do Q q 27.8399963 0 0 14.8800049 225.1199951 782.8800049 cm /Im2 Do Q q 12.4799957 0 0 14.8800049 263.5200043 782.8800049 cm /Im3 Do Q q 12.4799957 0 0 14.3999939 209.7599945 778.0800018 cm /Im4 Do Q q 12.4799957 0 0 19.1999969 570.7200012 405.6000061 cm /Im5 Do Q q 13.4400024 0 0 13.4400024 570.7200012 156.9600067 cm /Im6 Do Q q 13.4400024 0 0 18.2400055 572.6399994 44.6399994 cm /Im7 Do Q BT 0.243 g /T1_0 1 Tf 3 Tr 7.9001 0 0 7.9001 162.71 755.76 Tm (A )Tj ET BT /Suspect <>BDC 0.306 g /T1_0 1 Tf 0.05 Tc 8.6463 0 0 7.9001 172.16 755.76 Tm (STUDY )Tj EMC /Suspect <>BDC 0.243 g 8.4549 0 0 7.9001 207.28 755.76 Tm (OF )Tj EMC ET BT 0.306 g /T1_0 1 Tf 8.288 0 0 7.9001 222.64 755.76 Tm (GAS )Tj 0.243 g 8.6446 0 0 7.9001 244.25 755.76 Tm (TRANSFER )Tj 8.805 0 0 7.9001 295.62 755.76 Tm (IN )Tj 8.4612 0 0 7.9001 310.04 755.76 Tm (DIABETES )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 8.6373 0 0 7.9001 358.52 755.76 Tm (MELLITUS )Tj EMC /Suspect <>BDC -0.035 Tc 10.5182 0 0 11.1 508.76 755.29 Tm (405 )Tj EMC ET BT 0.149 g /T1_1 1 Tf 0.0341 Tc 8.6 0 0 8.6 130.5 732.24 Tm (Table )Tj 0.243 g -0.027 Tc 2.957 0 Td (2. )Tj 0.306 g 0.05 Tc 8.6653 0 0 8.6 166.48 732.24 Tm (-Regression )Tj 0.243 g 0.0188 Tc 8.6 0 0 8.6 220.7 732.24 Tm (coefficients )Tj 0.0149 Tc 5.583 0 Td (and )Tj 0.0321 Tc 2.015 0 Td (their )Tj 0.0213 Tc 2.397 0 Td (standard )Tj 0.0184 Tc 4.407 0 Td (errors )Tj -0.0122 Tc 3.06 0 Td (in )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.014 Tc 8.6 0 0 8.6 380.5568 732.24 Tm (all )Tj EMC ET BT /T1_1 1 Tf 0.0189 Tc 8.6 0 0 8.6 392.5796 732.24 Tm (subjects, )Tj 0.0217 Tc -30.474 -1.228 Td (smokers, )Tj 0.0428 Tc 4.463 0 Td (and )Tj 0.0234 Tc 2 0 Td (non-smokers )Tj 0.149 g 0.05 Tc 8.6234 0 0 8.6 239.02 721.68 Tm (fo)Tj 0.306 g 0 Tc 8.6 0 0 8.6 247.52 721.68 Tm (r )Tj 0.243 g 0.05 Tc 8.6243 0 0 8.6 251.79 721.68 Tm (FEV)Tj /T1_0 1 Tf 0 Tc 6.2 0 0 6.2 269.55 717.85 Tm (1 )Tj /T1_1 1 Tf 0.0149 Tc 8.6 0 0 8.6 274.47 721.68 Tm (and )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.0248 Tc 8.6 0 0 8.6 291.154 721.68 Tm (FVC )Tj EMC ET BT /T1_1 1 Tf 0.0355 Tc 8.6 0 0 8.6 310.891 721.68 Tm (\(%predicted\) )Tj 0.0249 Tc 6.314 0 Td (against )Tj 0.0228 Tc 3.573 0 Td (duration )Tj 0.0253 Tc -30.865 -1.395 Td (of )Tj 0.0308 Tc 1.116 0 Td (diabetes )Tj 0.0099 Tc 4.345 0 Td (\(yrs\) )Tj 0.0428 Tc 2.351 0 Td (and )Tj 0.0245 Tc 2.056 0 Td (pack-years )Tj 0.0136 Tc 5.426 0 Td (smoking. )Tj /T1_0 1 Tf 0.0227 Tc 8.7 0 0 8.7 130.52 687.61 Tm (Factor )Tj /T1_1 1 Tf 0.0249 Tc 8.6 0 0 8.6 130.35 665.53 Tm (FEV)Tj /T1_0 1 Tf 0 Tc 6.2 0 0 6.2 147.63 662.17 Tm (1 )Tj 0.0151 Tc 8.7 0 0 8.7 130.52 642.97 Tm (Duration )Tj 0.306 g 0.05 Tc 9.4598 0 0 8.7 164.55 642.97 Tm (of )Tj 0.243 g 8.7389 0 0 8.7 174.18 642.97 Tm (IDDM )Tj 0.0398 Tc 8.7 0 0 8.7 200.56 642.97 Tm (only )Tj 0.0404 Tc 8.1 0 0 8.1 245.68 642.97 Tm (all )Tj 0.306 g 0.0089 Tc 8.7 0 0 8.7 257.16 642.97 Tm (subjects )Tj 0.243 g 0.0192 Tc -1.324 -1.214 Td (smokers )Tj 0.0191 Tc -0.043 -1.27 Td (non-smokers )Tj 0.0151 Tc -13.19 -2.483 Td (Duration )Tj 0.306 g 0.05 Tc 9.4598 0 0 8.7 164.55 599.76 Tm (of )Tj 0.243 g 8.9102 0 0 8.7 173.7 599.76 Tm (IDDM )Tj 0.0145 Tc 8.7 0 0 8.7 201.03 599.76 Tm (allowing )Tj 0.306 g 0.0312 Tc 5.131 -0.054 Td (all )Tj 0.243 g 0.0089 Tc 1.321 0 Td (subjects )Tj 0.306 g 0.0143 Tc -14.563 -1.214 Td (for )Tj 0.243 g 0.029 Tc 1.392 0 Td (pack-years )Tj 0.0189 Tc 4.84 0 Td (smoking )Tj 0.306 g 0.0192 Tc 7.007 0 Td (smokers )Tj 0.243 g 0.0199 Tc -13.232 -2.538 Td (Pack)Tj 0.4 g 0.0085 Tc 2.034 0 Td (-ye)Tj 0.243 g 0.0023 Tc 1.325 0 Td (ars )Tj 0.306 g 0.0281 Tc 1.431 0 Td (smoking )Tj 0.0398 Tc 3.811 0 Td (only )Tj 0.0036 Tc 4.633 0 Td (all )Tj 0.0089 Tc 1.321 0 Td (subjects )Tj 0.243 g 0.0192 Tc -1.324 -1.269 Td (smokers )Tj /T1_1 1 Tf 0.0248 Tc 8.6 0 0 8.6 130.35 533.53 Tm (FVC )Tj /T1_0 1 Tf 0.0309 Tc 8.7 0 0 8.7 130.04 511.44 Tm (Duration )Tj 0.306 g 0.05 Tc 9.4598 0 0 8.7 164.07 511.44 Tm (of )Tj 0.243 g 8.7389 0 0 8.7 173.7 511.44 Tm (IDDM )Tj 0.0214 Tc 8.7 0 0 8.7 200.56 511.44 Tm (only )Tj 0.0036 Tc 5.185 0.055 Td (all )Tj 0.306 g 0.0168 Tc 1.266 0 Td (subjects )Tj 0.243 g 0.0284 Tc -1.324 -1.268 Td (smokers )Tj 0.0246 Tc -0.043 -1.27 Td (non-smokers )Tj 0.023 Tc -13.19 -2.482 Td (Duration )Tj 0.05 Tc 9.2796 0 0 8.7 164.07 468.25 Tm (oflDDM )Tj 0.0223 Tc 8.7 0 0 8.7 200.55 468.25 Tm (allowing )Tj -0.024 Tc 5.186 0 Td (all )Tj 0.306 g 0.0168 Tc 1.266 0 Td (subjects )Tj 0.0143 Tc -14.563 -1.269 Td (for )Tj 0.243 g 0.0229 Tc 1.447 0 Td (pack-years )Tj 0.0189 Tc 4.785 0 Td (smoking )Tj 0.0192 Tc 7.007 0 Td (smokers )Tj 0.0296 Tc -13.343 -2.483 Td (Pack-years )Tj 0.306 g 0.0189 Tc 4.901 0 Td (smoking )Tj 0.0398 Tc 3.811 0 Td (only )Tj 0.243 g 0.0036 Tc 4.633 0 Td (all )Tj 0.306 g 0.0168 Tc 1.321 0 Td (subjects )Tj 0.243 g 0.0192 Tc -1.324 -1.27 Td (smokers )Tj 0.0186 Tc 10.2 0 0 10.2 43.18 378.97 Tm (microangiopathy. )Tj 0.0317 Tc 7.852 0 Td (The )Tj 0.149 g 0 Tc 2.165 0 Td (l)Tj 0.306 g -0.0251 Tc 0.281 0 Td (ow )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0293 Tc 10.2 0 0 10.2 166.5184 378.97 Tm (FEY )Tj EMC ET BT 0.243 g /T1_1 1 Tf 0 Tc 5.2 0 0 5.2 187.52 376.56 Tm (1 )Tj /T1_0 1 Tf 0.037 Tc 10.2 0 0 10.2 196.22 378.97 Tm (and )Tj ET BT /Suspect <>BDC 0.306 g /T1_0 1 Tf 0.0483 Tc 10.2 0 0 10.2 217.3952 378.97 Tm (FYC )Tj EMC ET BT 0.243 g /T1_0 1 Tf -0.0079 Tc 10.2 0 0 10.2 243.752 378.97 Tm (in )Tj 0.0265 Tc 1.324 0 Td (the )Tj 0.149 g 0 Tc -20.987 -1.082 Td (r)Tj 0.306 g 0.0304 Tc 0.32 0 Td (etinopathy )Tj 0.243 g 0.0214 Tc 4.766 0 Td (patients )Tj 0.306 g 0.0128 Tc 3.525 0 Td (may )Tj 0.243 g 0.0158 Tc 2.025 0 Td (have )Tj 0.306 g 0.002 Tc 2.214 0 Td (been )Tj 0.243 g 0.0359 Tc 2.154 0 Td (due )Tj 0.306 g 0.0253 Tc 1.796 0 Td (to )Tj 0.243 g -0.0052 Tc 1.075 0 Td (differences )Tj -0.0079 Tc -17.927 -1.082 Td (in )Tj 0.306 g 0.0186 Tc 1.453 0 Td (smoking )Tj 0.243 g 0.0243 Tc 4.154 0 Td (history)Tj 0.4 g 0 Tc 2.903 0 Td (, )Tj 0.306 g 0.0286 Tc 0.908 0 Td (though )Tj 0.0299 Tc 3.565 0 Td (subgroup )Tj 0.0057 Tc 4.569 0 Td (analysis )Tj 0.05 Tc 11.1292 0 0 10.2 261.49 356.89 Tm (of )Tj 0.243 g 0.0216 Tc 10.2 0 0 10.2 42.58 345.84 Tm (smokers )Tj 0.037 Tc 3.722 0 Td (and )Tj 0.0157 Tc 1.844 0 Td (non-smokers )Tj 0.0079 Tc 5.6 0 Td (within )Tj 0.306 g 0.0029 Tc 2.964 0 Td (the )Tj 0.243 g 0.0297 Tc 1.507 0 Td (retinopathy )Tj 0.306 g 0.037 Tc 5.121 0 Td (and )Tj 0.243 g 0.025 Tc -20.697 -1.035 Td (non-retinopathy )Tj 0.0232 Tc 7.051 0 Td (groups )Tj 0.0069 Tc 3.107 0 Td (involved )Tj 0.306 g 0.0215 Tc 3.912 0 Td (too )Tj 0.243 g -0.035 Tc 9.9503 0 0 10.2 203.41 335.28 Tm (few )Tj 0.306 g 0.0078 Tc 10.2 0 0 10.2 221.14 335.28 Tm (subjects )Tj 0.243 g 0.0192 Tc 3.579 0 Td (for )Tj 0.0027 Tc -21.073 -1.081 Td (reliable )Tj 0.306 g 0.0032 Tc 3.379 0 Td (analysis. )Tj 0.243 g 0.05 Tc 10.2656 0 0 10.2 52.23 313.21 Tm (The )Tj 0.0162 Tc 10.2 0 0 10.2 72.47 313.21 Tm (relationship )Tj -0.004 Tc 5.225 0 Td (between )Tj 0.149 g 0.0075 Tc 3.615 0 Td (imp)Tj 0.306 g 0.0268 Tc 1.598 0 Td (airment )Tj 0.05 Tc 11.1292 0 0 10.2 214.93 313.21 Tm (of )Tj ET BT /Suspect <>BDC 0.243 g /T1_0 1 Tf 10.2291 0 0 10.2 226.52 313.21 Tm (FEY )Tj EMC ET BT 0.306 g /T1_0 1 Tf 0 Tc 6.2 0 0 6.2 247.95 310.81 Tm (1 )Tj 0.037 Tc 10.2 0 0 10.2 254.3 313.21 Tm (and )Tj ET BT /Suspect <>BDC 0.243 g /T1_0 1 Tf 0.0483 Tc 10.2 0 0 10.2 42.6806 302.1634 Tm (FVC )Tj EMC ET BT /T1_0 1 Tf 0.037 Tc 10.2 0 0 10.2 69.4964 302.1634 Tm (and )Tj 0.0298 Tc 2.212 0 Td (duration )Tj 0.306 g 0.05 Tc 11.1292 0 0 10.2 134.77 302.16 Tm (of )Tj 0.243 g 10.6237 0 0 10.2 149.69 302.16 Tm (IDDM )Tj 0.0017 Tc 10.2 0 0 10.2 186.23 302.16 Tm (was )Tj 0.0188 Tc 2.156 0 Td (certainly )Tj 0.0264 Tc 4.188 0 Td (con\255)Tj 0.0233 Tc -20.472 -1.034 Td (founded )Tj -0.035 Tc 10.0482 0 0 10.2 80.65 291.61 Tm (by )Tj 0.306 g 0.0139 Tc 10.2 0 0 10.2 92.98 291.61 Tm (smoking, )Tj 0.243 g 0.0081 Tc 4.109 0 Td (because )Tj 0.0396 Tc 3.425 0 Td (after )Tj 0.0131 Tc 2.212 0 Td (allowing )Tj 0.306 g 0.0192 Tc 3.811 0 Td (for )Tj 0.243 g 0.024 Tc 1.472 0 Td (pack\255)Tj 0.306 g 0.015 Tc -20.003 -1.083 Td (years )Tj 0.0233 Tc 2.952 0 Td (smoked )Tj 0.243 g 0.0265 Tc 4.059 0 Td (the )Tj 0.306 g 0.0174 Tc 2.059 0 Td (statistica)Tj 0.149 g 0 Tc 3.675 0 Td (l )Tj 0.306 g -0.0043 Tc 1.077 0 Td (significance )Tj 0.243 g 0.05 Tc 11.1292 0 0 10.2 239.89 280.56 Tm (of )Tj 0.306 g 0.0029 Tc 10.2 0 0 10.2 257.26 280.56 Tm (the )Tj 0.243 g 0.0162 Tc -21.034 -1.081 Td (relationship )Tj 0.0056 Tc 5.412 0 Td (with )Tj 0.0365 Tc 2.25 0 Td (duration )Tj 0.306 g 0.05 Tc 10.5727 0 0 10.2 162.62 269.53 Tm (of )Tj 0.243 g 10.6237 0 0 10.2 176.09 269.53 Tm (IDDM )Tj 0.0017 Tc 10.2 0 0 10.2 210.71 269.53 Tm (was )Tj 0.0041 Tc 2.063 0 Td (lost, )Tj 0.306 g 0.05 Tc 10.3398 0 0 10.2 253.81 269.53 Tm (and )Tj 0 Tc 10.2 0 0 10.2 42.14 258.49 Tm (a)Tj 0.149 g 0.519 0 Td (l)Tj 0.306 g 0.0304 Tc 0.23 0 Td (so )Tj 0.243 g 0.0081 Tc 1.662 0 Td (because )Tj 0.0029 Tc 3.997 0 Td (the )Tj 0.0138 Tc 1.977 0 Td (relationships )Tj -0.0024 Tc 6.024 0 Td (were )Tj 0.306 g 0.0169 Tc 2.626 0 Td (considerably )Tj 0.243 g 0.017 Tc -17.026 -1.083 Td (weaker )Tj 0.0336 Tc 3.285 0 Td (amongst )Tj 0.0157 Tc 3.868 0 Td (non-smokers )Tj 0.306 g 0.0392 Tc 5.693 0 Td (than )Tj 0.243 g 0.0257 Tc 2.157 0 Td (amongst )Tj 0.306 g 0.0216 Tc 3.855 0 Td (smokers )Tj 0.243 g 0.0198 Tc -18.869 -1.034 Td (\(table )Tj 0.306 g -0.035 Tc 10.1399 0 0 10.2 71.94 236.89 Tm (2\). )Tj /T1_1 1 Tf 0.05 Tc 13.9853 0 0 10 87.93 236.89 Tm (It )Tj 0.243 g /T1_0 1 Tf -0.035 Tc 9.3682 0 0 10.2 101.2 236.89 Tm (is )Tj 0.306 g 0.0203 Tc 10.2 0 0 10.2 112.78 236.89 Tm (therefore )Tj 0.243 g 0.003 Tc 4.284 0 Td (unlikely )Tj 0.306 g 0.05 Tc 10.5068 0 0 10.2 195.81 236.89 Tm (that )Tj 0.243 g 0.0365 Tc 10.2 0 0 10.2 218.78 236.89 Tm (duration )Tj 0.05 Tc 11.1292 0 0 10.2 261.01 236.89 Tm (of )Tj 10.6237 0 0 10.2 42.17 225.85 Tm (IDDM )Tj 0.0183 Tc 10.2 0 0 10.2 75.83 225.85 Tm (has )Tj 0.05 Tc 10.7542 0 0 10.2 93.01 225.85 Tm (an )Tj 0.0168 Tc 10.2 0 0 10.2 107.44 225.85 Tm (independent )Tj -0.0081 Tc 5.362 0 Td (effect )Tj 0.05 Tc 10.7226 0 0 10.2 188.54 225.85 Tm (on )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0293 Tc 10.2 0 0 10.2 203.48 225.85 Tm (FEY )Tj EMC ET BT /T1_0 1 Tf 0 Tc 6.5001 0 0 6.5001 224.42 223.44 Tm (1 )Tj 0.05 Tc 10.5727 0 0 10.2 231.26 225.85 Tm (or )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0273 Tc 10.2 0 0 10.2 243.8 225.85 Tm (FYC. )Tj EMC ET BT /T1_0 1 Tf 0.045 Tc 10.2 0 0 10.2 51.7544 214.8034 Tm (Thus )Tj 0.149 g -0.0079 Tc 2.448 0 Td (in )Tj 0.243 g 0.0282 Tc 1.045 0 Td (patients )Tj 0.306 g 0.0056 Tc 3.621 0 Td (with )Tj 0.243 g 0.023 Tc 2.117 0 Td (more )Tj 0.018 Tc 2.451 0 Td (prolonged )Tj 0.05 Tc 10.4524 0 0 10.2 217.85 214.8 Tm (IDDM )Tj 0.306 g 10.2803 0 0 10.2 250.53 214.8 Tm (than )Tj 0.243 g 0.008 Tc 10.2 0 0 10.2 42.26 203.76 Tm (previously )Tj 0.306 g 0.0174 Tc 4.985 0 Td (reported, )Tj 0.243 g 0.0061 Tc 4.47 0 Td (this )Tj 0.306 g 0.0295 Tc 2.106 0 Td (study )Tj 0.243 g 0.0183 Tc 2.977 0 Td (has )Tj 0.0292 Tc 2.015 0 Td (demonstrated )Tj 0.0276 Tc -16.556 -1.034 Td (normal )Tj 0.0002 Tc 3.239 0 Td (gas )Tj 0.0171 Tc 1.654 0 Td (transfer, )Tj 0.0056 Tc 3.766 0 Td (with )Tj 0.0386 Tc 2.071 0 Td (no )Tj 0.0205 Tc 1.318 0 Td (relationship )Tj 0.0038 Tc 5.273 0 Td (between )Tj -0.0234 Tc 3.661 0 Td (gas )Tj 0.0283 Tc -21.028 -1.083 Td (transfer )Tj 0.037 Tc 3.663 0 Td (and )Tj 0.306 g 0.0199 Tc 1.928 0 Td (either )Tj 0.243 g 0.0029 Tc 2.785 0 Td (the )Tj 0.0063 Tc 1.651 0 Td (presence )Tj 0.05 Tc 11.1292 0 0 10.2 184.21 182.16 Tm (of )Tj 0.0243 Tc 10.2 0 0 10.2 196.78 182.16 Tm (microangiopatby )Tj 0.0033 Tc -15.256 -1.081 Td (elsewhere )Tj 0.05 Tc 10.5727 0 0 10.2 85.34 171.13 Tm (or )Tj 0.0432 Tc 10.2 0 0 10.2 97.34 171.13 Tm (duration )Tj 0.306 g 0.05 Tc 11.1292 0 0 10.2 137.17 171.13 Tm (of )Tj 0.243 g 10.3699 0 0 10.2 149.21 171.13 Tm (IDDM. )Tj 0.149 g 0.0252 Tc 10.2 0 0 10.2 184.71 171.13 Tm (This )Tj 0.306 g 0.0295 Tc 2.113 0 Td (study )Tj 0.0305 Tc 2.588 0 Td (supports )Tj 0.243 g 0.0265 Tc -18.718 -1.082 Td (the )Tj -0.018 Tc 1.553 0 Td (view )Tj -0.035 Tc 9.0515 0 0 10.2 79.46 160.09 Tm ([9] )Tj 0.0351 Tc 10.2 0 0 10.2 93.1 160.09 Tm (that )Tj 0.0363 Tc 1.839 0 Td (pulmonary )Tj 0.306 g 0.0114 Tc 4.928 0 Td (functio)Tj 0.149 g 0 Tc 2.975 0 Td (n )Tj 0.306 g 0.0407 Tc 0.744 0 Td (abnormal)Tj 0.149 g 0.0269 Tc 4.096 0 Td (it)Tj 0.306 g -0.0052 Tc 0.565 0 Td (ies )Tj 0.243 g -0.0079 Tc 1.365 0 Td (in )Tj 0.05 Tc 10.4524 0 0 10.2 42.17 149.05 Tm (IDDM )Tj 0.306 g 0.016 Tc 10.2 0 0 10.2 75.74 149.05 Tm (are, )Tj 0.243 g 0.05 Tc 10.4373 0 0 10.2 95.91 149.05 Tm (if )Tj 0.306 g 0.0154 Tc 10.2 0 0 10.2 105.5 149.05 Tm (anything, )Tj 0.243 g 0.0067 Tc 4.325 0 Td (small )Tj 0.306 g 0.05 Tc 10.3398 0 0 10.2 176.05 149.05 Tm (and )Tj 0.243 g 0.003 Tc 10.2 0 0 10.2 196.32 149.05 Tm (unlikely )Tj 0.0253 Tc 3.716 0 Td (to )Tj 0.306 g 0.0078 Tc 1.274 0 Td (be )Tj 0.05 Tc 10.5727 0 0 10.2 261.02 149.05 Tm (of )Tj 0.243 g 0.0001 Tc 10.2 0 0 10.2 41.18 138.49 Tm (clinical )Tj 0.306 g -0.0051 Tc 3.29 0 Td (significance. )Tj ET BT /Suspect <>BDC 0.243 g /T1_2 1 Tf 0.0084 Tc 8.1 0 0 8.1 97.56 122.16 Tm (Acknowledgements: )Tj EMC ET BT /T1_0 1 Tf 0.0317 Tc 8.1 0 0 8.1 166.0131 122.16 Tm (The )Tj 0.306 g 0.0217 Tc 1.963 0 Td (writer )Tj 0.0476 Tc 2.784 0 Td (thanks )Tj 0.243 g 0.0373 Tc 3.138 0 Td (Dr. )Tj 0 Tc 1.778 0 Td (H )Tj 0.05 Tc 8.3389 0 0 8.1 252.92 122.16 Tm (Platt )Tj 0 Tc 8.1 0 0 8.1 89.67 113.04 Tm (for )Tj 0.0264 Tc 1.968 0 Td (pennjssion )Tj 0.306 g 0.05 Tc 8.1489 0 0 8.1 148.78 113.04 Tm (to )Tj 8.2025 0 0 8.1 161.16 113.04 Tm (study )Tj 0.0115 Tc 8.1 0 0 8.1 186.23 113.04 Tm (his )Tj 0.0261 Tc 1.958 0 Td (patients, )Tj 0.243 g 0.05 Tc 8.2971 0 0 8.1 236.6 113.04 Tm (Dr. )Tj 0.0216 Tc 8.1 0 0 8.1 255.32 113.04 Tm (D.J. )Tj 0.306 g 0.015 Tc -20.444 -1.125 Td (Lipscomb )Tj 0.0296 Tc 4.498 0 Td (for )Tj 0.243 g 0.0264 Tc 1.612 0 Td (providing )Tj 0.306 g 0.0302 Tc 4.444 0 Td (pulmonary )Tj 0.0125 Tc 4.965 0 Td (function )Tj 0.243 g 0.0109 Tc 3.92 0 Td (testing )Tj 0.306 g -0.0031 Tc -19.505 -1.068 Td (facilities, )Tj 0.243 g 0.05 Tc 8.1861 0 0 8.1 122.84 95.28 Tm (Mrs )Tj -0.0025 Tc 8.1 0 0 8.1 140.12 95.28 Tm (M. )Tj 0.027 Tc 1.6 0 Td (Kinnison )Tj 0.306 g 0.05 Tc 8.1466 0 0 8.1 187.6 95.28 Tm (and )Tj 0.0294 Tc 8.1 0 0 8.1 203.96 95.28 Tm (Mrs )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0011 Tc 8.1 0 0 8.1 220.646 95.28 Tm (S. )Tj EMC ET BT 0.243 g /T1_0 1 Tf 0.05 Tc 8.1757 0 0 8.1 230.32 95.28 Tm (Cooper )Tj 0.306 g 0.0296 Tc 8.1 0 0 8.1 259.11 95.28 Tm (for )Tj 0.243 g 0.0092 Tc -20.969 -1.126 Td (technical )Tj 0.306 g 0.0119 Tc 4.022 0 Td (assistance )Tj 0.05 Tc 8.1466 0 0 8.1 157.36 86.16 Tm (and )Tj 0.243 g 0.0336 Tc 8.1 0 0 8.1 172.28 86.16 Tm (Professor )Tj 0 Tc 4.33 0 Td (A)Tj 0.4 g 0.751 0 Td (. )Tj 0.243 g 0.0141 Tc 0.546 0 Td (Tattersfield )Tj 0.0296 Tc 5.094 0 Td (for )Tj 0.0158 Tc -20.968 -1.126 Td (her )Tj 0.306 g 0.0258 Tc 1.651 0 Td (comments )Tj 0.05 Tc 8.3916 0 0 8.1 140.08 77.04 Tm (on )Tj 0.243 g 0.0134 Tc 8.1 0 0 8.1 152.14 77.04 Tm (the )Tj 0.0234 Tc 1.6 0 Td (manuscript. )Tj 0.306 g 0.022 Tc 8.7 0 0 8.7 310.96 688.09 Tm (coefficient )Tj ET BT /Suspect <>BDC 0.243 g /T1_0 1 Tf -0.035 Tc 7.4422 0 0 8 370.43 688.09 Tm (SE )Tj EMC ET BT 0.306 g /T1_0 1 Tf 0.05 Tc 8.9298 0 0 8.7 406.06 688.56 Tm (tvalue )Tj ET BT /Suspect <>BDC 0.243 g /T1_0 1 Tf 0.0043 Tc 9.3 0 0 9.3 310.93 642.97 Tm (-0.438 )Tj EMC /Suspect <>BDC -0.0281 Tc 5.833 0.051 Td (0.198 )Tj EMC ET BT 0.149 g /T1_0 1 Tf 0.05 Tc 11.1758 0 0 9.3 405.47 643.44 Tm (-2)Tj 0.306 g -0.035 Tc 9.2844 0 0 9.3 415.49 643.44 Tm (.22 )Tj ET BT /Suspect <>BDC 0.243 g /T1_0 1 Tf 0.025 Tc 9.3 0 0 9.3 310.45 632.41 Tm (-0.717 )Tj EMC /Suspect <>BDC -0.0281 Tc 5.885 0.052 Td (0.267 )Tj EMC ET BT 0.149 g /T1_0 1 Tf 0.05 Tc 11.1758 0 0 9.3 405.47 632.89 Tm (-2)Tj 0.306 g -0.035 Tc 9.2844 0 0 9.3 415.49 632.89 Tm (.69 )Tj ET BT /Suspect <>BDC 0.243 g /T1_0 1 Tf 0.0147 Tc 9.3 0 0 9.3 310.93 621.36 Tm (-0.158 )Tj EMC /Suspect <>BDC -0.0152 Tc 5.833 0.053 Td (0.297 )Tj EMC /Suspect <>BDC 0.0143 Tc 4.386 0 Td (-0.53 )Tj EMC /Suspect <>BDC 0.0043 Tc -10.219 -2.375 Td (-0.391 )Tj EMC /Suspect <>BDC -0.0281 Tc 5.833 0 Td (0.195 )Tj EMC ET BT 0.306 g /T1_0 1 Tf 0.0272 Tc 9.3 0 0 9.3 405.9667 599.7654 Tm (-1.86 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 10.6171 0 0 9.3 310.92 588.73 Tm (-0)Tj 0.149 g -0.0186 Tc 9.3 0 0 9.3 319.97 588.73 Tm (.516 )Tj EMC /Suspect <>BDC 0.243 g -0.0281 Tc 4.861 0 Td (0.287 )Tj EMC /Suspect <>BDC 0.306 g 0.05 Tc 9.4995 0 0 9.3 405.97 588.73 Tm (-1)Tj 0.149 g -0.035 Tc 8.5664 0 0 9.3 415.5 588.73 Tm (.8)Tj 0.306 g 0 Tc 9.3 0 0 9.3 421.82 588.73 Tm (0 )Tj EMC /Suspect <>BDC 0.243 g 0.025 Tc -11.924 -2.324 Td (-0.190 )Tj EMC /Suspect <>BDC -0.0152 Tc 5.833 -0.051 Td (0.102 )Tj EMC /Suspect <>BDC 0.306 g 0.0272 Tc 4.386 0.051 Td (-2.00 )Tj EMC /Suspect <>BDC 0.243 g 0.025 Tc -10.271 -1.186 Td (-0.329 )Tj EMC /Suspect <>BDC -0.035 Tc 9.1937 0 0 9.3 365.19 556.09 Tm (0.131 )Tj EMC ET BT 0.306 g /T1_0 1 Tf 0.0272 Tc 9.3 0 0 9.3 405.97 556.09 Tm (-2.52 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 10.6171 0 0 9.3 310.92 511.92 Tm (-0)Tj 0.149 g -0.035 Tc 9.2861 0 0 9.3 319.97 511.92 Tm (.461 )Tj EMC /Suspect <>BDC 0.243 g -0.0281 Tc 9.3 0 0 9.3 365.18 511.92 Tm (0.213 )Tj EMC ET BT 0.149 g /T1_0 1 Tf 0.0137 Tc 9.3 0 0 9.3 405.9698 512.4129 Tm (-2.1)Tj 0.306 g 0 Tc 1.703 0 Td (6 )Tj ET BT /Suspect <>BDC 0.243 g /T1_0 1 Tf 0.025 Tc 9.3 0 0 9.3 310.9238 501.3738 Tm (-0.560 )Tj EMC /Suspect <>BDC -0.0152 Tc 5.833 0 Td (0.344 )Tj EMC ET BT 0.4 g /T1_0 1 Tf 0 Tc 9.3 0 0 9.3 405.9605 501.3738 Tm (-)Tj 0.243 g -0.009 Tc 0.494 0 Td (1.63 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0147 Tc 9.3 0 0 9.3 310.4402 490.3347 Tm (-0.353 )Tj EMC /Suspect <>BDC -0.0152 Tc 5.885 0 Td (0.259 )Tj EMC ET BT /T1_0 1 Tf 0.0272 Tc 9.3 0 0 9.3 405.9605 490.8183 Tm (-1.37 )Tj ET BT /Suspect <>BDC 0.306 g /T1_0 1 Tf 0.025 Tc 9.3 0 0 9.3 310.4402 468.2565 Tm (-0.406 )Tj EMC /Suspect <>BDC 0.243 g -0.0023 Tc 5.833 0 Td (0.210 )Tj EMC ET BT 0.149 g /T1_0 1 Tf 0.0401 Tc 9.3 0 0 9.3 405.4769 468.7308 Tm (-1.94 )Tj ET BT /Suspect <>BDC 0.306 g /T1_0 1 Tf 0.05 Tc 11.1758 0 0 9.3 310.43 457.21 Tm (-0)Tj 0.149 g -0.035 Tc 9.2861 0 0 9.3 319.97 457.21 Tm (.205 )Tj EMC /Suspect <>BDC 0.306 g -0.0023 Tc 9.3 0 0 9.3 364.7 457.69 Tm (0.362 )Tj EMC /Suspect <>BDC 0.243 g 0.0401 Tc 4.386 0 Td (-0.57 )Tj EMC /Suspect <>BDC 0.025 Tc -10.219 -2.374 Td (-0.216 )Tj EMC /Suspect <>BDC -0.0023 Tc 5.833 0 Td (0.110 )Tj EMC ET BT 0.149 g /T1_0 1 Tf 0.0272 Tc 9.3 0 0 9.3 405.4898 436.0954 Tm (-1.97 )Tj ET BT /Suspect <>BDC 0.243 g /T1_0 1 Tf 0.0043 Tc 9.3 0 0 9.3 310.4531 424.5634 Tm (-0.421 )Tj EMC /Suspect <>BDC -0.0023 Tc 5.833 0 Td (0.150 )Tj EMC ET BT /T1_0 1 Tf 0.0272 Tc 9.3 0 0 9.3 405.9734 425.0563 Tm (-2.82 )Tj -0.0204 Tc 9.6 0 0 9.6 387.8 378.97 Tm (References )Tj ET BT /Suspect <>BDC 0.306 g /T1_0 1 Tf -0.035 Tc 8.1 0 0 8.1 295.62 363.12 Tm (I. )Tj EMC /Suspect <>BDC 0.0205 Tc 1.589 0 Td (Sandler )Tj EMC /Suspect <>BDC 0.243 g 0 Tc 3.628 0 Td (M)Tj 0.4 g 0.937 0 Td (, )Tj EMC ET BT 0.243 g /T1_0 1 Tf 0.0161 Tc 8.1 0 0 8.1 350.8377 363.12 Tm (Bunn )Tj 0.05 Tc 8.371 0 0 8.1 371.51 363.12 Tm (AE)Tj 0.4 g 0 Tc 8.1 0 0 8.1 383.39 363.12 Tm (, )Tj ET BT /Suspect <>BDC 0.306 g /T1_0 1 Tf 0.0306 Tc 8.1 0 0 8.1 388.169 363.12 Tm (Stewart )Tj EMC ET BT 0.243 g /T1_0 1 Tf 0.05 Tc 8.1816 0 0 8.1 417.56 363.12 Tm (Rl. )Tj 0.4 g 0 Tc 8.1 0 0 8.1 430.95 363.12 Tm (-)Tj 0.243 g 0.0188 Tc 1.009 0 Td (Cross-sectional )Tj 0.306 g 0.0278 Tc 6.811 0 Td (study )Tj 0.05 Tc 8.9033 0 0 8.1 515.92 363.12 Tm (of )Tj 0.243 g 0.0377 Tc 8.1 0 0 8.1 294.25 354.49 Tm (pulmonary )Tj 0.306 g 0.0041 Tc 5.202 0 Td (function )Tj 0.0095 Tc 3.973 0 Td (in )Tj 0.243 g 0.0232 Tc 1.373 0 Td (patients )Tj 0.0021 Tc 3.849 0 Td (with )Tj 0.306 g 0.0136 Tc 2.304 0 Td (insulin)Tj 0.149 g 0 Tc 2.842 0 Td (-)Tj 0.306 g 0.036 Tc 0.298 0 Td (dependent )Tj 0.0249 Tc 4.919 0 Td (diabetes )Tj 0.0042 Tc -24.763 -1.126 Td (mellitus. )Tj 0.243 g /T1_3 1 Tf 0.05 Tc 7.7918 0 0 7.2 325.97 345.37 Tm (Am )Tj /T1_2 1 Tf 0.0238 Tc 8.1 0 0 8.1 340.86 345.37 Tm (Rev )Tj 0.0123 Tc 1.896 0 Td (Respir )Tj 0.0059 Tc 2.965 0 Td (Dis, )Tj /T1_0 1 Tf -0.035 Tc 7.8965 0 0 8.1 397.17 345.37 Tm (1987)Tj 0.4 g 0 Tc 8.1 0 0 8.1 412.19 345.37 Tm (, )Tj 0.243 g -0.0262 Tc 0.693 0 Td (135, )Tj 0.306 g 0.0326 Tc 1.984 0 Td (223-229. )Tj -0.035 Tc 7.5852 0 0 8.1 294.68 336.72 Tm (2. )Tj 0.0139 Tc 8.1 0 0 8.1 308.49 336.72 Tm (Schuyler )Tj 0.243 g 0.05 Tc 8.4293 0 0 8.1 344.12 336.72 Tm (MR)Tj 0.4 g 0 Tc 8.1 0 0 8.1 357.95 336.72 Tm (, )Tj 0.306 g 0.0237 Tc 0.969 0 Td (Niewoehner )Tj 0.243 g 0.0469 Tc 5.798 0 Td (DE, )Tj 0.037 Tc 2.367 0 Td (lnkley )Tj ET BT /Suspect <>BDC 0.306 g /T1_0 1 Tf 0.05 Tc 8.1174 0 0 8.1 459.69 336.72 Tm (SR, )Tj EMC ET BT 0.243 g /T1_0 1 Tf 8.5069 0 0 8.1 478.04 336.72 Tm (Kohn )Tj -0.035 Tc 8.194 0 0 8.7 504.44 336.72 Tm (R. )Tj 0.537 g 0 Tc 8.7 0 0 8.7 517.82 336.72 Tm (-)Tj 0.306 g 0.04 Tc 8.1 0 0 8.1 294.23 327.61 Tm (Abnormal )Tj 0.243 g 0.0053 Tc 4.911 0 Td (lung )Tj 0.306 g 0.0101 Tc 2.309 0 Td (elasticity )Tj 0.0095 Tc 4.21 0 Td (in )Tj 0.243 g 0.0148 Tc 1.277 0 Td (juvenile )Tj 0.306 g 0.0249 Tc 3.819 0 Td (diabetes )Tj 0.0116 Tc 3.978 0 Td (mellitus. )Tj ET BT /Suspect <>BDC /T1_3 1 Tf 0.0432 Tc 7.2 0 0 7.2 494.45 327.61 Tm (Am )Tj EMC /Suspect <>BDC /T1_2 1 Tf 0.0238 Tc 8.1 0 0 8.1 510.3 327.61 Tm (Rev )Tj EMC ET BT 0.243 g /T1_2 1 Tf 0.0123 Tc 8.1 0 0 8.1 294.7833 318.4894 Tm (Respir )Tj -0.0139 Tc 2.965 0 Td (Dis, )Tj /T1_0 1 Tf -0.0305 Tc 2.03 0 Td (1976)Tj 0.4 g 0 Tc 1.915 0 Td (, )Tj 0.306 g -0.035 Tc 7.9309 0 0 8.1 356.37 318.49 Tm (113, )Tj 0.036 Tc 8.1 0 0 8.1 372.39 318.49 Tm (37-41. )Tj -0.035 Tc 7.7865 0 0 8.1 294.63 309.84 Tm (3. )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0426 Tc 8.1 0 0 8.1 308.49 309.84 Tm (Schnapf )Tj EMC ET BT 0.243 g /T1_0 1 Tf 0.0073 Tc 8.1 0 0 8.1 340.7604 309.84 Tm (BM)Tj 0.4 g 0 Tc 1.589 0 Td (, )Tj 0.243 g 0.0328 Tc 0.841 0 Td (Banks )Tj 0.0118 Tc 3.2 0 Td (RA, )Tj 0.0088 Tc 2.238 0 Td (Silverstein )Tj 0.05 Tc 8.5901 0 0 8.1 443.95 309.84 Tm (JH, )Tj 0.0315 Tc 8.1 0 0 8.1 461.24 309.84 Tm (Rosenbloom )Tj 0.0119 Tc 5.93 0 Td (AL, )Tj 0.306 g 0.0251 Tc -26.557 -1.126 Td (Chesrown )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0204 Tc 8.1 0 0 8.1 332.4905 300.7194 Tm (SE, )Tj EMC ET BT 0.243 g /T1_0 1 Tf 0.0201 Tc 8.1 0 0 8.1 348.4394 300.7194 Tm (Loughlin )Tj 0.306 g 0.05 Tc 8.3867 0 0 8.1 382.96 300.72 Tm (GM. )Tj 0.4 g 0 Tc 8.1 0 0 8.1 403.59 300.72 Tm (-)Tj 0.243 g 0.0389 Tc 1.073 0 Td (Pulmonary )Tj 0.306 g 0.021 Tc 5.149 0 Td (function )Tj 0.0095 Tc 4.032 0 Td (in )Tj 0.0064 Tc 1.304 0 Td (insulin\255)Tj 0.0286 Tc -25.068 -1.125 Td (dependent )Tj 0.243 g 0.0249 Tc 4.741 0 Td (diabetes )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0067 Tc 8.1 0 0 8.1 364.305 291.6075 Tm (mellitus )Tj EMC ET BT /T1_0 1 Tf 0.0218 Tc 8.1 0 0 8.1 394.5585 291.6075 Tm (with )Tj 0.0053 Tc 2.304 0 Td (limited )Tj 0.306 g 0.0464 Tc 3.291 0 Td (joint )Tj 0.0203 Tc 2.463 0 Td (mobility. )Tj 0.243 g /T1_2 1 Tf 0.05 Tc 8.7132 0 0 8.1 494.53 291.61 Tm (Am )Tj 0.0238 Tc 8.1 0 0 8.1 510.3 291.61 Tm (Rev )Tj 0.0005 Tc -26.607 -1.067 Td (Respir )Tj 0.306 g -0.0139 Tc 2.965 0 Td (Dis, )Tj /T1_0 1 Tf -0.0261 Tc 2.03 0 Td (1984, )Tj -0.035 Tc 7.9309 0 0 8.1 356.37 282.97 Tm (130, )Tj 0.025 Tc 8.1 0 0 8.1 372.39 282.97 Tm (930-932. )Tj -0.035 Tc 7.5461 0 0 8.1 294.21 273.84 Tm (4. )Tj 0.243 g 0.0413 Tc 8.1 0 0 8.1 308.14 273.84 Tm (Vracko )Tj -0.0023 Tc 7.9001 0 0 7.9001 335.96 273.84 Tm (R, )Tj 0.05 Tc 8.2685 0 0 8.1 345.53 273.84 Tm (Thoming )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 8.1158 0 0 8.1 380.12 273.84 Tm (D, )Tj EMC ET BT 0.306 g /T1_0 1 Tf 8.2416 0 0 8.1 390.68 273.84 Tm (Huang )Tj 0.149 g 8.4713 0 0 8.1 415.61 273.84 Tm (TW)Tj 0.4 g 0 Tc 8.1 0 0 8.1 429.43 273.84 Tm (.)Tj 0.537 g 0.484 0 Td (-)Tj 0.243 g -0.001 Tc 0.895 0 Td (Basal )Tj 0.306 g 0.0285 Tc 2.485 0 Td (lamina )Tj 0.05 Tc 8.9033 0 0 8.1 486.15 273.84 Tm (of )Tj 0.243 g 0.0247 Tc 8.1 0 0 8.1 495.28 273.84 Tm (alveolar )Tj 0.306 g 0.0281 Tc -24.89 -1.126 Td (epithelium )Tj 0.05 Tc 8.1466 0 0 8.1 334.48 264.72 Tm (and )Tj 0.0078 Tc 8.1 0 0 8.1 351.76 264.72 Tm (capillaries: )Tj 0.243 g 0.0357 Tc 5.037 0 Td (quantitative )Tj 0.0201 Tc 5.63 0 Td (changes )Tj 0.0218 Tc 3.92 0 Td (with )Tj 0.306 g 0.0148 Tc 2.421 0 Td (ageing )Tj 0.243 g 0.0095 Tc 3.26 0 Td (in )Tj 0.306 g 0.0249 Tc -27.438 -1.065 Td (diabetes )Tj 0.0042 Tc 3.8 0 Td (mellitus. )Tj /T1_2 1 Tf 0.05 Tc 8.3646 0 0 8.3 356.29 256.09 Tm (Am )Tj 0.243 g 0.0238 Tc 8.1 0 0 8.1 371.1 256.09 Tm (Rev )Tj 0.306 g 0.0005 Tc 1.896 0 Td (Respir )Tj 0.243 g 0.05 Tc 8.2081 0 0 8.1 410.48 256.09 Tm (Di)Tj 0.4 g 0.0177 Tc 8.1 0 0 8.1 418.59 256.09 Tm (s, )Tj 0.243 g /T1_0 1 Tf -0.0261 Tc 1.088 0 Td (1979, )Tj ET BT /Suspect <>BDC 0.306 g /T1_0 1 Tf -0.035 Tc 7.9309 0 0 8.1 448.53 256.09 Tm (120, )Tj EMC ET BT /T1_0 1 Tf 0.025 Tc 8.1 0 0 8.1 464.55 256.09 Tm (973-983. )Tj /T1_2 1 Tf -0.035 Tc 7.5657 0 0 9 294.16 246.97 Tm (5. )Tj 0.243 g /T1_0 1 Tf 0.0292 Tc 8.1 0 0 8.1 308.6 246.97 Tm (Kodolva )Tj 0.306 g /T1_1 1 Tf 0.0011 Tc 8.2 0 0 8.2 339.58 246.97 Tm (1M, )Tj 0.243 g /T1_0 1 Tf 0.021 Tc 8.1 0 0 8.1 355.64 246.97 Tm (Lysenko )Tj -0.016 Tc 3.852 0 Td (LV)Tj 0.4 g 0 Tc 1.352 0 Td (, )Tj 0.306 g 0.0307 Tc 0.472 0 Td (Saltykov )Tj 0.243 g /T1_1 1 Tf 0.05 Tc 8.5278 0 0 8.2 433.82 246.97 Tm (88. )Tj 0.306 g /T1_0 1 Tf 8.6764 0 0 8.1 448.7 246.97 Tm (-Pulmonary )Tj 0.0201 Tc 8.1 0 0 8.1 495.28 246.97 Tm (changes )Tj 0.0095 Tc -24.828 -1.067 Td (in )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0085 Tc 8.1 0 0 8.1 303.2938 238.3273 Tm (iliabetes )Tj EMC ET BT 0.243 g /T1_0 1 Tf -0.0032 Tc 8.1 0 0 8.1 334.0657 238.3273 Tm (mellitus. )Tj 0.306 g /T1_2 1 Tf 0.0456 Tc 3.869 0 Td (Arkh )Tj 0.0011 Tc 2.481 0 Td (Patol, )Tj 0.243 g /T1_0 1 Tf -0.0261 Tc 2.862 0 Td (1982, )Tj 0.0206 Tc 7.9001 0 0 7.9001 428.61 238.33 Tm (44, )Tj 0.306 g 0.036 Tc 8.1 0 0 8.1 441.99 238.33 Tm (35-40. )Tj /T1_3 1 Tf -0.035 Tc 6.7984 0 0 7.8001 294.07 229.21 Tm (6. )Tj 0.243 g /T1_0 1 Tf 0.0447 Tc 8.1 0 0 8.1 308.12 229.21 Tm (Kida )Tj 0.05 Tc 8.9426 0 0 8.1 330.2 229.21 Tm (K, )Tj 0.306 g 0.0315 Tc 8.1 0 0 8.1 345.59 229.21 Tm (Utsuyama )Tj ET BT /Suspect <>BDC 0.243 g /T1_0 1 Tf -0.0025 Tc 8.1 0 0 8.1 386.3573 229.21 Tm (M, )Tj EMC ET BT /T1_0 1 Tf 0.032 Tc 8.1 0 0 8.1 401.2046 229.21 Tm (Takizawa )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0453 Tc 8.1 0 0 8.1 440.0846 229.21 Tm (T, )Tj EMC ET BT 0.149 g /T1_0 1 Tf 0.05 Tc 8.2195 0 0 8.1 453.05 229.21 Tm (Thu)Tj 0.306 g 0.0105 Tc 8.1 0 0 8.1 467.99 229.21 Tm (rlbeck )Tj 0.243 g -0.0006 Tc 3.316 0 Td (WM. )Tj 0.306 g 0 Tc 2.837 0 Td (-)Tj 0.0326 Tc -27.673 -1.126 Td (Changes )Tj 0.243 g -0.035 Tc 7.9356 0 0 8.1 326.82 220.09 Tm (in )Tj 0.306 g 0.0251 Tc 8.1 0 0 8.1 336.41 220.09 Tm (lung )Tj 0.243 g 0.0234 Tc 2.258 0 Td (morphological )Tj 0.0113 Tc 6.569 0 Td (features )Tj 0.05 Tc 8.1466 0 0 8.1 438.16 220.09 Tm (and )Tj 0.306 g 0.0167 Tc 8.1 0 0 8.1 453.99 220.09 Tm (elasticity )Tj 0.0174 Tc 4.149 0 Td (caused )Tj 0.243 g 0.017 Tc 3.27 0 Td (by )Tj 0.306 g 0.028 Tc -27.215 -1.068 Td (streptozotoein-induced )Tj 0.243 g 0.0249 Tc 10.078 0 Td (diabetes )Tj 0.0151 Tc 3.8 0 Td (mellitus )Tj 0.306 g 0.0095 Tc 3.727 0 Td (in )Tj 0.0298 Tc 1.126 0 Td (growing )Tj 0.0215 Tc 3.859 0 Td (rats. )Tj 0.243 g /T1_3 1 Tf 0.05 Tc 7.4801 0 0 7.2 494.93 211.44 Tm (Am )Tj /T1_2 1 Tf 0 Tc 8.1 0 0 8.1 510.3 211.44 Tm (R)Tj 0.4 g 0.636 0 Td (e)Tj 0.243 g 0.477 0 Td (v )Tj 0.306 g 0.0123 Tc -27.838 -1.125 Td (Respir )Tj -0.0139 Tc 3.025 0 Td (Dis, )Tj /T1_0 1 Tf -0.0261 Tc 2.089 0 Td (1983, )Tj 0.243 g -0.0328 Tc 2.548 0 Td (128)Tj 0.4 g 0 Tc 1.441 0 Td (, )Tj ET BT /Suspect <>BDC 0.306 g /T1_0 1 Tf -0.0328 Tc 8.1 0 0 8.1 372.6891 202.3275 Tm (125)Tj 0.537 g 0 Tc 1.446 0 Td (-)Tj 0.306 g -0.0262 Tc 0.628 0 Td (131. )Tj EMC ET BT /T1_0 1 Tf -0.035 Tc 7.6478 0 0 8.1 294.16 193.21 Tm (7. )Tj 0.0312 Tc 8.1 0 0 8.1 308.12 193.21 Tm (Hamlin )Tj 0.0494 Tc 3.61 0 Td (CR. )Tj 0.243 g 0.05 Tc 8.3044 0 0 8.1 354.2 193.21 Tm (Kohn )Tj -0.0056 Tc 8.7 0 0 8.7 377.72 193.21 Tm (RR)Tj 0.4 g 0 Tc 1.368 0 Td (, )Tj 0.243 g 0.0088 Tc 8.1 0 0 8.1 395.48 193.21 Tm (Luschin )Tj 0.306 g 0.0132 Tc 8.7 0 0 8.7 425.23 193.21 Tm (JH. )Tj 0 Tc 1.76 0 Td (-)Tj 0.243 g 0.0453 Tc 8.1 0 0 8.1 448.79 193.21 Tm (Apparent )Tj 0.306 g 0.0086 Tc 4.436 0 Td (accelerated )Tj 0.243 g 0.0266 Tc -23.585 -1.067 Td (ageing )Tj 0.306 g 0.05 Tc 8.9033 0 0 8.1 317.68 184.57 Tm (of )Tj 0.0106 Tc 8.1 0 0 8.1 326.8 184.57 Tm (collagen )Tj 0.243 g 0.0095 Tc 3.735 0 Td (in )Tj 0.0249 Tc 1.006 0 Td (diabetes )Tj 0.0042 Tc 3.681 0 Td (mellitus. )Tj /T1_2 1 Tf 0.0133 Tc 3.746 0 Td (Diabeles, )Tj /T1_0 1 Tf -0.0261 Tc 4.281 0 Td (1975, )Tj 0.306 g 0.0363 Tc 2.34 0 Td (24, )Tj 0.0314 Tc 1.536 0 Td (902-904)Tj 0.149 g 0 Tc 3.546 0 Td (. )Tj 0.306 g -0.0038 Tc -27.967 -1.127 Td (8. )Tj 0.0441 Tc 1.726 0 Td (Cotes )Tj 0.243 g 0.05 Tc 8.7621 0 0 8.1 330.67 175.44 Tm (JE)Tj 0.4 g 0 Tc 8.1 0 0 8.1 340.15 175.44 Tm (. )Tj 0.537 g 0.662 0 Td (-)Tj 0.243 g /T1_2 1 Tf 0.0082 Tc 7.7 0 0 7.7 353.36 175.44 Tm (In)Tj 0.4 g 0 Tc 0.908 0 Td (: )Tj 0.243 g /T1_0 1 Tf 0.0316 Tc 8.1 0 0 8.1 366.68 175.44 Tm (Lung )Tj 0.306 g 0.0168 Tc 2.601 0 Td (function. )Tj 0.243 g 0.05 Tc 8.1076 0 0 8.1 421.89 175.44 Tm (4th )Tj 0.306 g 0.0207 Tc 8.1 0 0 8.1 436.76 175.44 Tm (Ed., )Tj 0.243 g -0.007 Tc 2.193 0 Td (Blackwell)Tj 0.4 g 0 Tc 4.078 0 Td (, )Tj 0.243 g 0.0445 Tc 0.663 0 Td (London, )Tj -0.0261 Tc -24.504 -1.125 Td (1979. )Tj 0.306 g -0.014 Tc -0.095 -1.067 Td (9. )Tj 0.0449 Tc 1.711 0 Td (Schemthaner )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 8.1037 0 0 8.1 357.52 157.69 Tm (G, )Tj EMC ET BT 0.243 g /T1_0 1 Tf 8.2134 0 0 8.1 370.04 157.69 Tm (Haber )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0 Tc 8.1 0 0 8.1 395.96 157.69 Tm (P)Tj 0.4 g 0.581 0 Td (, )Tj EMC ET BT 0.243 g /T1_0 1 Tf 0.0485 Tc 8.1 0 0 8.1 406.5143 157.69 Tm (Kummer )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0408 Tc 8.1 0 0 8.1 441.563 157.69 Tm (F, )Tj EMC ET BT /T1_0 1 Tf 0.0206 Tc 8.1 0 0 8.1 453.0731 157.69 Tm (Ludwig )Tj 0 Tc 3.674 0 Td (H)Tj 0.4 g 0.873 0 Td [(. )-162(-)]TJ 0.243 g 0.0316 Tc 1.794 0 Td (Lung )Tj 0.306 g 0.0101 Tc -26.021 -1.126 Td (elasticity )Tj 0.0095 Tc 4.151 0 Td (in )Tj 0.0161 Tc 1.158 0 Td (juvenile-onset )Tj 0.243 g 0.0249 Tc 6.307 0 Td (diabetes )Tj 0.306 g 0.0042 Tc 3.919 0 Td (mellitus. )Tj /T1_2 1 Tf 0.05 Tc 8.7132 0 0 8.1 451.81 148.57 Tm (Am )Tj 0.243 g 0.0238 Tc 8.1 0 0 8.1 467.58 148.57 Tm (Rev )Tj 0.0005 Tc 2.074 0 Td (Respir )Tj 0.306 g 0.0059 Tc 3.025 0 Td (Dis, )Tj /T1_0 1 Tf -0.0261 Tc -26.474 -1.067 Td (1977, )Tj 0.243 g -0.035 Tc 7.9309 0 0 8.1 315.57 139.93 Tm (116, )Tj -0.0218 Tc 8.1 0 0 8.1 331.57 139.93 Tm (544)Tj 0.4 g 0.05 Tc 10.0583 0 0 8.1 343.08 139.93 Tm (-5)Tj 0.243 g -0.035 Tc 8.0868 0 0 8.1 352.29 139.93 Tm (46)Tj 0.4 g 0 Tc 8.1 0 0 8.1 360.31 139.93 Tm (. )Tj ET BT /Suspect <>BDC 0.243 g /T1_0 1 Tf 0.0392 Tc 8.1 0 0 8.1 294.1978 121.6807 Tm (RESUME: )Tj EMC ET BT 0.149 g /T1_0 1 Tf 0 Tc 8.1 0 0 8.1 335.4754 121.6807 Tm (L)Tj 0.4 g 0.05 Tc 8.4101 0 0 8.1 340.23 121.68 Tm ('on )Tj 0.306 g 0 Tc 8.1 0 0 8.1 354.64 121.68 Tm (a )Tj ET BT /Suspect <>BDC 0.243 g /T1_0 1 Tf 0.0156 Tc 8.1 0 0 8.1 361.8409 121.68 Tm (decrit, )Tj EMC ET BT 0.306 g /T1_0 1 Tf 0.0291 Tc 8.1 0 0 8.1 386.797 121.68 Tm (chez )Tj 0.02 Tc 2.252 0 Td (des )Tj 0.0232 Tc 1.848 0 Td (patients )Tj 0.243 g 0.0384 Tc 3.663 0 Td (atteints )Tj 0.306 g 0.05 Tc 8.435 0 0 8.1 478.48 121.68 Tm (d'un )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0346 Tc 8.1 0 0 8.1 497.2 121.68 Tm (diabete )Tj EMC /Suspect <>BDC 0.0126 Tc -25.13 -1.125 Td (sucre )Tj EMC ET BT /T1_0 1 Tf 0.029 Tc 8.1 0 0 8.1 314.8042 112.5675 Tm (insulino-dependant, )Tj 0.243 g 0.0492 Tc 8.898 0 Td (une )Tj 0.306 g 0.0367 Tc 2.005 0 Td (alteration )Tj 0.05 Tc 8.2998 0 0 8.1 440.08 112.57 Tm (du )Tj 0.0361 Tc 8.1 0 0 8.1 453.1 112.57 Tm (transfert )Tj 0.243 g 0.006 Tc 4.083 0 Td (gazeux )Tj 0.05 Tc 8.2998 0 0 8.1 513.04 112.57 Tm (du )Tj 0.0242 Tc 8.1 0 0 8.1 293.74 103.93 Tm (monoxyde )Tj 0.05 Tc 8.2927 0 0 8.1 331.12 103.93 Tm (de )Tj 0.306 g 0.0318 Tc 8.1 0 0 8.1 341.2 103.93 Tm (carbone, )Tj 0.0247 Tc 3.919 0 Td (mais )Tj 0.243 g 0 Tc 2.246 0 Td (l)Tj 0.4 g 0.05 Tc 8.4101 0 0 8.1 393.03 103.93 Tm ('on )Tj 0.243 g 8.2644 0 0 8.1 406.07 103.93 Tm (n'a )Tj 0.0384 Tc 8.1 0 0 8.1 418.48 103.93 Tm (documente )Tj 0.0409 Tc 4.919 0 Td (aucune )Tj 0.0316 Tc 3.2 0 Td (correlation )Tj 0.306 g 0.05 Tc 8.1609 0 0 8.1 293.19 94.8 Tm (entre )Tj 0.243 g -0.035 Tc 7.9707 0 0 8.1 316.25 94.8 Tm (les )Tj 0.05 Tc 8.1122 0 0 8.1 330.22 94.8 Tm (troub)Tj 0.4 g -0.035 Tc 7.9707 0 0 8.1 349.37 94.8 Tm (les )Tj 0.243 g 0.05 Tc 8.2998 0 0 8.1 362.8 94.8 Tm (du )Tj 0.306 g 0.0291 Tc 8.1 0 0 8.1 377.26 94.8 Tm (transfer! )Tj 0.05 Tc 8.3173 0 0 8.1 411.75 94.8 Tm (et )Tj 0.243 g -0.035 Tc 7.9307 0 0 8.1 423.31 94.8 Tm (Ia )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0101 Tc 8.1 0 0 8.1 434.89 94.8 Tm (presence )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 8.1739 0 0 8.1 468.88 94.8 Tm (d'autres )Tj 0.306 g 0.0151 Tc 8.1 0 0 8.1 501.49 94.8 Tm (signes )Tj 0.0184 Tc -25.715 -1.126 Td (cliniques )Tj 0.243 g 0.0141 Tc 4.385 0 Td (de )Tj ET BT /Suspect <>BDC 0.306 g /T1_0 1 Tf 0.0243 Tc 8.1 0 0 8.1 341.7337 85.6794 Tm (micro-angiopatrue )Tj EMC ET BT /T1_0 1 Tf 0.028 Tc 8.1 0 0 8.1 409.3525 85.6794 Tm (diabetique. )Tj 0.027 Tc 5.393 0 Td (Cette )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.042 Tc 8.1 0 0 8.1 476.0641 85.6794 Tm (etude )Tj EMC ET BT /T1_0 1 Tf -0.0209 Tc 8.1 0 0 8.1 500.1373 85.6794 Tm (vise )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0 Tc 12.4 0 0 12.4 517.79 85.68 Tm (a )Tj EMC ET BT /T1_0 1 Tf 0.0339 Tc 8.1 0 0 8.1 293.2 77.04 Tm (determiner )Tj -0.035 Tc 7.9241 0 0 8.1 333.49 77.04 Tm (si )Tj 7.3018 0 0 8.1 341.72 77.04 Tm (Je )Tj 0.243 g 0.0217 Tc 8.1 0 0 8.1 350.86 77.04 Tm (transfer! )Tj 0.306 g 0.006 Tc 3.964 0 Td (gazeux )Tj 0.05 Tc 8.2998 0 0 8.1 409.36 77.04 Tm (du )Tj 0.243 g 0.0242 Tc 8.1 0 0 8.1 421.42 77.04 Tm (monoxyde )Tj 0.306 g 0.05 Tc 8.2927 0 0 8.1 460.24 77.04 Tm (de )Tj 0.0393 Tc 8.1 0 0 8.1 471.28 77.04 Tm (carbone )Tj 0.0183 Tc 3.732 0 Td (est )Tj 0.0249 Tc 1.541 0 Td (en )Tj ET endstream endobj 16 0 obj <>/Filter/JBIG2Decode/Height 1752/ImageMask true/Length 21030/Name/X/Subtype/Image/Type/XObject/Width 1240>>stream 0ȧ׻h5ȾM3УaۛOf ts-ˢP57#x\Rø0 * b 3#좁3W|S8L3G^o3sv;IBpHW2LzU¡m5xaE#2Zvz]a.we%(X% g-ZV(>kf *ZzSEr}\95 '$QIǍ$? {.5 J#R/j*_ɍYO~o (2rFbVqr=;(N #z(noh,c%QT2͍1?g>ksH_lgf3^d+X`sTHNx]zQ_cuaD|VRb3I͐c),iu.߆|t͛{.q?1--Nó6gaF/ b#QWF;`ݥO;w14\ŬRK-ThD{mIU)QGR[X fN,WTVt;/\(wkV.K uLnċR2iv N]_˺z?p]*R^),oS7ZP!L="YgU0_.5jM!jIԙ,Lh'n6a wON4Iس2JǗ6{G¿QtUgΙʗ _`S ҃Й Ԧ{ t+BwQ[9mȜK[+lZ #XZ3 :,AhzU-d 9D ^1a,ΰU'Ћz5Aڳ` ׁr|Z%s '݋i=F:?eBzk$ X@_<ÿptTyY306 %pOS%~'FvMg&\xα; Fc/$p,T_pk\:a^YwHh-#(2GbUTW Q{BWwp f:_sP`Tv$XeJȸ`dcPҾPNWoQdmPXbp> g&R,Ty_At0xvAeFӋqV!fTf%3i#<Ԕ=ҵ 01-odΪ1pEEҧzjVϲ;^Ͻ'q&ށ]Ab5N! y9EF"61q\~u&+X{EAJwDί jɡuPNŢSj<C ;Kh.BA(ɵt7BCrH.v ,%sNwC}Ld4Iz&{lIU@:bF 墙d E$~uF9<NxzZJ~]I%O^C 1AeOSC]V$"d` BR \ { _)8@lJ6W@f܊~,vOŧ5>Z4Ӡ -n:.NPGJ!>4q/) { WBk]:{"J̒4}<:&z>0GlGl9^ A5w AO}*-4p~TMRP*@.4oHuk`']4OY@FnpspN5Eў5hJ vP7=4\QR[,J%9V-*xq|?,^АD#i*AZo`duYo|-{W#E"GߋwJ<G{;҅6UnOGg~J ~~{me iH Re|;Y3wlh*_defUh`96duLx_v@@MpN(Z>rs =f ?@EIqq|ޠ0ϽmOGׁwgHM)|o9aA7(-k!UNw'WAҋ8HK/-f̷bz ?EA+-|]&^W4`WTчn;s%кBo"D.566A}.r(^'@s8]Y9]UA~`! Ӄ܋/jj>ݎ1 "0;- "L0$yNy;־\S ̌E|kmXc\Bќw-_YϼC\pI&`CRš[|~C( H#ؓr(! mrߟiA_e-_jN(p7!bNK :$bM\JۦZwwMX˥ZX=iS86K.Qzo)ZO CK2ۧ6x؆c&S/7;FOWoqߥc+4aBnU^!d!AdBR,/H QTMO X1+c5Mɬi3' A_E;5@jL K z[0^^g 7Tb ~O|X- &آzIlRwȍ_ 鯊8F#kzE]| EH!Id0oHzRjk1uUf&zQMZW/ΎBI7'o3ftu^?Pn1ͤ,$Ylir-LuB ^š#]kJõiE=rc'<8:֪ê;;T0ZrD-LN:LRubһ(Ѽ+h+2ʇƴ?!PwKF"4ɡ=Vׇx[S 5ե*GfyQ6?dʎGN1L2s*Hi,|C TV^@jV~Ԋj]ȊcWkZXOJ!fy2/Ԋ W:U}@ A)IIBg3@Aw{HA?"ga5rW?CxD~AmRP-t$h Y!jgoRʲ(|?a!}z( 6ha!>$s3 8ӣN Uk'4F+AQN"ǐ%c5*AEF?vE8xe ZGZ8ceCd Fe`9H}jA5}R<]1Qa25iqF:`]r_ t3Ja(Y-)UA K㬺C7 )p\/h͂1O~`;3TܲJ1Y@\Cf'h#3!nn]ČRJ(M!QC < S 48@W;sX]-b^xes5fpVB X4zZT0J6 SPjQ)=gGDٱA5I"HyW <6Y)>k&qcɡhB7TLׂ,7`?nt|^X-bS?H7В딂;<<E̓Y X6+&k` u? _e߸}U jaS7W0|A*z-E&ڊF_>d# 7-rZLIpȄ>\vh5޲("tW'L]D{fޫ!QoXi}.ܹvf4^CCD2}ЁN1pB<:qISl*q7fwctg 8QQnmyL2l ԬQ([ܤGҰp$C=A@9Tt c.rĨpA$tKpip=Kh?{1{T;TWWߣ$ke+rndx@k>3:.&yC=NŽ΋Khh: Va?ԭe$,uڂ#&Pn\^IS4<c M ْwaO!&x? RmwyqL6i(|R(ݶ!UR&8nF5 a=WJeqjS3D/fzSJf(ܠ]%DӘ`Uq<1oc>e m+yJUZ "Cp%i4s=s'K\`;5[-N :>'$HYqZ&#uJSB3C,6p񘔊hD;9ևd ᥄ټtpMe/Z]O7]38ү|N ir[+q+o {\vYi1Hij~MWN Ft(o{Cތx'iv1-B6])Ү0ڂ1$S4x>T#UbMip JFtm^ԡcX-S{ɫg#8r7 PZKTcJ6 a6 Mlz\Diwx{&ZK5w}W UJ*[ o L3Ʀ*m+tZfӑR+׭M߱w6^s5}$9e7sHS5Zeߑg|8rG6ce>!:!xT([jBZ9䟗tǿѵ.a2ԆƫmTQ_frK JA"Դz0 d˔"sڅd53g#F3!Qv a-gӦczXӵB&%ix7B9d<87N"3! T-G;  yF+eUf|:Y:SrY ixiFǡUB[Z>nٓ$.bi}kZv_L%=l{ywTO-zՓ :WVDZ{<^KP0YlP9^{J Kopꒉ7jcP}?]rtoG9tU2sF\x)6cדB QV,_W+,n)L=Y^0X Ax:8tj"jqvfc]kXo` K4:r*аN¾6)"(nK41Z-\ FwC,g' pHߍ+w`K{/]o*o'd))`=zkcà TtO${I EEW;!wf9JD'f< H NHD F_s fadb#JZ_=sD?&Daz:'.xߎfp/3e8?Ӝ3sNYX&'*&"v an2'(_RIlnJ%᮵oICRS2y d̿;HP/f'A뢿[.i;LVs :KaNN: 9,ݗ`cddg&Ĵ棣dg?%| I*!ٻa"BAK칣OZW֙.2y q.o;eW.0ꃰ`,,&^'q;@֡UE㝓$fhZ.˦o6q&'{csW.ùl lHHuȲ?xoUi! B&= W"ۡ1+C ЏaJ [XdMWC8o gNL\;_QSC7 t[fTwM >t2<{'2o_dXBXJ:lpIOwDn(=Kz P cŷRgRb037(hB fEH]f$4_vS=^D@kdWG)m3%Sr R#ocD3Պ w6VY9;]<+l8'Hh-)MɥOx%M?[4{?dҚ+JFST$S~'chjMGఝ o)]E8FP63Aس%4OҴLtiQ(NqQ*bS>L 6!eH '#!}+=0< $uFîMzO(?׊4H|6G1ܸI[gh`/{/ ljuHKYf$K|*ۮ -<`""p(D/vϹ ޸| pT{ZNHǛ ٮيX7oA8 mEI2a aq6N>DŽh'E 61;aFI|.|ΜbuNYzgȡao.O TnP2 AJ o[j#s(QF |?p9sF8Op&1yř6(yХ%xJւViRH"VԾ "mHI0!QP#hĪѻH`_5W-J,ȻJ<\iqC;yă6wbzHf9ZRkhi`||8ȃ \5v ~X%}M8X+_=QYлuQu#jC[3c뮻AFRE[Ͻ,C_7v;uH,$gaop{EydS"w U*Anbd{50 b->jvH43_?So-dMQEF=_:#'A=Ujn-I<&H7e(X>/?nH\8>6{\MW$@&d1 Vm H95aO& ̠zl\ d`jBBDS$`iQͼ^D>_WAУqTFy-J")z9rq(OV7`p-JE%ʱ+-d/%30Ϸ=~s cQ؆gч8f`%#-#O!i4(\75b;cM>{zֹ { E-:/\O"` ifg5N4#$. [HL"kase ʋ`rUۮXB$hoN&u-oa@0?3ɘHv7)NEBMNN{k /t~iNs`+.F]EQf<}u9t.㫘zGC6]/jwqz_eJҶP`Hdb&?⢸sj RnXWPBPХ+ fQ3j=Mmw")YBg%G܉Z-UȨ֧p:- 摓 D56"/ohϏL9z/O٤ V/&|=t1 \*_w/}o79sv8}:8,8zsxb$1G&g<[n^}~2oj[Pz gA@&nXH@sm6^]n=B]1/HI}TpKPnoYU x/J%TP_3ՅWG,c*\oW,Cw=F帉{bՕ;re,.e Nvٞ 7&>?L0Fu\y_'?Q~,!n5+f?møŒ=ˑ "0n5N@ Nߎ< ;%6ǝ:ZhE]ncp˰]m B7&Kqߎ Ⱦm!$'uHI [ 6Iל/ Ȼl-06״_Z.d!,ЛV,l"ݛWO%$e^[mDGAPL/f=vњR!}ˢO⼷b,}ۉYW` NaH `CBOU:#y;=YׅږZMA3[ q@O8ͅu^0!Zyn{ $e ~uaPKswnLrZ=5 gKY}|( ќ/3\ ؉gXg<1l=9y :n~7@I`_ehȰNfS8n9ڠ+{K~r81MǚJ+2[{ädsY?!uš91hK;+)0' iz&s ΟݟWB-Җ4!F=m?۝%8 F%L0U|Lp:Frݕfo+yGmWL燗t4 RI;ǽLJXj@Š Sm2{2mxʐJ1${7UD=!ݪnLE3#nUxv< xbԓώV||*/ .{wE9nU}f!^L,ȓjB1yIe?9>:.c Cd9]!˴C 5F*E-~>v":ՄV,:?̠gRS/ ψBxi-v`Ri=W]* 5{“_(Ec3PIH|}O`zUE溘2۴" lsL5:=x>|MP ASRgj Q~~S3rFs/! 3FXs6+& D?0#Ht0@ !e RaR/|5 xMB`7*p@& ś^,Mꩂf6;ccV[q>yx,zgqjLsoeܺ{xsP#*H%+ a!60\(qHT(A< RoUۙ0rlP`'SӋj?4Ұ_Rq_e&\Z$y%NfE[ Mgf9| ǩԑɏe'O?x[%]ttJNѨ{xpr.\ժbB3huu|k6sĨZXЀnQ`S=9xˮ Nw&m)) i۩` ;Ӽmdkse9_P U΍14i8v m~9w `dE D!Zڅuc6ŀz%<#~{&rnUv:)K ܯ|Pԅ 7g/i8=Oṱ ƝGab{L]w\RpHw<-~^7=//t1}!NcIjc%ȋ\(U~?R MVm_c><Dv?h*0V}xQDY[u q"(Qʍ~f¶U{5w$>s** LVoϨ23ZْR7Xr#Z`3291RsK=h)GH8)a{9UvH^H; ALxDw8s&,%v> 젬 Vn7&CK}+@^: "_5;a4@@SAEу&5YK~&/ôގoYYy2 Nj8,E`h6_xu^[h1ӳ|(fX B_.l8QnTI6MhoQwSAOvLQ*|<ʯoOs r8;m +glo6SaQ5|cW5gk0< EBHx@+%/}]Z}7rR-OU4gea"q?@1:P2s^–d8^(@97s+e+̐'ci= u eLԿRL J%Vִ׹vhQE9J'%-fˌ B+-& %;U>.  Z]|_o ' =4)]g߸xUN}#A[bYnj~@$O|?$T;eBkdC]Ue*#N l25Ԟ1y% XJ>O!<$_H rj$ cPsdS62 icBnMȝVudoFsy7Q/-'eLJ5tUitFE+Xw帵PS#}OA2<h- b|:};aQigIFN}_y'ͫwΦƫ7[N?ukap%VQn72'N/Jc22ʵ<:p0NY *V"fJz56$;n^{p|~Fٲq{Yf-<zU/Үr. 0]E>.|̝~?y[6} Z&;FnQ7 +ЍJarz}rZ3rJBQT"=(^f'$z+}\m rnX<o `}n5Q-u3k<ޤ|HJw (V`0bI5"JCn9~5&.YVs*Wkl z!"/>_s@hN#5cN g$a!cǨ8دc<=r8~-a.ΣRkψsÛSoUbQIG2_`bnnk5'@ߨ.ïW5pz&>'׎xHeg&u>Ī!r M@CΆK#GNwxj=\ ŝWN#ҙ+H=8M@A]C}/F~+qK~,6oOu C!*4_3VJ hWa=.jҋ  qժfD'z1r&8ŞZ"holuj|\%shu,ϋu IDPf, 'ǰ.黢շ}To8sN,M$0XTHrs.ÏkN`* 8ͩ<8 kL${A_RsgxIsT ijo6hKH0rcgBq4[ޝ1O /]٧.xϜ՝-ժr}ST2""=v^aU/nI–&p۴Eu5rt?}2k̔^lZ[!'|tIr t {i0܍}?FLLFXoY-mS5+w%n`q&/W[9E$a2L33 ̊w p5퇃4[G{x0[ہQ kv? (4Q\$EorDa? c RՊЁ5Ԋ!|!H)ưtb`A[= 4{f3g#H[_P(p|yHlqN//{Tl֦qNowz$Rd% y^C~XrO"-*ޑ+t/c6*96!~Ïp 4=@.WS=!(2Ѭe:@␥D!TGݙ#%U7_WyShrag%rب/~wjYw6x݌D%XoUp~_+XB}r"S"5SV cZ 2S/cp׌&)*FhА9jxTXO$7,We+#a~l"N h:W̸'PY׋|YenmUډ͐~Ku7]L0$Hh.'o"R:3B16'uƿ(x |nȈx.@.7$bz#G$֊Y` !4e8W6zU-Jھ3:%@`Tם g|Dzg^P+_Z |7ߵp~Vד6HCLPD!&,Fe:KC3=,\HnXpiCrX׊$u=q!/ǫC\?174=rǺpÌA0C'I5GBGV>vލaXt?Hޭ{B%Lj#zo1,w jZ3&ClF,bİH''1T !i@fsF~"غ]>0p./!$c1C{XuorqHbS}\]QGA ÊΪWYLr.*Caz-INF/"ISPB9jº3BQ$i\OWW΍EY'P$S4,7ѹ{ڞ/.!-Xkfj viZWlnIR7\"VtM'߸i\EHFc byN~'J?B=5ZO7]~}Ki T'˹ڳ8;~Wg.̬YI,EAԔe1]f .V_VaFl 5U9Q#If57t|*wNDkqqb7v2&K?=ҥfV̽꼻O(Plf"6&bCw>;hٚ<$mZZ~ꚤvRe`OIv"L Ń{N+o ƠXZ5ȹN-[~]CpIq@njWH_ FU D0JSy,xGeȆA\:٦$tTﷲ7E3Qt͈ Kݍ1J`J1rqOL pq34)7:C7뚶<^Z@!Jo3&xV,zZ4uwǩХ1jh /o<ƦVr4D{MfǛ +I7ʖ 2jXOlf[Ŕ9>ShpTg #knbueTV%Ee<;4f, :֑@ja=r0ŀ׼VXcTQ03(*jPQDPz+ѧE`W<w &1;ޣ^IPZa sʜጆUjK:Y;DOusS7e9lq_XMF}E]ۢaUQ%:H`ThuE2vLw) FK-ӹq}`41Xz͇ {)Ŏt,;bM:ߒ ܴk)y݉E%IUXp q"w¯׻s:O#.׏P*:B\ޫ)'o#oq`@BڴG{;y Ϙ鬂I "ۇ4r!Ŕg5Uuim 7S1?a%.;)>ߍS tZyM? ̏I + Y诼=6z士Uwm3=IYAANXv&%ȵc8'xå/͹1oczZ\ MҀ]Ќ#kHkJ`ps@{\T ,:#wi=bmIB|{[;{LU6Fd+f*4!#Cuڇ[@ .t'ӫ]@Ϲ}~.+86p10_>=pDK3cF>ڏgc<:LJY/-Q@-N$cȷI,"jP3v‘2i4ͭ)B2Xy=B=XebnN 랠'+O _3[ tcQhmHh^pzc X`WR/:{a5]2>p7|?q՚`뙐sHYW CމTPǏ@ b˭=%zD΁ m:I-Kj?5^-s<1:%b3 endstream endobj 17 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr "colrjjp2cOQ/" " R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ t  #: @>@D >ր    endstream endobj 18 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr:colrujp2cOQ/::R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ  t ! @@: h@ %|"@|"Tmjʚ \    endstream endobj 19 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrcolrwjp2cOQ/R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴt : @ /|!: QB2     endstream endobj 20 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrcolrsjp2cOQ/R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴt @ )@ L|!: ̈́`y0    endstream endobj 21 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr(colrdjp2cOQ/((R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ t   |"]    endstream endobj 22 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrcolrxjp2cOQ/R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴt @ $ :@>:[t  J0%B  endstream endobj 23 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr&colrijp2cOQ/&&R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ  t ! : :  |"]    endstream endobj 24 0 obj <>stream h2T0P0"SCsCsS#C#= endstream endobj 25 0 obj <>/ProcSet[/PDF/Text/ImageB/ImageC]/XObject<>>>/Rotate 0/Type/Page>> endobj 26 0 obj <>stream q 0.216 0.216 0.216 rg 595.1999969 0 0 840.9600067 0 0 cm /Im0 Do Q q 20.1600037 0 0 18.2400055 332.6399994 781.9199982 cm /Im1 Do Q q 12.4799957 0 0 17.2799988 499.6799927 782.8800049 cm /Im2 Do Q q 12.4799957 0 0 18.2400055 538.0800018 781.9199982 cm /Im3 Do Q q 20.1600037 0 0 35.5200043 0.4799957 735.8399963 cm /Im4 Do Q q 11.5200043 0 0 18.2400055 1.4400024 689.7599945 cm /Im5 Do Q q 12.9600067 0 0 12.4799957 0 413.2799988 cm /Im6 Do Q q 10.0800018 0 0 18.2400055 0 374.8800049 cm /Im7 Do Q q 9.1199951 0 0 14.3999939 0 98.3999939 cm /Im8 Do Q q 12 0 0 43.6799927 0 0 cm /Im9 Do Q BT /Suspect <>BDC 0.294 0.294 0.29 rg /T1_0 1 Tf -0.035 Tc 3 Tr 10.1789 0 0 10.5 62.36 754.8 Tm (406 )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 9.87 0 0 7.9001 274.5 754.8 Tm (J. )Tj 8.8554 0 0 8.1 286.04 754.8 Tm (BRITTON )Tj 0.0215 Tc 8.1 0 0 8.1 62.39 731.29 Tm (relation )Tj 0.0064 Tc 3.547 0 Td (avec )Tj -0.035 Tc 7.9307 0 0 8.1 108.91 731.29 Tm (Ia )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0101 Tc 8.1 0 0 8.1 117.61 731.29 Tm (presence )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 8.2974 0 0 8.1 149.2 731.29 Tm (d'une )Tj 0.0219 Tc 8.1 0 0 8.1 170.86 731.29 Tm (micro-angiopathie, )Tj 0.0249 Tc 8.288 0 Td (en )Tj 0.0278 Tc 1.372 0 Td (mesurant )Tj 0.0064 Tc 4.201 0 Td (le )Tj 0.05 Tc 8.4409 0 0 8.1 62.36 722.17 Tm (Kco )Tj 0.0291 Tc 8.1 0 0 8.1 79.6 722.17 Tm (chez )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0263 Tc 8.1 0 0 8.1 97.3876 722.17 Tm (20 )Tj EMC ET BT /T1_0 1 Tf 0.0232 Tc 8.1 0 0 8.1 108.4846 722.17 Tm (patients )Tj 0.0299 Tc 3.604 0 Td (atteints )Tj 0.05 Tc 8.2927 0 0 8.1 165.04 722.17 Tm (de )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0346 Tc 8.1 0 0 8.1 175.6 722.17 Tm (diabete )Tj EMC /Suspect <>BDC 0.0275 Tc 3.374 0 Td (sucre )Tj EMC ET BT /T1_0 1 Tf 0.0245 Tc 8.1 0 0 8.1 223.6087 722.17 Tm (insulino-dependant )Tj 0.0235 Tc -19.972 -1.067 Td (complique )Tj 0.05 Tc 8.4273 0 0 8.1 100.81 713.53 Tm (par )Tj 0.0492 Tc 8.1 0 0 8.1 115.68 713.53 Tm (une )Tj 0.0261 Tc 1.954 0 Td (retinopathie, )Tj 0.05 Tc 8.3173 0 0 8.1 177.99 713.53 Tm (et )Tj 0.0291 Tc 8.1 0 0 8.1 187.6 713.53 Tm (chez )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0263 Tc 8.1 0 0 8.1 206.3515 713.53 Tm (20 )Tj EMC ET BT /T1_0 1 Tf 0.0232 Tc 8.1 0 0 8.1 217.9345 713.53 Tm (patients )Tj 0.0273 Tc 3.719 0 Td (sans )Tj 0.0204 Tc 2.264 0 Td (retino\255)Tj 0.0174 Tc -25.242 -1.126 Td (pathie. )Tj -0.0038 Tc 3.431 0 Td (Les )Tj 0.0316 Tc 1.962 0 Td (patients )Tj 0.05 Tc 8.138 0 0 8.1 136.72 704.41 Tm (ont )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.021 Tc 8.1 0 0 8.1 152.55 704.41 Tm (ete )Tj EMC /Suspect <>BDC /C0_0 1 Tf 0 Tc 2.8115 0 0 6.24 167.04 704.41 Tm <00700061006900720074007E00530020>Tj EMC ET BT /T1_0 1 Tf 0.0199 Tc 8.1 0 0 8.1 191.51 704.41 Tm (raisonnabJement )Tj 0.05 Tc 8.2675 0 0 8.1 252.49 704.41 Tm (pour )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0022 Tc 8.1 0 0 8.1 273.08 704.41 Tm (J'age )Tj EMC ET BT /T1_0 1 Tf 0.016 Tc 8.1 0 0 8.1 61.832 695.7592 Tm (\(moyenne )Tj -0.035 Tc 8.0868 0 0 8.1 97.89 695.76 Tm (47 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 7.531 0 0 8.1 108.4 695.76 Tm (a.ns )Tj EMC ET BT /T1_0 1 Tf 0.0442 Tc 8.1 0 0 8.1 122.32 695.76 Tm (dans )Tj -0.035 Tc 7.8836 0 0 8.1 141.05 695.76 Tm (le )Tj 0.0403 Tc 8.1 0 0 8.1 149.21 695.76 Tm (groupe )Tj 0.0261 Tc 3.258 0 Td (avec )Tj 0.0212 Tc 2.26 0 Td (retinopathie, )Tj -0.035 Tc 7.5814 0 0 8.1 239.49 695.76 Tm (41 )Tj 0.021 Tc 8.1 0 0 8.1 250.48 695.76 Tm (ans )Tj 0.0442 Tc 1.719 0 Td (dans )Tj 0.0064 Tc 2.312 0 Td (le )Tj 0.0285 Tc -27.318 -1.125 Td (groupe )Tj 0.0273 Tc 3.373 0 Td (sans )Tj 0.0213 Tc 2.264 0 Td (retinopatbie\), )Tj 0.0049 Tc 6.162 0 Td (mais )Tj 0.0101 Tc 2.363 0 Td (ceux )Tj 0.0215 Tc 2.43 0 Td (atteints )Tj 0.0493 Tc 3.556 0 Td (d'une )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0041 Tc 8.1 0 0 8.1 247.6855 686.6475 Tm (rcitinopathie )Tj EMC ET BT /T1_0 1 Tf 0.025 Tc 8.1 0 0 8.1 61.8553 677.9967 Tm (avaient )Tj 0.0195 Tc 3.447 0 Td (une )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0253 Tc 8.1 0 0 8.1 104.5747 677.9967 Tm (duree )Tj EMC ET BT /T1_0 1 Tf 0.0223 Tc 8.1 0 0 8.1 126.712 677.9967 Tm (moyenne )Tj 0.05 Tc 8.2998 0 0 8.1 160.24 678 Tm (du )Tj 0.0247 Tc 8.1 0 0 8.1 172.24 678 Tm (diabete )Tj 0.0205 Tc 3.448 0 Td (plus )Tj 0.0279 Tc 2.064 0 Td (longue )Tj -0.0052 Tc 3.198 0 Td (\(23 )Tj 0.05 Tc 8.1073 0 0 8.1 256.72 678 Tm (ans )Tj ET BT /Suspect <>BDC /T1_1 1 Tf -0.035 Tc 6.5063 0 0 7.7 271.53 678 Tm (vs )Tj EMC ET BT /T1_0 1 Tf 7.5202 0 0 8.1 281.5 678 Tm (13 )Tj -0.0019 Tc 8.1 0 0 8.1 61.84 668.89 Tm (ans\). )Tj 0.0259 Tc 2.257 0 Td (Le )Tj -0.0042 Tc 1.239 0 Td (coefficient )Tj 0.05 Tc 8.2927 0 0 8.1 126.16 668.89 Tm (de )Tj 0.0217 Tc 8.1 0 0 8.1 136.3 668.89 Tm (transfer! )Tj 0.05 Tc 8.2998 0 0 8.1 166.96 668.89 Tm (du )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 8.1333 0 0 8.1 178 668.89 Tm (CO )Tj EMC /Suspect <>BDC 0.0429 Tc 8.1 0 0 8.1 191.41 668.89 Tm (s'avera )Tj EMC ET BT /T1_0 1 Tf 0.0273 Tc 8.1 0 0 8.1 217.9132 668.89 Tm (normal )Tj 0.0442 Tc 3.191 0 Td (dans )Tj -0.0135 Tc 2.253 0 Td (les )Tj 0.0269 Tc 1.243 0 Td (deux )Tj 0.0222 Tc 5.038 7.704 Td (groupes, )Tj 0.0471 Tc 3.788 0 Td (sans )Tj 0.204 g 0.0409 Tc 2.019 0 Td (aucune )Tj 0.294 0.294 0.29 rg -0.001 Tc 3.259 0 Td (difference )Tj 0.0056 Tc 4.263 0 Td (significative )Tj 0.0393 Tc 5.217 0 Td (entre )Tj 0.0348 Tc 2.37 0 Td (eux. )Tj 0.0259 Tc 2.08 0 Td (Le )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0444 Tc 8.1 0 0 8.1 509.7319 731.2924 Tm (VEMS )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 8.3173 0 0 8.1 535.11 731.29 Tm (et )Tj 0.002 Tc 8.1 0 0 8.1 312.69 722.65 Tm (!a )Tj 0.0269 Tc 1.031 0 Td (capacite )Tj 0.0081 Tc 3.741 0 Td (vitale )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0051 Tc 8.1 0 0 8.1 372.3951 722.65 Tm (forcee )Tj EMC ET BT /T1_0 1 Tf 0.0457 Tc 8.1 0 0 8.1 394.9374 722.65 Tm (sont )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0118 Tc 8.1 0 0 8.1 411.7773 722.65 Tm (infcirieurs )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 8.1466 0 0 8.1 445.84 722.65 Tm (aux )Tj 0.0238 Tc 8.1 0 0 8.1 461.26 722.65 Tm (valeurs )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0236 Tc 8.1 0 0 8.1 488.1682 722.65 Tm (predites )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 8.2717 0 0 8.1 517.36 722.65 Tm (dans )Tj -0.035 Tc 7.8836 0 0 8.1 536.09 722.65 Tm (le )Tj 0.0403 Tc 8.1 0 0 8.1 312.41 713.53 Tm (groupe )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0303 Tc 8.1 0 0 8.1 339.8285 713.53 Tm (retinopathique )Tj EMC ET BT /T1_0 1 Tf -0.0266 Tc 8.1 0 0 8.1 392.4461 713.53 Tm ([92 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.035 Tc 6.3602 0 0 6.7 406.01 713.53 Tm (\(SEM )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 8.189 0 0 8.1 423.27 713.53 Tm (3.6%\) )Tj 8.9571 0 0 8.1 446.79 713.53 Tm (et )Tj -0.035 Tc 7.6588 0 0 8.1 456.39 713.53 Tm (91 )Tj 0.05 Tc 8.3377 0 0 8.1 467.42 713.53 Tm (\(4%\) )Tj 0.016 Tc 8.1 0 0 8.1 488.63 713.53 Tm (respectivement, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0461 Tc 8.1 0 0 8.1 312.9734 704.4094 Tm (p<0.05\)], )Tj EMC ET BT /T1_0 1 Tf 0.0049 Tc 8.1 0 0 8.1 348.9455 704.4094 Tm (mais )Tj -0.035 Tc 7.9585 0 0 8.1 367.67 704.41 Tm (ne )Tj 0.0457 Tc 8.1 0 0 8.1 377.65 704.41 Tm (sont )Tj 0.02 Tc 2.148 0 Td (pas )Tj 0.0127 Tc 1.644 0 Td (significativement )Tj 0.0168 Tc 7.411 0 Td (differents )Tj 0.0496 Tc (des )Tj 0.0139 Tc 6.052 0 Td (valeurs )Tj 0.022 Tc -25.3 -1.068 Td (pridites )Tj 0.05 Tc 8.2717 0 0 8.1 339.76 695.76 Tm (dans )Tj -0.035 Tc 7.8836 0 0 8.1 358.01 695.76 Tm (le )Tj 0.0285 Tc 8.1 0 0 8.1 365.69 695.76 Tm (groupe )Tj 0.0273 Tc 3.136 0 Td (sans )Tj 0.0212 Tc 2.086 0 Td (retinopathie. )Tj 0.0419 Tc 5.562 0 Td (Cette )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 8.1938 0 0 8.1 473.19 695.76 Tm (etude )Tj EMC ET BT /T1_0 1 Tf 0.0464 Tc 8.1 0 0 8.1 493.84 695.76 Tm (demontre )Tj 0.05 Tc 8.142 0 0 8.1 528.88 695.76 Tm (que )Tj -0.035 Tc 7.9307 0 0 8.1 312.91 686.65 Tm (Ia )Tj 0.021 Tc 8.1 0 0 8.1 321.51 686.65 Tm (fooction )Tj 0.0288 Tc 3.864 0 Td (pulmonaire )Tj 0.048 Tc 5.084 0 Td (est )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0307 Tc 8.1 0 0 8.1 406.0011 686.65 Tm (oormale )Tj EMC ET BT /T1_0 1 Tf 0.0442 Tc 8.1 0 0 8.1 436.7244 686.65 Tm (dans )Tj 0.0064 Tc 2.253 0 Td (le )Tj 0.0445 Tc 1.006 0 Td (diabete )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0275 Tc 8.1 0 0 8.1 490.9296 686.65 Tm (sucre )Tj EMC ET BT /T1_0 1 Tf 0.0246 Tc 8.1 0 0 8.1 511.131 686.65 Tm (insulino\255)Tj 0.0372 Tc -24.535 -1.068 Td (dependant, )Tj 0.05 Tc 8.3173 0 0 8.1 352.23 678 Tm (et )Tj 0.0283 Tc 8.1 0 0 8.1 360.88 678 Tm (qu'il )Tj 0.0339 Tc 2.142 0 Td (n'y )Tj 0 Tc 1.532 0 Td (a )Tj 0.009 Tc 0.781 0 Td (pas, )Tj 0.05 Tc 8.3843 0 0 8.1 411.75 678 Tm (en )Tj 0.0294 Tc 8.1 0 0 8.1 422.32 678 Tm (outre, )Tj 0.0141 Tc 2.726 0 Td (de )Tj 0.0299 Tc 1.253 0 Td (relation )Tj 0.05 Tc 8.1609 0 0 8.1 482.79 678 Tm (entre )Tj -0.035 Tc 7.9707 0 0 8.1 502.97 678 Tm (les )Tj 0.0315 Tc 8.1 0 0 8.1 513.58 678 Tm (troubles )Tj 0.05 Tc 8.2998 0 0 8.1 312.4 669.36 Tm (du )Tj 0.0287 Tc 8.1 0 0 8.1 324.46 669.36 Tm (transfert )Tj 0.0109 Tc 3.843 0 Td (et )Tj -0.035 Tc 7.9307 0 0 8.1 364.75 669.36 Tm (Ia )Tj 0.0185 Tc 8.1 0 0 8.1 373.45 669.36 Tm (presence )Tj 0.05 Tc 8.2974 0 0 8.1 405.04 669.36 Tm (d'une )Tj 0.0254 Tc 8.1 0 0 8.1 426.7 669.36 Tm (micro-angiopathie. )Tj ET endstream endobj 27 0 obj <>stream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endstr endstream endobj 28 0 obj <>stream Hd͊zy8 >sRhF^#y QG#Oç==o/ϧ;c_mӷKv|~_oo~y>}~W=|z>{O݇q~?>Ï?o+~ߒ~;%zΏx߽w;>lp?(O?{wٸ^ PZUuTGu^5P5FjFDMԤU PjVjUmFmک]uPuNNE]E5|| _#_k55|| _#_k55|| _#_k55|| _#_k5Z||-_+_kZ||-_+_kZ||-_+_kZ||-_+_ku:||_'_uu:||_'_uu:||_'_uu:||_'_uz||=_/_z||=_/_z||=_/_z||=_/_ || ߀o77 || ߀o77 || ߀o77 || ߀o77 KG#(~? ?G#(~? ?G#(~? ?G#(~? ?z $߄o77MM&|| $߄o77MM&|| $߄o77MM&|| $߄o77MM&||3,ߌo77f||3,ߌo77f||3,ߌo77f||3,ߌo77f|| "߂oȷ[--|| "߂oȷ[--|| "߂oȷ[--|| "߂oȷ[--||+*ߊoŷʷ[V||+*ߊoŷʷ[V||+*ߊoŷʷ[V||+*ߊoŷʷ[V|| &߆o÷ɷmm6|| &߆o÷ɷmm6|| &߆o÷ɷmm6|| &߆o÷ɷmm6|ۯ\t;]~~߅ww;]~~߅ww;]~~߅ww;]~~߅w߁w;;|C߁w;;|C߁w;;|C߁w;;|C߉w;;NN|'S߉w;;NN|'S߉w;;NN|'S߉w;;NN|'S ߅w]..|K ߅w]..|K ߅w]..|K ߅w]..|?|x>/Filter/JBIG2Decode/Height 1752/ImageMask true/Length 6004/Name/X/Subtype/Image/Type/XObject/Width 1240>>stream AFEPI^PHF̍ R(^RJ';HLmV"Vq .;g[LL*_ \/^|'tLT!Nƕ< .. 4Q>{IYj d`R#l#'iQ1j@aDz_9?f[MvS0 ])̕أÃ[#6/ˆ n8QV(3V҈ӒKec?vΜRP/fBwYѰ{U'Ҽ ){:i矽^b owpּcB%di1sdLk!k'+Qݤ%&{I!\"d-IE,a$ʟ~ _m-H<8&elCX烮:Ň|*ҧ,.{w!_;?-&s%/5Q77#$*9\^l.I&SHrk oߊ뫍jcK{CIן~E;?SkoTwzU:yj5qSVyvs"h >&{J`TiH|"6Kɘӗd~ѣ_N~/'-s.xyuO6G~Rm +1xr$9} ȾP\hoA3c^pedU-UK8G59刬PƄ*?-4#F' {ū!ZΑxI+ \Z2Tט'麘x[r6 LadГ6mNf΃bo%6/pKvҗabX`,pv!o~C@ `y8(0 9cg`0=60I!V9܌{5vGT!Fz;;QubnN,{ws7s"3c*Ħ>9Hg'ׇV)Z ̥2 QP3fp˼l!!s3}U=.42&& ԕg_J8%VcRIģF (VJYjX2@ܞGǕ"X#M(E\uZl|=S,^,Z-Lf{[cq랧"5+ *>j㚆"E^gG Fж3@zv|xF^l*4HNpm$15HC3Xsl%ox\M؀3q7m*+8RqI߾bk,P "(5UXHc$=sėk7XlZg :Z{PvKܫMx{Zc;^VW)s-Vר7Kj*܆,E3 ͱpcL jji>p{P  #\<8>;!D/:F\öQk&sj?ÔIyKt9Yi 87b\씼E~% nm}MI1#n5$)xB62&#+5GZ$CF/7BuJ=0pg LJ{*~ܼCh <٨!F/\{^H-]dp8as%f<<,kL?!g4~2rMcN!w⯭''F:oK,_ۋS( r2B\N_\1Ƕ.>#5rVѓ)Xe߁01ԭn91h8Dx5JvT8)U-bUR؎YM@(VZe DU9rUhT1]&FD58֡!ywBrz vc\"Қ-^{#[9mCY8п m oz"(/ʈ.q#mcKNj%Ul㗗Z?nڦ{=KHz{4I}4H>2WWqx$W-[aX[ }Zh)1l}S@G&4"i2 _WJ8JsG[ 'e>NX%d%9SWu'S9e'U=_Ja*ў9qdb=_ΘIX.j^^^n_+`!R7{8v `>Fh *)nO?" GhpV1Օgsԥi FfjW<)@n*s8a3v#,\ɂّl )*iH: {H6̀c7)NjUQ2j H)UOU$xzdhjetVYp^!${r .ag# ~ysL+F@F5U?N(vYÂ:19Ԛ q 9P_(4В<)b֜r`;_"@\N+6VNוmCxii[=IUjWmJqntEaw\IMtbs|}V-0HESGoOT,(x/up>ufd:U#-]顡pP0"h EqY|\6~0J AVگM"7)`y:&h"'أ‡~_"\rh2IC&W1.`gT9=5{2E-ʿAee`>B _nFc^U.) N8!S޷;ֻt{~/,^terr$aZJ % }#8eR^vYD0yDt8 .N X$#7z$fS+Y]^ W(7s29QD<dI.}F9۹,`S*rE' h=F="'؎xX_rH]Rw1ڢ1F{0qޜA3%mO,RyQZP,ҁudpMu6 ;󝙉sO]νhcĴs4FiXz!*oe9B4" +ō۷e4i2bL>k!VǬYƈm]\0f//6Uq¶YMՂM9o[Z,10/s{wY ;Fak4n.V~0m.~E7b;eԁ{k.Y]b(xfxHF3GhѰ$u˪o8v=8=D)̋-e)ze.RZlbHvЌ nv(B=B5G5-n;H~^\< 0F Alu ӔP*!egu.υ}=jIxQzu}LMz٦&vNdRCAЅt<X9g\3m\Sn `Yv4"@Q0`+ؖqW Q4l0p]?b k~;⨟%Qy,rY#xgK/^c*b=2ػU[p;' M1]`+t01!5:|@:H΄x&+&j ]MSwA#khK>OA|d-œ AFBzz; j${C9=KE6+EtI(̈́/mkVw>lfEeWPVSyX"GTmE.Zڮ^t֩uЯQLߨx?P9bP O&@2U-˜샅˕A̯G"[wi 5KZ];`B=VCaC|7\a7E @ɗupiѦkiCbBt@,[ ˃9:g'R9yzltbn+iYݗz2M]9+5/{y Oﻰ!y`~нq1 Ȅ<_*S<@7%e ΰ(FOáfGXۻo>s&=xRN 9^ĩfuǫ)ytm,>oWLN_랰;wOWw ӣo6søAP?!66G \}qT_}g4|#䰫[0Li{I*8lŋ$⍷lCu]`!ClJjT% .9Jɖ; >=-Lp=yt-ߍqk6GLVij%8agBQI(q2Y7V+K6q; 赀tk Z0bm%*UL1!ݑwnjh$ãlbyXCVW*Qگ2M.I,u;!DG;`xC?W'F-7lV6[L) #U7C\ smv9 oI$JEn!'x:mPgCDB>V@'sR߶h=A#z< d>g|TyPMS1qTpr| yKcm^9M-l0W}d_Mۏ̸@撿f Vwx}uy 0k鰋`hQu. ah_T<XͩJtrAÈHofabF P9z1W贬`lQ"MYzK$RuNԲQڋ6{IP2$"{Fl kg Zf8{W2#$F(ʧ-&UQY,m^ξG0(o@Bdy6!h6O5Km~z[.anv5Kfu#[czc#KX\C}KIO^H VEp177.+i^S4Gi(epa^MT endstream endobj 30 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr&*colrrjp2cOQ/*&*&R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ[}CPV" @: Š@ |": >    endstream endobj 31 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr$colrjjp2cOQ/$$R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ t ڀ @: @ :|!    endstream endobj 32 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr&colrzjp2cOQ/&&R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ t ! !@ @ !:|" :(nl   endstream endobj 33 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrJ*colrjp2cOQ/*J*JR \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ1I2cD*C" '|!:@ * :47Ȧ'Z pXπ   endstream endobj 34 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr&colrnjp2cOQ/&&R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ t  :@ : ܀ :(tdC   endstream endobj 35 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrcolrxjp2cOQ/R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴt!  2@@ ) :>   5 X    endstream endobj 36 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr&colrbjp2cOQ/&&R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHP]$B@HHPHHPHHPHHPHHPϴ t  @:@ |!     endstream endobj 37 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrcolrajp2cOQ/R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴt!  :@ !    endstream endobj 38 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr[colrmjp2cOQ/[[R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ #t "  &:(بk|#z    endstream endobj 39 0 obj <>stream h\j0EeɢH~("؋6`Pp#%#)P+]H{@EX { Evcp8T_P($ pm \w!ACLJ)Lɯw^*6po?x&${TǼ!F~I0"Pĵb8\TWzYf~JHE`ޒu_^^U->UFnj+2,[Q&󈓻Zⴒ38<8I1`0{+ endstream endobj 40 0 obj <>stream h޼RMk0 +JaBM6acX'$@ii0+ j542;3`ځ(. ւ-G @U a"~;;ŐMeҼe&?x&U;&})jEV,!V KNӄ܅U/1ȓiO?3(Cg .=(g`R& endstream endobj 41 0 obj <>stream h23W0P0P07T0T4U ($敄$QER+JS+LC* RKJA%vv@c]KsAvv<7! endstream endobj 42 0 obj <>stream 2012-10-24T10:36:46+01:00 2012-09-17T11:43:58+01:00 2012-10-24T10:36:46+01:00 Canon iR-ADV C2020L PDF application/pdf uuid:dad6b821-a7b6-4e7c-a9bd-e5cd72729cf4 uuid:65c44b63-f805-4c05-a15d-153f96a6192b Adobe Acrobat 10.14 Paper Capture Plug-in endstream endobj 43 0 obj <>stream h27P0Pw/+Q0L)67 )BHDT$ endstream endobj 44 0 obj <>stream hL @_J3". W]BDk 2|Z9ZBn/ IZ"]R_Œ9(GP kQy+& 's|\x 0“O@x$ oA-Wb> n'. endstream endobj 45 0 obj <>/Filter/FlateDecode/ID[<9AFDE652F89FFA44BC72CE157973B37D>]/Info 71 0 R/Length 178/Root 73 0 R/Size 72/Type/XRef/W[1 3 1]>>stream hbb&F' ɸ1<D2' `v fZ0D24EAu& CۍP5ac#S@$ L,6$3Y`vR0bf>tA$`w{, c '0bd0" endstream endobj startxref 116 %%EOF